data_2eod_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eod _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.6 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.696 0.284 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -114.12 117.97 42.88 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 104.85 1.38 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 12.5 t -57.52 135.47 56.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 81.9 m -82.4 -10.41 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -89.91 -69.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.0 p -79.67 4.33 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.8 p 42.76 37.06 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -118.51 160.62 21.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.37 130.85 37.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.98 170.12 16.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 206' ' ' THR . 2.4 t -80.81 127.76 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -46.13 -27.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.12 -35.0 66.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 207' ' ' ILE . 34.7 p -87.41 -50.71 6.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 208' ' ' GLN . 2.9 tp -33.54 -42.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 207' ' ' ILE . 92.7 mm-40 -49.76 -49.58 47.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.1 t -86.24 -45.3 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.484 ' O ' ' N ' ' A' ' 213' ' ' GLN . 11.0 t60 -45.28 -47.22 12.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mt-30 -34.74 -33.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.0 m-85 -78.91 -46.85 17.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mm-40 -63.15 -45.48 91.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.9 t -35.34 120.49 0.62 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.627 0.727 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -50.44 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.69 2.26 . . . . 0.0 112.338 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -43.62 -40.91 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 tp -39.69 127.29 1.49 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.615 0.722 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 141.95 46.56 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.5 m -137.79 138.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -71.18 139.11 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.4 t -67.32 135.28 93.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -20.54 34.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -91.82 0.05 57.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 39.62 52.43 2.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 5.2 p -69.03 -51.53 38.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 159.12 -37.74 0.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.483 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 226' ' ' GLY . 6.9 p -37.03 -33.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 90.99 -94.75 2.0 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.1 p -117.17 147.26 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 231' ' ' ALA . 11.6 p -157.14 131.77 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.63 146.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -58.92 -37.7 77.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.35 2.95 29.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.24 -15.14 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.4 tp -65.17 -44.5 69.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.91 -62.68 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.327 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -61.02 -45.61 96.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -53.59 -48.28 69.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.358 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.1 mt -59.37 -17.34 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 32.8 ttmt -62.41 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 15.7 p-10 -128.2 -45.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.5 m -34.54 -64.98 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.752 0.31 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 30.5 mt-30 -107.81 103.86 51.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.2 Cg_endo -69.72 99.9 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.649 2.233 . . . . 0.0 112.338 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.16 140.7 15.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.4 m -87.21 -22.97 24.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -73.58 -69.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.1 p -77.78 -4.21 45.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 51.36 38.98 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -112.29 179.99 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -115.9 121.89 43.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -137.38 175.02 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.53 154.36 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -62.73 -25.26 68.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -68.47 -17.6 64.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 208' ' ' GLN . 55.5 p -112.38 -42.76 3.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.6 tp -33.73 -33.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 206' ' ' THR . 16.3 mm100 -62.34 -49.95 73.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 t -84.49 -44.5 13.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 213' ' ' GLN . 38.1 t60 -45.02 -50.87 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -33.03 -36.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 210' ' ' HIS . 14.9 m-85 -79.98 -48.3 13.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.5 mt-30 -57.29 -44.28 83.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.9 t -33.74 116.05 0.46 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.67 0.748 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -46.91 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.69 2.26 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -42.91 -25.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.18 132.23 31.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.575 0.702 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 137.45 35.49 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.26 . . . . 0.0 112.34 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.0 m -136.1 140.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.37 132.32 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.56 136.89 96.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.653 0.739 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -32.8 18.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.703 2.269 . . . . 0.0 112.352 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -80.5 -4.15 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 45.05 47.89 9.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 13.4 p -64.93 -49.68 69.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 156.18 -37.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 226' ' ' GLY . 7.5 p -34.34 -37.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.162 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.8 -75.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 81.7 p -136.4 150.58 48.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.403 ' CG1' HD11 ' A' ' 235' ' ' LEU . 8.0 p -157.82 133.76 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.053 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.14 142.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ttt-85 -54.84 -43.94 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.21 6.55 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -113.96 -10.89 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.602 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 8.4 tp -66.41 -44.48 57.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.624 0.726 . . . . 0.0 110.914 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.98 -64.92 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -59.81 -47.79 89.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.439 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -51.09 -50.55 58.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.9 mt -59.92 -15.4 21.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 18.5 ttmt -69.64 -65.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' SER . 51.7 m-20 -123.34 -49.17 1.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.5 t -34.93 -69.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.729 0.3 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 26.7 mm100 -107.65 105.21 55.54 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.606 0.717 . . . . 0.0 110.944 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.1 Cg_endo -69.74 102.69 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.5 t -52.54 145.69 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.9 m -90.09 -26.5 20.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -69.52 -73.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.57 -4.11 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.3 p 54.08 31.3 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -100.88 -176.59 3.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.27 121.91 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.546 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 68.5 m-85 -136.15 152.36 50.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.476 ' CG2' HG21 ' A' ' 206' ' ' THR . 18.9 m -76.0 139.35 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -43.72 -23.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 203' ' ' VAL . 5.7 t70 -72.85 -44.01 61.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 208' ' ' GLN . 66.5 p -84.41 -45.71 12.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 206' ' ' THR . 3.3 tp -34.02 -34.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 206' ' ' THR . 21.7 mt-30 -58.37 -56.88 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.956 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.3 m -75.01 -37.92 61.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.546 ' CE1' ' CE2' ' A' ' 202' ' ' PHE . 36.0 t60 -44.85 -49.21 10.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -34.14 -34.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.9 m-85 -78.88 -47.08 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.5 mm-40 -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.8 t -34.41 109.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.4 Cg_endo -69.85 -50.64 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.273 . . . . 0.0 112.328 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 215' ' ' PRO . 12.7 mmt180 -36.79 -31.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.1 tp -52.23 135.88 40.36 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 138.34 37.74 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.361 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.2 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.89 130.26 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.7 t -61.06 136.69 93.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.659 0.742 . . . . 0.0 110.834 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -29.6 23.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -83.68 -6.89 59.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 46.79 52.0 11.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 6.6 p -68.36 -51.54 43.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 161.2 -35.91 0.4 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.511 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.7 p -39.28 -26.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.143 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.43 -70.05 3.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 59.8 p -147.54 147.55 30.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.473 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 11.8 p -154.23 140.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.4 143.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.83 -39.14 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -81.88 3.22 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -5.95 12.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.598 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.67 -44.51 80.64 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.586 0.708 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.99 -63.45 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.684 2.256 . . . . 0.0 112.3 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.05 -29.07 61.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.46 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.408 ' NE2' ' HB2' ' A' ' 243' ' ' CYS . 15.9 t60 -70.05 -54.87 11.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.11 -14.2 2.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.65 -66.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 24.0 t0 -106.78 -62.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 241' ' ' ASP . 54.9 m -34.44 -66.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.408 ' HB2' ' NE2' ' A' ' 238' ' ' HIS . 1.8 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.768 0.318 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -117.21 115.69 37.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.731 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 109.67 2.37 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.0 t -53.3 123.08 10.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 40.2 m -74.89 4.2 6.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -104.07 -59.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.3 7.73 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 38.8 p 41.46 46.69 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -120.63 155.07 34.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.95 115.07 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -135.8 145.29 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.2 t -47.83 149.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -69.17 -28.97 66.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.61 -36.67 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLN . 69.5 p -82.69 -44.59 15.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.1 tp -33.54 -34.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.6 mt-30 -65.91 -50.4 64.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 75.0 p -73.82 -40.65 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.9 t60 -58.54 -50.14 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 210' ' ' HIS . 8.1 mm-40 -33.95 -36.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 210' ' ' HIS . 32.4 m-85 -70.93 -49.38 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 210' ' ' HIS . 51.6 mt-30 -65.08 -42.84 93.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -33.82 123.72 0.48 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -49.5 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -41.6 -38.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 tp -45.58 134.09 6.16 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.588 0.709 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.13 39.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.8 m -134.53 133.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.76 143.68 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.093 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.29 134.62 89.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -23.31 30.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.09 2.7 53.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 37.97 50.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 9.1 p -67.4 -48.81 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 157.62 -41.86 0.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 226' ' ' GLY . 12.6 p -33.82 -38.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 111.162 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.0 -97.38 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 16.6 p -112.67 146.02 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.526 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 11.3 p -157.54 130.98 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.144 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.49 145.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 232' ' ' ARG . 3.5 tmt_? -62.08 -33.58 74.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.62 -4.28 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -106.05 -8.57 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.622 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.9 tp -68.89 -43.1 25.98 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.625 0.726 . . . . 0.0 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.0 Cg_exo -47.94 -65.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.377 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.33 -33.72 71.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.89 -51.85 62.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 58.4 mt -57.43 -18.85 20.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -63.16 -66.71 0.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.4 m-20 -125.76 -46.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.1 m -35.02 -65.35 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.763 0.316 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 21.9 mm-40 -112.59 103.31 55.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.634 0.73 . . . . 0.0 110.944 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.1 Cg_endo -69.72 105.77 1.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.343 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.4 t -56.41 136.51 53.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -84.12 -17.15 41.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -78.97 -69.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.7 p -79.1 -2.64 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p 50.33 42.56 26.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -117.17 177.57 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -111.16 115.4 29.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -137.98 144.0 40.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.3 156.23 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -63.75 -24.85 67.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.77 -27.97 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.5 p -99.09 -37.62 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 5.2 tp -38.61 -27.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 206' ' ' THR . 13.5 mm100 -63.6 -56.36 16.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -79.98 -42.46 23.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.9 t60 -41.16 -48.87 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.849 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -35.2 -38.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.38 -44.33 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.3 mt-30 -63.42 -47.89 80.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -34.57 107.29 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.727 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.65 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt-85 -41.8 -30.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.0 tp -52.6 135.41 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.585 0.707 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.405 ' C ' HG11 ' A' ' 219' ' ' VAL . 53.9 Cg_endo -69.77 141.91 46.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.405 HG11 ' C ' ' A' ' 218' ' ' PRO . 18.4 m -138.38 136.58 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.48 134.98 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.0 t -66.68 135.28 94.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.619 0.723 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.02 29.02 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -85.96 -1.88 57.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 40.98 53.93 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 5.4 p -71.66 -52.0 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 154.39 -28.42 0.69 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.458 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.3 p -44.03 -24.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.52 -96.28 1.93 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.4 p -116.39 145.19 43.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.47 ' CG1' HD11 ' A' ' 235' ' ' LEU . 12.0 p -155.51 128.08 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.45 145.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -59.82 -40.68 89.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -80.62 6.1 13.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.07 -8.14 12.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.2 tp -69.88 -42.56 18.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 0.0 110.946 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.97 -64.3 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.35 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.35 -33.53 76.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.46 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.412 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 15.0 t60 -64.25 -48.61 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.73 -19.62 51.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -62.24 -66.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' SER . 9.5 t0 -125.59 -45.41 1.78 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.7 t -35.63 -65.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.6 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.77 0.319 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.76 116.2 54.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 201' ' ' GLU . 53.9 Cg_endo -69.74 98.03 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 34.5 t -50.97 142.83 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 74.3 m -88.28 -16.26 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -83.39 -69.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.1 p -78.06 -2.71 38.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.5 p 50.42 30.97 4.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -103.76 -174.73 2.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 194' ' ' PRO . 19.8 mm-40 -129.47 120.59 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.16 177.02 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.17 155.64 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.12 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -71.18 -31.15 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -26.72 59.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 209' ' ' SER . 70.2 p -91.27 -42.94 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.3 tp -33.46 -38.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 206' ' ' THR . 56.7 mm-40 -56.95 -49.69 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' THR . 50.3 p -76.93 -37.34 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 213' ' ' GLN . 20.8 t60 -52.54 -48.49 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 77.7 mt-30 -34.36 -36.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 210' ' ' HIS . 15.8 m-85 -76.59 -47.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 210' ' ' HIS . 56.1 mm-40 -62.37 -47.88 82.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -34.94 102.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.638 0.733 . . . . 0.0 110.856 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -46.77 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 -45.37 -29.91 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -45.89 125.28 6.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.682 2.254 . . . . 0.0 112.351 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.92 126.79 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.125 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.45 132.82 54.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.74 135.59 92.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -23.75 30.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -92.11 0.14 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 39.8 54.99 2.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.1 p -71.27 -51.04 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 163.67 -34.22 0.29 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.422 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 228' ' ' GLY . 13.9 p -42.49 -26.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.414 ' N ' HG11 ' A' ' 227' ' ' VAL . . . 79.31 -65.84 3.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 p -146.24 146.51 30.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.118 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 231' ' ' ALA . 14.8 p -157.77 135.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -37.12 142.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -56.11 -41.74 75.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -76.25 -10.47 59.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -97.05 -13.59 22.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.851 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.608 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.42 -44.53 82.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.94 -64.62 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 0.0 112.345 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -60.78 -29.96 71.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -67.83 -44.65 76.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 47.0 mt -63.85 -15.9 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -65.64 -66.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.5 t70 -124.84 -46.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 241' ' ' ASP . 1.8 t -34.99 -69.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.71 0.291 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.409 ' NE2' ' HB2' ' A' ' 204' ' ' PHE . 2.2 pt20 -119.12 127.06 26.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.591 0.71 . . . . 0.0 110.972 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 102.38 1.01 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 31.4 t -50.62 143.99 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.0 m -86.58 -15.91 38.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -84.09 -70.49 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.9 p -77.2 -1.02 27.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.1 p 46.91 49.19 14.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -137.26 162.39 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.2 125.48 31.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -135.13 149.45 50.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.08 144.39 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.409 ' HB2' ' NE2' ' A' ' 193' ' ' GLN . 2.0 p90 -66.82 -34.55 78.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -73.24 -22.78 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.7 p -99.89 -25.33 14.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 4.4 tp -52.45 -15.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.46 -47.52 32.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 m -86.83 -40.34 15.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 213' ' ' GLN . 10.7 t60 -44.42 -47.96 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 210' ' ' HIS . 18.1 mm-40 -35.96 -38.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -71.63 -44.97 63.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 210' ' ' HIS . 45.5 mt-30 -65.22 -40.66 94.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.8 t -34.65 112.33 0.43 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -36.81 9.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.26 . . . . 0.0 112.28 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -55.62 -33.42 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tp -43.83 124.75 4.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 129.73 18.11 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.364 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.77 130.03 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.54 132.64 54.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.68 133.15 93.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -10.67 29.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.24 . . . . 0.0 112.345 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -98.84 -5.06 31.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 45.13 54.27 7.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 3.6 p -73.44 -53.95 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 162.03 -37.04 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.4 p -39.5 -27.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.34 -73.32 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.46 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.4 p -134.5 149.36 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.522 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 13.6 p -156.47 126.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -37.01 143.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.38 -46.77 73.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.8 6.79 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.64 -11.09 13.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.601 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 10.0 tp -67.23 -44.24 47.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.581 0.705 . . . . 0.0 110.897 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.5 Cg_exo -48.03 -59.68 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -64.02 -46.98 89.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -52.0 -49.71 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 55.5 mt -54.38 -19.34 5.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 6.0 tmtm? -61.52 -65.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 241' ' ' ASP . 37.8 t0 -127.23 -44.62 1.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 241' ' ' ASP . 19.9 m -35.51 -64.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.968 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.1 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.733 0.301 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -121.01 119.77 29.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.574 0.702 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 100.94 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.304 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 7.9 t -51.29 119.89 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.9 m -72.17 1.27 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -99.04 -58.11 2.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.3 p -97.81 3.58 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.2 p 47.3 36.6 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -113.07 147.38 37.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -85.97 119.78 26.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.95 166.37 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 20.5 t -71.16 145.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 204' ' ' PHE . 0.7 OUTLIER -61.74 -31.19 71.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.04 -31.66 62.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 208' ' ' GLN . 27.2 p -82.99 -40.37 20.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 208' ' ' GLN . 3.0 tp -43.1 -22.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.465 ' N ' HG23 ' A' ' 207' ' ' ILE . 18.2 mt-30 -68.07 -50.28 56.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 -41.88 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.482 ' O ' ' N ' ' A' ' 213' ' ' GLN . 44.1 t60 -40.42 -52.54 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.2 mt-30 -32.7 -41.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.19 -49.86 63.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.5 mt-30 -63.97 -47.97 78.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.0 t -33.93 116.98 0.49 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.603 0.716 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -47.04 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . 0.462 ' CD ' ' OE2' ' A' ' 233' ' ' GLU . 11.0 mmm180 -43.27 -37.47 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 tp -44.06 133.58 4.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.607 0.718 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 130.47 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -126.86 126.11 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.183 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.39 132.65 48.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.19 131.69 95.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.65 0.738 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -21.15 33.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -86.56 -14.89 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 54.55 54.14 9.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 5.9 p -73.83 -49.21 26.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 158.25 -36.95 0.52 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.524 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.3 p -39.19 -32.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.45 -67.15 3.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.495 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 61.5 p -144.49 143.84 31.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.42 136.11 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.54 134.84 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -52.6 -41.58 63.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.462 ' OE2' ' CD ' ' A' ' 216' ' ' ARG . 21.8 pt-20 -69.25 -14.58 63.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -107.22 10.6 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.6 tp -76.44 -44.59 3.39 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.2 Cg_exo -47.99 -65.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.635 2.223 . . . . 0.0 112.385 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.39 58.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.423 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 23.5 t60 -68.93 -56.22 8.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.84 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.4 mt -53.5 -29.29 35.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -66.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 242' ' ' SER . 2.8 m-20 -116.96 -58.38 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.5 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.0 t -29.38 -70.28 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.411 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.2 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.732 0.301 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -107.35 109.98 62.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 99.72 0.77 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.7 t -52.35 144.81 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.7 m -89.72 -25.33 21.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.96 -69.17 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.84 -5.91 52.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 56.8 p 50.74 42.5 27.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.0 mtmm -118.36 177.6 4.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -111.19 123.7 50.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -138.72 156.08 47.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.461 ' CG1' HG22 ' A' ' 206' ' ' THR . 9.5 p -76.31 140.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -53.11 -26.94 18.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -65.43 -27.58 68.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 208' ' ' GLN . 71.3 p -104.17 -32.71 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.116 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 206' ' ' THR . 8.8 tp -35.48 -30.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 206' ' ' THR . 27.6 mt-30 -66.48 -60.68 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.0 p -69.24 -43.53 73.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.0 t60 -40.57 -50.17 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 210' ' ' HIS . 32.9 mt-30 -32.67 -37.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.8 m-85 -79.23 -46.36 17.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 210' ' ' HIS . 73.5 mt-30 -59.73 -47.14 86.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' GLN . 6.2 t -34.04 117.93 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -50.9 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.34 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -39.05 -32.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.99 133.64 58.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.619 0.723 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 131.87 22.18 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.73 2.286 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.36 144.32 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -79.4 138.7 37.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 18.7 t -59.74 135.4 89.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.15 19.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -76.96 -20.22 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 60.15 53.7 4.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.9 p -76.44 -50.75 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 160.28 -31.61 0.39 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.9 p -39.41 -25.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.913 0.387 . . . . 0.0 111.177 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 79.96 -93.12 1.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.9 p -118.6 147.09 44.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.773 0.32 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.406 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 12.3 p -158.27 130.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.96 139.91 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.083 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -53.24 -44.72 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.61 -1.21 20.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.423 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 7.8 m-20 -106.0 -23.09 12.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.5 tp -54.55 -43.69 98.29 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.93 -62.38 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.676 2.251 . . . . 0.0 112.357 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.89 -30.67 70.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.526 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.421 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 18.4 t60 -68.01 -54.26 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.2 mt -55.44 -29.74 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -53.46 -67.07 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 242' ' ' SER . 36.2 t70 -121.13 -51.29 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.1 t -32.76 -69.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.761 0.315 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.54 114.48 54.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 96.58 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 22.5 t -51.69 133.64 30.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' A' ' 196' ' ' THR . 19.3 m -83.56 -10.86 58.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.179 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.456 ' CE2' HD13 ' A' ' 217' ' ' LEU . 18.2 m-85 -86.3 -65.25 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 22.4 p -84.35 0.89 47.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.4 p 49.23 33.47 5.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 -174.84 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -127.91 125.96 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.41 170.86 15.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.7 t -68.23 146.86 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -61.53 -25.78 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.91 -43.7 29.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.6 p -73.7 -48.84 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 206' ' ' THR . 2.8 tp -33.15 -35.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 23.7 mm100 -58.1 -54.58 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 m -78.76 -41.14 31.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.4 t60 -44.17 -46.65 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -36.37 -39.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -68.87 -43.32 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 mm100 -68.8 -41.67 78.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.1 t -35.1 113.17 0.47 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -47.19 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -42.48 -37.16 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.456 HD13 ' CE2' ' A' ' 197' ' ' TYR . 8.4 tp -48.37 137.4 11.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.584 0.707 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 141.8 45.9 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.307 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.76 129.57 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.73 133.79 56.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.68 133.12 89.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.652 0.739 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -12.64 33.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -97.28 -8.89 28.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 50.26 50.37 18.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.7 p -70.72 -50.88 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 157.56 -34.87 0.54 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.504 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.466 HG13 ' CE1' ' A' ' 238' ' ' HIS . 7.3 p -41.45 -23.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.98 -98.46 2.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.7 p -115.61 147.59 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 231' ' ' ALA . 12.5 p -158.04 130.85 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.11 142.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -58.24 -41.72 84.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.53 -2.78 40.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.42 -17.37 15.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.609 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -57.35 -44.55 99.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.667 0.746 . . . . 0.0 110.977 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.95 -65.66 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.34 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.03 -23.86 57.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.466 ' CE1' HG13 ' A' ' 227' ' ' VAL . 14.1 t60 -74.05 -48.36 30.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 110.83 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.21 -13.1 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -66.87 -64.62 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 242' ' ' SER . 10.4 t70 -122.3 -53.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 241' ' ' ASP . 2.7 m -34.21 -69.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.794 0.331 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.477 ' NE2' ' CB ' ' A' ' 204' ' ' PHE . 7.2 pt20 -113.96 122.57 34.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.578 0.704 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 99.33 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.713 2.275 . . . . 0.0 112.311 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.0 t -51.08 143.78 10.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.6 m -87.27 -26.05 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.538 ' CE2' HD11 ' A' ' 217' ' ' LEU . 15.7 m-85 -72.52 -69.97 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.1 p -77.06 -3.22 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 46.7 p 52.09 31.48 8.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -114.7 177.09 4.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -106.74 126.95 52.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -138.45 151.98 47.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.434 ' CG1' HG21 ' A' ' 206' ' ' THR . 11.1 p -76.9 133.41 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.477 ' CB ' ' NE2' ' A' ' 193' ' ' GLN . 2.2 p90 -50.45 -21.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.16 -33.44 74.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 209' ' ' SER . 46.0 p -101.83 -38.16 7.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 206' ' ' THR . 2.8 tp -33.35 -38.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 206' ' ' THR . 29.4 mm100 -55.71 -49.74 72.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 206' ' ' THR . 69.4 p -83.26 -38.49 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 211' ' ' GLN . 8.8 t60 -53.98 -45.71 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 210' ' ' HIS . 5.5 mt-30 -38.34 -38.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -72.11 -52.72 15.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 214' ' ' CYS . 15.4 mm100 -57.46 -51.18 70.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.456 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.9 t -33.83 107.53 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -41.9 3.84 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -52.22 -38.26 57.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 197' ' ' TYR . 3.7 tp -38.91 129.08 1.19 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.584 0.707 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 134.23 27.63 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.713 2.276 . . . . 0.0 112.352 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 15.7 m -129.25 136.61 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.85 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.6 t -63.72 135.17 96.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.643 0.735 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -33.36 16.61 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -79.46 -20.67 46.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 61.96 54.63 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 10.7 p -75.42 -49.85 17.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 160.95 -38.47 0.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.518 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 226' ' ' GLY . 9.2 p -34.25 -39.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.47 -99.99 2.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -112.79 138.09 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 231' ' ' ALA . 14.8 p -150.13 134.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.3 143.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 46.8 ttt-85 -61.88 -39.86 93.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.49 2.38 29.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -110.81 -12.98 14.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.3 tp -60.99 -43.36 90.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.96 -65.65 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.351 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.53 -28.58 56.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -70.14 -56.33 7.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.822 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.41 -32.24 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -50.39 -66.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 27.6 t70 -124.05 -49.3 1.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.5 t -34.22 -68.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.773 0.32 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -118.43 108.97 40.88 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 102.83 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 6.9 t -52.91 120.19 5.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.3 m -72.84 2.78 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.401 ' O ' ' CZ ' ' A' ' 216' ' ' ARG . 5.5 m-85 -101.38 -64.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.0 p -89.04 5.69 43.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p 45.87 35.07 2.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -98.24 -174.57 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -131.57 103.58 6.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.75 176.09 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 206' ' ' THR . 39.2 t -82.98 124.13 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -38.21 -29.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 203' ' ' VAL . 23.7 t0 -77.62 -42.21 35.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 203' ' ' VAL . 58.5 p -78.99 -50.81 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 206' ' ' THR . 2.3 tp -33.21 -42.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.151 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.412 ' N ' ' CG2' ' A' ' 207' ' ' ILE . 67.2 mm-40 -45.4 -57.42 4.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -71.32 -49.35 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 213' ' ' GLN . 14.2 t60 -40.52 -51.11 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.867 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.5 mt-30 -32.86 -38.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.7 m-85 -69.68 -49.04 57.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' HIS . 78.2 mm-40 -65.78 -45.46 82.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 213' ' ' GLN . 12.0 t -32.77 118.38 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.7 Cg_endo -69.79 -50.11 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.356 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 215' ' ' PRO . 24.7 mmm-85 -34.29 -37.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.9 tp -44.3 129.08 4.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.601 0.715 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 138.97 39.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.353 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.31 127.35 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.16 133.61 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.2 t -60.44 135.52 91.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -28.32 25.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -81.92 -7.81 59.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 48.39 53.42 12.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 9.4 p -72.79 -51.02 20.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 156.33 -35.15 0.6 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.536 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.471 HG12 ' CE1' ' A' ' 238' ' ' HIS . 6.7 p -37.68 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.148 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.85 -93.54 1.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.49 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.5 p -117.66 146.61 43.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.799 0.333 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.529 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 14.4 p -157.64 127.91 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -37.3 153.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -66.2 -43.83 85.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -78.47 7.15 7.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -14.32 11.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.4 tp -63.3 -43.58 80.41 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.599 0.714 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.5 Cg_exo -47.93 -65.44 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.729 2.286 . . . . 0.0 112.345 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.21 -25.63 57.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.471 ' CE1' HG12 ' A' ' 227' ' ' VAL . 7.8 t60 -72.57 -52.77 14.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 110.817 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.43 -18.71 12.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -69.98 -63.86 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 242' ' ' SER . 11.2 t0 -115.31 -56.35 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 241' ' ' ASP . 20.0 m -34.06 -69.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 3.0 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.755 0.312 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 202' ' ' PHE . 29.9 tp60 -107.8 116.52 57.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.897 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 106.56 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.675 2.25 . . . . 0.0 112.315 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.17 138.44 56.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 196' ' ' THR . 4.8 m -86.25 -13.8 45.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.68 -64.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.914 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 p -85.93 -0.05 54.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 49.49 36.45 10.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -113.42 169.8 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -104.32 122.74 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 193' ' ' GLN . 73.1 m-85 -138.61 175.14 9.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.72 144.8 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -64.67 -27.96 69.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.07 -43.59 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 208' ' ' GLN . 52.8 p -73.97 -44.06 56.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.19 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 206' ' ' THR . 3.2 tp -33.67 -33.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 206' ' ' THR . 34.6 mm-40 -57.5 -58.43 8.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.7 m -77.45 -41.63 38.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 5.4 t60 -41.88 -46.43 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -38.52 -39.23 0.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -67.73 -39.76 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 55.3 mm-40 -73.8 -36.67 65.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.9 t -34.26 118.2 0.52 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.586 0.708 . . . . 0.0 110.903 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -24.43 29.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.327 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -84.4 25.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.4 tp -100.42 131.1 24.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.59 0.71 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 119.65 6.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.33 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.02 141.14 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.23 127.95 34.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.6 t -57.96 132.75 83.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.638 0.732 . . . . 0.0 110.928 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -12.14 32.13 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.698 2.265 . . . . 0.0 112.305 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -97.06 -8.42 30.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 47.71 53.06 11.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 4.2 p -73.12 -53.78 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 161.81 -32.13 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.4 p -44.54 -24.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 111.145 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.74 -81.05 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -132.55 148.75 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.467 ' CG1' HD13 ' A' ' 235' ' ' LEU . 12.9 p -156.41 136.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.69 147.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -65.26 -30.53 71.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -86.76 -1.69 57.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.87 -21.99 13.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 10.3 tp -56.32 -44.35 99.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.93 -65.63 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.686 2.257 . . . . 0.0 112.362 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.42 98.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 4.1 t60 -56.11 -49.24 74.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.0 mt -57.29 -27.4 62.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -55.58 -67.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.482 ' O ' ' C ' ' A' ' 242' ' ' SER . 5.6 p-10 -121.08 -52.02 2.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.1 t -31.54 -68.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.468 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.7 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.744 0.307 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -107.45 113.6 61.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 104.48 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.663 2.242 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.09 146.52 14.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.0 m -89.59 -26.44 20.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.18 -69.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.7 p -76.51 -4.2 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.0 p 49.57 39.13 16.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -121.31 164.59 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -93.97 128.04 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -137.92 160.59 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 20.9 t -69.21 138.18 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.12 -35.56 75.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -70.89 -15.92 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.3 p -107.94 -20.97 13.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 3.8 tp -50.56 -17.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -78.21 -42.19 32.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 93.6 p -85.06 -44.44 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.3 t60 -44.28 -47.84 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -34.88 -36.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 210' ' ' HIS . 17.4 m-85 -75.6 -45.34 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 36.5 mt-30 -64.71 -47.68 77.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' A' ' 213' ' ' GLN . 11.7 t -34.12 112.69 0.42 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.7 Cg_endo -69.8 -50.79 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.9 mmm-85 -38.06 -30.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 215' ' ' PRO . 5.1 tp -61.17 132.26 92.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.56 0.695 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 140.41 42.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.386 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.5 m -139.03 125.44 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.092 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.42 139.19 44.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.0 t -59.18 134.07 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.587 0.708 . . . . 0.0 110.93 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 1.13 4.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 224' ' ' GLN . 73.8 m-20 -121.3 9.0 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 223' ' ' ASN . 2.7 mp0 36.97 41.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 29.5 p -58.59 -47.41 84.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 151.46 -34.63 0.89 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 226' ' ' GLY . 11.8 p -37.14 -37.1 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.38 -102.37 2.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.524 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 35.5 p -118.22 123.29 45.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.429 HG21 ' N ' ' A' ' 231' ' ' ALA . 7.9 p -132.45 143.73 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.429 ' N ' HG21 ' A' ' 230' ' ' VAL . . . -52.69 137.65 30.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -49.73 -54.74 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.9 pm0 -66.06 -4.58 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -104.88 -13.79 15.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.631 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -61.07 -42.68 87.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.99 -64.06 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -56.4 -43.81 90.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -56.01 -56.22 23.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.9 mt -56.45 -14.29 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 1.3 tmmm? -64.88 -65.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 242' ' ' SER . 38.9 t0 -121.02 -51.75 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.2 m -35.46 -65.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.74 0.305 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -113.91 106.52 53.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 101.56 0.93 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 29.8 t -54.94 142.08 31.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.5 m -89.56 -13.5 37.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.32 -65.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 24.4 p -82.3 -2.64 53.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 25.2 p 48.94 37.61 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -104.83 -174.86 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -130.19 102.63 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -119.85 173.64 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.5 t -73.1 144.09 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.422 ' O ' ' CG2' ' A' ' 207' ' ' ILE . 2.6 p90 -59.17 -34.45 72.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -69.0 -35.45 76.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 28.4 p -82.45 -32.15 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 204' ' ' PHE . 7.7 tp -48.87 -18.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -69.57 -47.9 62.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -88.29 -38.29 15.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 16.3 t60 -44.13 -51.29 8.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 51.8 mt-30 -34.3 -36.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 210' ' ' HIS . 28.2 m-85 -75.13 -46.31 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.5 mt-30 -62.9 -42.4 99.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.3 t -34.08 118.09 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.587 0.708 . . . . 0.0 110.889 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -49.44 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.266 . . . . 0.0 112.371 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -40.53 -37.76 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.6 tp -44.64 125.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 144.81 54.89 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.83 126.28 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.95 141.99 37.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.061 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.0 t -67.05 134.87 93.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -16.32 37.57 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -96.18 -6.7 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 48.04 53.81 11.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 4.5 p -72.33 -54.05 10.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 159.61 -24.46 0.31 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 p -48.67 -22.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.16 -89.3 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.9 p -124.92 145.78 49.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.18 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.8 p -153.79 134.79 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.22 152.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -70.11 -32.14 70.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.45 -1.8 58.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -114.18 -16.61 12.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 3.3 tp -61.76 -44.29 90.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 0.0 110.909 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.8 Cg_exo -48.01 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.667 2.244 . . . . 0.0 112.306 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.82 39.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.35 -51.1 56.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.71 -22.5 46.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -60.1 -63.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 242' ' ' SER . 17.0 t0 -125.3 -47.2 1.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.5 t -36.0 -66.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.93 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.736 0.303 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -119.52 116.87 33.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.598 0.713 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 96.93 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 30.1 t -51.42 135.14 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.2 m -83.77 -11.36 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -86.14 -69.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.4 p -79.17 -0.79 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p 47.81 42.56 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -125.34 159.79 30.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -90.61 129.38 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -138.63 171.24 14.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -76.16 159.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -77.16 -30.46 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.05 -20.01 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 30.6 p -104.77 -49.04 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 206' ' ' THR . 2.0 tp -33.35 -34.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 14.4 mm-40 -57.18 -56.63 19.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -77.79 -42.52 33.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.6 t60 -43.7 -46.72 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 210' ' ' HIS . 41.8 mt-30 -35.45 -35.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 m-85 -80.41 -42.96 21.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.8 t -33.29 123.5 0.44 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.59 0.71 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -44.2 2.17 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.331 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -45.27 -40.3 7.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 tp -39.21 128.82 1.29 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 123.4 10.05 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.37 140.39 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.03 135.21 50.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.069 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 29.9 t -61.99 134.65 94.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.726 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -30.64 21.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.705 2.27 . . . . 0.0 112.368 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -81.17 -9.68 59.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 49.04 52.93 13.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 11.2 p -71.38 -49.84 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 159.92 -39.14 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.538 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 238' ' ' HIS . 7.6 p -33.77 -38.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.26 -87.74 0.98 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.473 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 11.9 p -127.62 146.35 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.093 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 231' ' ' ALA . 7.9 p -158.08 132.43 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -37.47 141.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -38.49 68.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -80.45 -3.31 49.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -104.99 -16.79 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.9 tp -61.14 -42.69 87.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.726 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.97 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.731 2.287 . . . . 0.0 112.327 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.8 -23.88 59.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.474 ' CE1' HG12 ' A' ' 227' ' ' VAL . 10.5 t60 -73.76 -47.14 41.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.4 mt -62.4 -11.16 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -77.27 -64.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 242' ' ' SER . 20.0 t0 -108.58 -63.1 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.7 m -33.16 -71.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.434 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.777 0.322 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -114.23 105.78 53.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.711 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 105.41 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.39 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 4.9 t -55.23 123.87 15.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.8 m -76.76 3.77 11.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.6 -63.96 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.53 9.15 21.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.7 p 39.7 42.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -108.68 -175.44 2.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.8 107.24 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -124.62 158.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 206' ' ' THR . 4.7 t -61.35 128.43 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -40.55 -32.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.8 -43.42 65.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 203' ' ' VAL . 46.9 p -72.23 -42.93 65.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.163 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.464 HG21 ' N ' ' A' ' 208' ' ' GLN . 3.6 tp -38.68 -29.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.464 ' N ' HG21 ' A' ' 207' ' ' ILE . 0.5 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -72.84 -37.7 67.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLN . 19.5 t60 -49.68 -50.4 43.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 19.2 mt-30 -34.32 -45.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.901 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -62.51 -45.81 91.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' HIS . 31.0 mm100 -67.86 -50.79 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -34.39 110.64 0.39 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.9 Cg_endo -69.8 -43.72 2.46 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 215' ' ' PRO . 15.5 mmm180 -34.46 -40.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.2 tp -40.29 127.3 1.73 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.592 0.711 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.42 33.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.73 135.99 54.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.35 57.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 38.7 t -58.93 131.51 86.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -3.57 12.25 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.252 . . . . 0.0 112.339 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -104.86 -11.54 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 53.44 53.18 12.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 6.3 p -76.21 -48.02 21.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 152.86 -30.09 0.82 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.48 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.3 p -42.94 -24.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.53 -91.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -120.14 150.13 41.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.47 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 12.5 p -158.25 133.9 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -44.23 142.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.49 -49.4 70.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.05 6.74 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -112.6 -14.73 13.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.1 tp -61.9 -43.56 87.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.544 0.688 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.99 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.27 . . . . 0.0 112.345 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.89 -34.83 61.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.558 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 18.4 t60 -65.6 -61.24 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.425 ' HA ' ' CB ' ' A' ' 243' ' ' CYS . 67.2 mt -49.07 -36.86 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -50.4 -67.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 7.8 p-10 -112.4 -57.2 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.448 ' HB3' ' CG ' ' A' ' 238' ' ' HIS . 5.5 t -33.81 -67.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.558 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.78 0.324 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -108.21 109.73 61.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.03 2.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.705 2.27 . . . . 0.0 112.301 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.56 148.36 49.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.6 m -90.23 -29.23 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.37 -69.65 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.52 -3.44 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 34.8 p 46.0 45.84 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -119.26 -175.36 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -119.74 123.4 43.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -138.62 160.66 39.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 204' ' ' PHE . 10.0 p -80.35 143.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.088 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.423 ' N ' HG23 ' A' ' 203' ' ' VAL . 2.0 p90 -51.86 -22.81 4.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 207' ' ' ILE . 76.7 p -99.29 -46.87 5.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.155 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.8 tp -33.29 -38.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 26.2 mt-30 -54.39 -55.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.08 -44.37 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 9.7 t60 -39.67 -50.65 2.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 210' ' ' HIS . 49.5 mm-40 -32.62 -39.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' HIS . 6.9 m-85 -75.84 -46.76 28.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.8 mm-40 -59.34 -43.93 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -33.94 113.8 0.43 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.586 0.708 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -47.58 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.386 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 11.9 mmm180 -38.32 -37.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 216' ' ' ARG . 7.7 tp -37.92 130.7 0.94 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.587 0.708 . . . . 0.0 110.964 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 125.86 12.66 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.351 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.9 m -122.29 136.02 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -67.29 139.54 57.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.34 130.61 94.23 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -12.46 32.85 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 0.0 112.321 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -96.46 -19.94 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 61.57 48.18 5.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.2 p -69.04 -52.11 32.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 162.83 -40.17 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 226' ' ' GLY . 11.5 p -36.03 -40.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.412 ' N ' HG13 ' A' ' 227' ' ' VAL . . . 95.56 -89.34 1.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.486 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 28.6 p -122.28 142.67 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.095 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.501 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 12.9 p -153.87 139.32 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.43 138.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -52.9 -41.15 64.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.425 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.8 pt-20 -78.93 -11.77 60.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.428 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 6.1 m-20 -92.24 -25.36 18.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.599 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.1 tp -54.16 -43.92 97.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.587 0.708 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -48.0 -60.36 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.222 . . . . 0.0 112.358 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -64.01 -31.92 82.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.414 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 5.7 t60 -65.36 -52.02 56.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.39 -33.04 58.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -48.95 -66.6 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.3 p30 -121.39 -52.04 2.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.3 t -32.51 -67.78 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.414 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.5 t . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 42.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.748 0.308 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -110.46 106.25 57.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.873 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 99.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 48.4 t -53.67 142.41 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 79.5 m -89.4 -20.33 24.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.46 ' CE2' HD12 ' A' ' 217' ' ' LEU . 13.7 m-85 -76.47 -65.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.93 -2.26 56.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.3 p 49.83 37.03 12.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -107.34 -174.45 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -130.21 112.9 13.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.404 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 75.9 m-85 -121.7 177.34 5.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 206' ' ' THR . 60.4 t -80.27 123.11 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.424 ' C ' HG21 ' A' ' 207' ' ' ILE . 1.3 p90 -39.63 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 203' ' ' VAL . 6.5 t70 -80.41 -40.06 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 203' ' ' VAL . 81.8 p -79.64 -47.35 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 208' ' ' GLN . 2.1 tp -34.67 -31.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' THR . 32.8 mm-40 -53.12 -53.8 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -76.92 -47.39 21.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.2 t60 -40.93 -48.01 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 210' ' ' HIS . 9.3 mt-30 -33.73 -38.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 210' ' ' HIS . 10.6 m-85 -77.65 -44.92 26.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 210' ' ' HIS . 25.6 mm-40 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.467 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -32.65 116.5 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -46.42 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.627 2.218 . . . . 0.0 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . 0.431 ' NH1' ' OE2' ' A' ' 233' ' ' GLU . 26.8 mmt-85 -41.28 -34.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.46 HD12 ' CE2' ' A' ' 197' ' ' TYR . 7.8 tp -55.54 136.52 70.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.565 0.698 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 153.94 68.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.45 131.38 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.161 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.12 135.89 57.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 47.3 t -59.48 134.25 88.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -17.51 37.55 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -94.69 -6.54 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 49.06 51.3 16.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 22.8 p -74.37 -48.26 29.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 154.91 -30.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.494 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.405 HG12 ' CE1' ' A' ' 238' ' ' HIS . 4.4 p -38.58 -26.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.18 -84.33 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.9 p -132.37 145.62 51.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.451 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 12.1 p -158.05 129.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.06 143.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -62.41 -44.7 95.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.431 ' OE2' ' NH1' ' A' ' 216' ' ' ARG . 16.4 pt-20 -70.04 -2.53 13.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.53 -12.54 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -58.17 -42.84 97.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.615 0.721 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.98 -65.83 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.49 -33.65 59.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 242' ' ' SER . 45.9 t60 -66.13 -50.16 64.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.5 mt -67.56 -25.51 65.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.988 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -56.39 -67.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.85 -32.38 0.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.456 ' O ' ' ND1' ' A' ' 238' ' ' HIS . 2.5 m -77.77 45.5 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 238' ' ' HIS . 17.8 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.753 0.311 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -107.43 103.92 50.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 100.58 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 51.5 t -52.26 149.62 5.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.4 m -90.59 -41.08 11.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.156 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.05 -70.12 0.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.5 p -75.26 -6.85 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.896 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.7 p 49.71 39.71 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -113.04 174.2 6.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.866 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -109.08 121.78 45.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.82 174.25 10.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.455 HG21 ' N ' ' A' ' 204' ' ' PHE . 14.6 p -97.91 144.14 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.13 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.455 ' N ' HG21 ' A' ' 203' ' ' VAL . 1.9 p90 -53.56 -21.94 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.28 -27.0 62.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 208' ' ' GLN . 64.7 p -102.39 -43.08 5.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 206' ' ' THR . 3.7 tp -35.94 -30.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.9 mt-30 -62.17 -52.96 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -81.94 -38.78 24.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' A' ' 213' ' ' GLN . 18.9 t60 -49.19 -51.05 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 210' ' ' HIS . 24.9 mt-30 -33.74 -38.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' HIS . 54.9 m-85 -72.95 -48.22 38.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.1 mt-30 -62.87 -50.2 71.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.2 t -34.15 113.7 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.629 0.728 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.67 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 15.5 mmm180 -43.29 -41.15 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 216' ' ' ARG . 11.8 tp -38.25 131.69 0.99 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 139.43 40.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.667 2.245 . . . . 0.0 112.3 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.3 134.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -64.44 127.87 33.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.9 t -58.21 131.45 84.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -12.42 32.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -95.19 -18.02 21.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 61.55 49.55 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 6.3 p -68.74 -52.07 34.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 155.71 -35.18 0.63 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.512 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.1 p -38.47 -26.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 111.141 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.71 -71.97 2.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 64.9 p -145.97 147.25 31.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.138 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 10.1 p -154.13 144.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -47.64 134.87 12.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -51.7 -36.57 47.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.42 ' OE1' ' C ' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.65 -17.05 58.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.825 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.451 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.2 m-20 -91.37 -25.5 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.571 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -48.27 -45.96 66.73 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.1 Cg_exo -47.94 -60.8 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 0.0 112.371 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -65.96 -20.72 69.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -76.84 -50.46 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 26.2 mt -53.88 -22.5 10.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -56.26 -67.2 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.6 m-20 -127.15 -49.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 241' ' ' ASP . 22.0 m -31.5 -64.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.7 m 55.99 47.78 19.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 30.2 m 58.03 45.15 18.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -144.45 165.64 27.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 t -112.73 90.01 3.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.836 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.9 m -87.16 -59.05 2.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.44 97.7 2.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -96.22 106.09 18.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -65.06 157.12 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.6 p -115.2 141.6 47.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -114.12 117.97 42.88 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 104.85 1.38 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 12.5 t -57.52 135.47 56.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 81.9 m -82.4 -10.41 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -89.91 -69.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.0 p -79.67 4.33 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.8 p 42.76 37.06 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -118.51 160.62 21.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.37 130.85 37.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.98 170.12 16.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 206' ' ' THR . 2.4 t -80.81 127.76 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -46.13 -27.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.12 -35.0 66.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 207' ' ' ILE . 34.7 p -87.41 -50.71 6.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 208' ' ' GLN . 2.9 tp -33.54 -42.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 207' ' ' ILE . 92.7 mm-40 -49.76 -49.58 47.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.1 t -86.24 -45.3 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.484 ' O ' ' N ' ' A' ' 213' ' ' GLN . 11.0 t60 -45.28 -47.22 12.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mt-30 -34.74 -33.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.0 m-85 -78.91 -46.85 17.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mm-40 -63.15 -45.48 91.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.9 t -35.34 120.49 0.62 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.627 0.727 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -50.44 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.69 2.26 . . . . 0.0 112.338 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -43.62 -40.91 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 tp -39.69 127.29 1.49 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.615 0.722 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 141.95 46.56 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.5 m -137.79 138.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -71.18 139.11 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.4 t -67.32 135.28 93.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -20.54 34.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -91.82 0.05 57.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 39.62 52.43 2.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 5.2 p -69.03 -51.53 38.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 159.12 -37.74 0.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.483 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 226' ' ' GLY . 6.9 p -37.03 -33.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 90.99 -94.75 2.0 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.1 p -117.17 147.26 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 231' ' ' ALA . 11.6 p -157.14 131.77 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.63 146.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -58.92 -37.7 77.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.35 2.95 29.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.24 -15.14 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.4 tp -65.17 -44.5 69.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.91 -62.68 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.327 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -61.02 -45.61 96.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -53.59 -48.28 69.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.358 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.1 mt -59.37 -17.34 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 32.8 ttmt -62.41 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 15.7 p-10 -128.2 -45.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.5 m -34.54 -64.98 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t -45.44 155.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.81 -51.41 48.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 35.3 p -44.29 168.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -113.39 137.85 50.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 56.0 mt -149.55 135.19 18.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 179.839 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 45.8 m -136.84 163.77 29.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 28.8 t -48.52 130.67 17.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -93.13 -112.66 2.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.9 m -105.46 91.26 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.85 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 92.7 p -104.5 162.4 13.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.811 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.03 -175.21 24.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -95.51 91.07 5.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.292 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.01 171.38 3.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.0 p -119.52 133.34 55.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 30.5 mt-30 -107.81 103.86 51.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.2 Cg_endo -69.72 99.9 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.649 2.233 . . . . 0.0 112.338 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.16 140.7 15.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.4 m -87.21 -22.97 24.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -73.58 -69.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.1 p -77.78 -4.21 45.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 51.36 38.98 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -112.29 179.99 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -115.9 121.89 43.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -137.38 175.02 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.53 154.36 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -62.73 -25.26 68.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -68.47 -17.6 64.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 208' ' ' GLN . 55.5 p -112.38 -42.76 3.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.6 tp -33.73 -33.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 206' ' ' THR . 16.3 mm100 -62.34 -49.95 73.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 t -84.49 -44.5 13.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 213' ' ' GLN . 38.1 t60 -45.02 -50.87 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -33.03 -36.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 210' ' ' HIS . 14.9 m-85 -79.98 -48.3 13.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.5 mt-30 -57.29 -44.28 83.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.9 t -33.74 116.05 0.46 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.67 0.748 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -46.91 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.69 2.26 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -42.91 -25.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.18 132.23 31.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.575 0.702 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 137.45 35.49 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.26 . . . . 0.0 112.34 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.0 m -136.1 140.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.37 132.32 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.56 136.89 96.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.653 0.739 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -32.8 18.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.703 2.269 . . . . 0.0 112.352 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -80.5 -4.15 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 45.05 47.89 9.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 13.4 p -64.93 -49.68 69.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 156.18 -37.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 226' ' ' GLY . 7.5 p -34.34 -37.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.162 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.8 -75.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 81.7 p -136.4 150.58 48.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.403 ' CG1' HD11 ' A' ' 235' ' ' LEU . 8.0 p -157.82 133.76 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.053 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.14 142.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ttt-85 -54.84 -43.94 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.21 6.55 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -113.96 -10.89 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.602 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 8.4 tp -66.41 -44.48 57.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.624 0.726 . . . . 0.0 110.914 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.98 -64.92 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -59.81 -47.79 89.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.439 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -51.09 -50.55 58.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.9 mt -59.92 -15.4 21.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 18.5 ttmt -69.64 -65.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' SER . 51.7 m-20 -123.34 -49.17 1.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.5 t -34.93 -69.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.6 t -48.92 146.25 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -67.59 109.33 3.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 246' ' ' ALA . 28.8 p -38.92 105.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 245' ' ' THR . . . -35.16 132.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.2 tt -114.89 104.38 11.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.8 t -125.23 144.23 50.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.878 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.9 p -149.66 170.72 18.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -163.97 -99.43 0.14 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.515 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.9 m -83.39 104.12 13.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 m 45.35 39.08 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.797 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 190' ' ' LYS . . . 72.16 -81.34 0.58 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.457 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 189' ' ' GLY . 28.6 mttp -37.4 122.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.323 . . . . 0.0 110.886 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.6 mtp85 -62.43 157.47 20.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 7.6 p -141.68 123.8 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 26.7 mm100 -107.65 105.21 55.54 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.606 0.717 . . . . 0.0 110.944 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.1 Cg_endo -69.74 102.69 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.5 t -52.54 145.69 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.9 m -90.09 -26.5 20.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -69.52 -73.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.57 -4.11 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.3 p 54.08 31.3 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -100.88 -176.59 3.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.27 121.91 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.546 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 68.5 m-85 -136.15 152.36 50.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.476 ' CG2' HG21 ' A' ' 206' ' ' THR . 18.9 m -76.0 139.35 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -43.72 -23.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 203' ' ' VAL . 5.7 t70 -72.85 -44.01 61.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 208' ' ' GLN . 66.5 p -84.41 -45.71 12.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 206' ' ' THR . 3.3 tp -34.02 -34.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 206' ' ' THR . 21.7 mt-30 -58.37 -56.88 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.956 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.3 m -75.01 -37.92 61.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.546 ' CE1' ' CE2' ' A' ' 202' ' ' PHE . 36.0 t60 -44.85 -49.21 10.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -34.14 -34.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.9 m-85 -78.88 -47.08 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.5 mm-40 -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.8 t -34.41 109.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.4 Cg_endo -69.85 -50.64 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.273 . . . . 0.0 112.328 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 215' ' ' PRO . 12.7 mmt180 -36.79 -31.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.1 tp -52.23 135.88 40.36 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 138.34 37.74 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.361 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.2 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.89 130.26 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.7 t -61.06 136.69 93.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.659 0.742 . . . . 0.0 110.834 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -29.6 23.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -83.68 -6.89 59.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 46.79 52.0 11.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 6.6 p -68.36 -51.54 43.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 161.2 -35.91 0.4 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.511 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.7 p -39.28 -26.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.143 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.43 -70.05 3.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 59.8 p -147.54 147.55 30.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.473 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 11.8 p -154.23 140.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.4 143.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.83 -39.14 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -81.88 3.22 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -5.95 12.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.598 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.67 -44.51 80.64 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.586 0.708 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.99 -63.45 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.684 2.256 . . . . 0.0 112.3 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.05 -29.07 61.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.46 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.408 ' NE2' ' HB2' ' A' ' 243' ' ' CYS . 15.9 t60 -70.05 -54.87 11.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.11 -14.2 2.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.65 -66.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 24.0 t0 -106.78 -62.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 241' ' ' ASP . 54.9 m -34.44 -66.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.408 ' HB2' ' NE2' ' A' ' 238' ' ' HIS . 1.8 t -68.97 133.69 48.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -106.77 94.22 5.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 22.0 m -54.2 124.92 17.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -121.37 38.03 4.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.75 167.96 21.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.854 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 72.9 m -154.7 165.16 37.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.367 . . . . 0.0 110.831 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.7 t -111.66 -51.88 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.911 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 145.17 -44.14 0.9 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.458 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.0 m -73.05 118.23 15.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 110.848 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.1 m 54.14 40.9 32.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.07 164.54 24.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -70.46 135.6 48.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.558 ' HB2' ' CD1' ' A' ' 204' ' ' PHE . 4.2 mtp-105 -79.09 155.23 28.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.0 p -130.39 129.8 43.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -117.21 115.69 37.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.731 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 109.67 2.37 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.0 t -53.3 123.08 10.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 40.2 m -74.89 4.2 6.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -104.07 -59.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.3 7.73 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 38.8 p 41.46 46.69 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -120.63 155.07 34.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.95 115.07 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -135.8 145.29 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.2 t -47.83 149.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 191' ' ' ARG . 1.7 p90 -69.17 -28.97 66.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.61 -36.67 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLN . 69.5 p -82.69 -44.59 15.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.1 tp -33.54 -34.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.6 mt-30 -65.91 -50.4 64.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 75.0 p -73.82 -40.65 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.9 t60 -58.54 -50.14 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 210' ' ' HIS . 8.1 mm-40 -33.95 -36.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 210' ' ' HIS . 32.4 m-85 -70.93 -49.38 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 210' ' ' HIS . 51.6 mt-30 -65.08 -42.84 93.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -33.82 123.72 0.48 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -49.5 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -41.6 -38.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 tp -45.58 134.09 6.16 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.588 0.709 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.13 39.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.8 m -134.53 133.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.76 143.68 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.093 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.29 134.62 89.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -23.31 30.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.09 2.7 53.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 37.97 50.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 9.1 p -67.4 -48.81 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 157.62 -41.86 0.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 226' ' ' GLY . 12.6 p -33.82 -38.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 111.162 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.0 -97.38 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 16.6 p -112.67 146.02 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.526 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 11.3 p -157.54 130.98 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.144 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.49 145.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 232' ' ' ARG . 3.5 tmt_? -62.08 -33.58 74.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.62 -4.28 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -106.05 -8.57 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.622 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.9 tp -68.89 -43.1 25.98 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.625 0.726 . . . . 0.0 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.0 Cg_exo -47.94 -65.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.377 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.33 -33.72 71.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.89 -51.85 62.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 58.4 mt -57.43 -18.85 20.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -63.16 -66.71 0.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.4 m-20 -125.76 -46.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.1 m -35.02 -65.35 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.8 t -43.74 113.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.69 86.76 7.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -58.11 138.35 56.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -77.41 131.85 38.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.41 -43.41 75.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.093 179.863 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.0 p -55.54 -45.81 77.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.811 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 29.0 t -90.28 -46.78 8.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.03 -83.61 0.28 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.6 t -160.22 117.52 2.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 0.0 110.866 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.2 t -88.0 92.87 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 152.78 -48.52 0.54 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.497 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -131.19 139.36 49.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -108.31 161.15 15.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.4 p -110.35 138.98 46.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 21.9 mm-40 -112.59 103.31 55.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.634 0.73 . . . . 0.0 110.944 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.1 Cg_endo -69.72 105.77 1.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.343 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.4 t -56.41 136.51 53.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -84.12 -17.15 41.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -78.97 -69.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.7 p -79.1 -2.64 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p 50.33 42.56 26.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -117.17 177.57 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -111.16 115.4 29.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -137.98 144.0 40.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.3 156.23 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -63.75 -24.85 67.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.77 -27.97 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.5 p -99.09 -37.62 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 5.2 tp -38.61 -27.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 206' ' ' THR . 13.5 mm100 -63.6 -56.36 16.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -79.98 -42.46 23.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.9 t60 -41.16 -48.87 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.849 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -35.2 -38.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.38 -44.33 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.3 mt-30 -63.42 -47.89 80.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -34.57 107.29 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.727 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.65 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt-85 -41.8 -30.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.0 tp -52.6 135.41 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.585 0.707 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.405 ' C ' HG11 ' A' ' 219' ' ' VAL . 53.9 Cg_endo -69.77 141.91 46.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.405 HG11 ' C ' ' A' ' 218' ' ' PRO . 18.4 m -138.38 136.58 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.48 134.98 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.0 t -66.68 135.28 94.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.619 0.723 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.02 29.02 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -85.96 -1.88 57.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 40.98 53.93 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 5.4 p -71.66 -52.0 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 154.39 -28.42 0.69 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.458 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.3 p -44.03 -24.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.52 -96.28 1.93 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.4 p -116.39 145.19 43.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.47 ' CG1' HD11 ' A' ' 235' ' ' LEU . 12.0 p -155.51 128.08 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.45 145.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -59.82 -40.68 89.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -80.62 6.1 13.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.07 -8.14 12.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.2 tp -69.88 -42.56 18.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 0.0 110.946 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.97 -64.3 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.35 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.35 -33.53 76.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.46 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.412 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 15.0 t60 -64.25 -48.61 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.73 -19.62 51.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -62.24 -66.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' SER . 9.5 t0 -125.59 -45.41 1.78 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.7 t -35.63 -65.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.5 t -54.62 103.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -97.44 47.77 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.2 t -87.54 130.86 34.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 247' ' ' LEU . . . -89.1 -44.27 10.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 246' ' ' ALA . 1.5 tt 36.36 53.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 179.859 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.5 p -124.39 117.22 23.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.883 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 26.9 m 59.29 43.42 16.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -92.01 70.45 1.79 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.0 m -106.09 175.59 5.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 110.824 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 94.3 p -114.4 126.9 55.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.818 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.31 -152.24 18.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.474 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm 59.71 54.16 4.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.5 ttt-85 -62.69 169.64 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.6 p -122.8 138.7 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.76 116.2 54.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 201' ' ' GLU . 53.9 Cg_endo -69.74 98.03 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 34.5 t -50.97 142.83 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 74.3 m -88.28 -16.26 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -83.39 -69.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.1 p -78.06 -2.71 38.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.5 p 50.42 30.97 4.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -103.76 -174.73 2.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 194' ' ' PRO . 19.8 mm-40 -129.47 120.59 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.16 177.02 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.17 155.64 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.12 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -71.18 -31.15 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -26.72 59.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 209' ' ' SER . 70.2 p -91.27 -42.94 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.3 tp -33.46 -38.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 206' ' ' THR . 56.7 mm-40 -56.95 -49.69 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' THR . 50.3 p -76.93 -37.34 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 213' ' ' GLN . 20.8 t60 -52.54 -48.49 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 77.7 mt-30 -34.36 -36.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 210' ' ' HIS . 15.8 m-85 -76.59 -47.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 210' ' ' HIS . 56.1 mm-40 -62.37 -47.88 82.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -34.94 102.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.638 0.733 . . . . 0.0 110.856 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -46.77 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 -45.37 -29.91 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -45.89 125.28 6.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.682 2.254 . . . . 0.0 112.351 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.92 126.79 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.125 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.45 132.82 54.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.74 135.59 92.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -23.75 30.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -92.11 0.14 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 39.8 54.99 2.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.1 p -71.27 -51.04 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 163.67 -34.22 0.29 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.422 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 228' ' ' GLY . 13.9 p -42.49 -26.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.414 ' N ' HG11 ' A' ' 227' ' ' VAL . . . 79.31 -65.84 3.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 p -146.24 146.51 30.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.118 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 231' ' ' ALA . 14.8 p -157.77 135.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -37.12 142.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -56.11 -41.74 75.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -76.25 -10.47 59.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -97.05 -13.59 22.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.851 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.608 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.42 -44.53 82.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.94 -64.62 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 0.0 112.345 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -60.78 -29.96 71.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -67.83 -44.65 76.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 47.0 mt -63.85 -15.9 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -65.64 -66.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.5 t70 -124.84 -46.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 241' ' ' ASP . 1.8 t -34.99 -69.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.5 t -45.91 162.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -121.03 127.18 51.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 87.2 m -127.53 139.06 53.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -129.08 -35.69 1.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.99 150.18 43.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.842 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 50.5 m -152.39 137.0 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 110.837 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 53.7 p -123.74 176.46 6.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 119.72 -99.73 0.76 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.8 t -82.24 141.72 32.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.872 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -72.9 170.35 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.887 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -109.28 -64.39 0.55 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -90.26 150.23 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.938 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.93 162.73 12.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 66.5 p -134.81 138.37 44.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.409 ' NE2' ' HB2' ' A' ' 204' ' ' PHE . 2.2 pt20 -119.12 127.06 26.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.591 0.71 . . . . 0.0 110.972 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 102.38 1.01 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 31.4 t -50.62 143.99 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.0 m -86.58 -15.91 38.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -84.09 -70.49 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.9 p -77.2 -1.02 27.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.1 p 46.91 49.19 14.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -137.26 162.39 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.2 125.48 31.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -135.13 149.45 50.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.08 144.39 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.409 ' HB2' ' NE2' ' A' ' 193' ' ' GLN . 2.0 p90 -66.82 -34.55 78.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -73.24 -22.78 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.7 p -99.89 -25.33 14.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 4.4 tp -52.45 -15.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.46 -47.52 32.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 m -86.83 -40.34 15.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 213' ' ' GLN . 10.7 t60 -44.42 -47.96 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 210' ' ' HIS . 18.1 mm-40 -35.96 -38.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -71.63 -44.97 63.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 210' ' ' HIS . 45.5 mt-30 -65.22 -40.66 94.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.8 t -34.65 112.33 0.43 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -36.81 9.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.26 . . . . 0.0 112.28 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -55.62 -33.42 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tp -43.83 124.75 4.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 129.73 18.11 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.364 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.77 130.03 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.54 132.64 54.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.68 133.15 93.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -10.67 29.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.24 . . . . 0.0 112.345 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -98.84 -5.06 31.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 45.13 54.27 7.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 3.6 p -73.44 -53.95 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 162.03 -37.04 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.4 p -39.5 -27.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.34 -73.32 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.46 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.4 p -134.5 149.36 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.522 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 13.6 p -156.47 126.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -37.01 143.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.38 -46.77 73.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.8 6.79 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.64 -11.09 13.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.601 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 10.0 tp -67.23 -44.24 47.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.581 0.705 . . . . 0.0 110.897 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.5 Cg_exo -48.03 -59.68 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -64.02 -46.98 89.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -52.0 -49.71 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 55.5 mt -54.38 -19.34 5.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 6.0 tmtm? -61.52 -65.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 241' ' ' ASP . 37.8 t0 -127.23 -44.62 1.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 241' ' ' ASP . 19.9 m -35.51 -64.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.0 t -45.93 112.34 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -72.39 103.26 3.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 t -155.93 156.16 34.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.178 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 247' ' ' LEU . . . -62.94 104.92 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 246' ' ' ALA . 5.8 mp -35.91 -52.43 0.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.19 179.797 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.2 p -118.79 118.73 32.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.0 p -132.91 143.79 49.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -124.8 -88.35 0.77 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.514 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.8 p -132.42 -51.01 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.3 t -72.73 127.1 31.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -172.98 146.06 8.8 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.494 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -56.16 134.55 53.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -60.83 144.67 52.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.1 p -119.09 149.69 41.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -121.01 119.77 29.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.574 0.702 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 100.94 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.304 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 7.9 t -51.29 119.89 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.9 m -72.17 1.27 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -99.04 -58.11 2.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.3 p -97.81 3.58 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.2 p 47.3 36.6 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -113.07 147.38 37.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -85.97 119.78 26.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.95 166.37 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 20.5 t -71.16 145.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 204' ' ' PHE . 0.7 OUTLIER -61.74 -31.19 71.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.04 -31.66 62.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 208' ' ' GLN . 27.2 p -82.99 -40.37 20.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 208' ' ' GLN . 3.0 tp -43.1 -22.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.465 ' N ' HG23 ' A' ' 207' ' ' ILE . 18.2 mt-30 -68.07 -50.28 56.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 -41.88 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.482 ' O ' ' N ' ' A' ' 213' ' ' GLN . 44.1 t60 -40.42 -52.54 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.2 mt-30 -32.7 -41.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.19 -49.86 63.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.5 mt-30 -63.97 -47.97 78.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.0 t -33.93 116.98 0.49 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.603 0.716 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -47.04 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.462 ' CD ' ' OE2' ' A' ' 233' ' ' GLU . 11.0 mmm180 -43.27 -37.47 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 tp -44.06 133.58 4.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.607 0.718 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 130.47 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -126.86 126.11 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.183 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.39 132.65 48.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.19 131.69 95.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.65 0.738 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -21.15 33.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -86.56 -14.89 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 54.55 54.14 9.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 5.9 p -73.83 -49.21 26.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 158.25 -36.95 0.52 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.524 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.3 p -39.19 -32.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.45 -67.15 3.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.495 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 61.5 p -144.49 143.84 31.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.42 136.11 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.54 134.84 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -52.6 -41.58 63.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.462 ' OE2' ' CD ' ' A' ' 216' ' ' ARG . 21.8 pt-20 -69.25 -14.58 63.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -107.22 10.6 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.6 tp -76.44 -44.59 3.39 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.2 Cg_exo -47.99 -65.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.635 2.223 . . . . 0.0 112.385 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.39 58.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.423 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 23.5 t60 -68.93 -56.22 8.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.84 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.4 mt -53.5 -29.29 35.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -66.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 242' ' ' SER . 2.8 m-20 -116.96 -58.38 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.5 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.0 t -29.38 -70.28 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.411 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.2 t -51.76 129.12 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 39.6 m-20 -98.84 96.79 8.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -77.37 145.87 37.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -104.82 141.53 36.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.73 152.56 23.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 179.819 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 2.0 m -47.69 146.05 2.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.903 0.382 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 95.3 p -97.34 173.67 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.8 64.65 1.2 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.468 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 89.7 p -52.08 -45.19 64.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.844 0.354 . . . . 0.0 110.856 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.9 p -113.68 177.71 4.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -63.19 -148.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.505 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -148.18 120.06 8.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.882 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -61.09 133.51 56.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.6 p -110.73 140.46 45.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -107.35 109.98 62.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 99.72 0.77 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.7 t -52.35 144.81 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.7 m -89.72 -25.33 21.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.96 -69.17 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.84 -5.91 52.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 56.8 p 50.74 42.5 27.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 25.0 mtmm -118.36 177.6 4.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -111.19 123.7 50.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -138.72 156.08 47.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.461 ' CG1' HG22 ' A' ' 206' ' ' THR . 9.5 p -76.31 140.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -53.11 -26.94 18.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -65.43 -27.58 68.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 208' ' ' GLN . 71.3 p -104.17 -32.71 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.116 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 206' ' ' THR . 8.8 tp -35.48 -30.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 206' ' ' THR . 27.6 mt-30 -66.48 -60.68 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.0 p -69.24 -43.53 73.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.0 t60 -40.57 -50.17 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 210' ' ' HIS . 32.9 mt-30 -32.67 -37.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.8 m-85 -79.23 -46.36 17.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 210' ' ' HIS . 73.5 mt-30 -59.73 -47.14 86.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' GLN . 6.2 t -34.04 117.93 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -50.9 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.34 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -39.05 -32.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.99 133.64 58.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.619 0.723 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 131.87 22.18 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.73 2.286 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.36 144.32 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -79.4 138.7 37.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 18.7 t -59.74 135.4 89.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.15 19.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -76.96 -20.22 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 60.15 53.7 4.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.9 p -76.44 -50.75 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 160.28 -31.61 0.39 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.9 p -39.41 -25.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.913 0.387 . . . . 0.0 111.177 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 79.96 -93.12 1.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.9 p -118.6 147.09 44.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.773 0.32 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.406 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 12.3 p -158.27 130.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.96 139.91 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.083 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -53.24 -44.72 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.61 -1.21 20.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.423 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 7.8 m-20 -106.0 -23.09 12.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.5 tp -54.55 -43.69 98.29 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.93 -62.38 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.676 2.251 . . . . 0.0 112.357 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.89 -30.67 70.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.526 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.421 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 18.4 t60 -68.01 -54.26 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.2 mt -55.44 -29.74 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -53.46 -67.07 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 242' ' ' SER . 36.2 t70 -121.13 -51.29 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.1 t -32.76 -69.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.3 t -52.96 160.51 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -100.47 123.3 44.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 72.7 p -83.22 147.17 28.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.85 170.25 16.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.58 100.92 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.906 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 2.1 t -140.61 113.15 8.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 87.6 p -55.92 168.61 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 168.66 168.05 30.18 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.434 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 m -157.55 105.07 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.8 t -100.93 139.9 35.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -79.03 -104.83 0.22 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -109.33 114.39 28.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.752 0.31 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -68.49 136.07 52.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 22.9 p -116.96 145.44 43.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.15 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.54 114.48 54.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 96.58 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 22.5 t -51.69 133.64 30.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' A' ' 196' ' ' THR . 19.3 m -83.56 -10.86 58.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.179 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.456 ' CE2' HD13 ' A' ' 217' ' ' LEU . 18.2 m-85 -86.3 -65.25 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 22.4 p -84.35 0.89 47.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.4 p 49.23 33.47 5.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 -174.84 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -127.91 125.96 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.41 170.86 15.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.7 t -68.23 146.86 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -61.53 -25.78 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.91 -43.7 29.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.6 p -73.7 -48.84 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 206' ' ' THR . 2.8 tp -33.15 -35.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 23.7 mm100 -58.1 -54.58 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 m -78.76 -41.14 31.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.4 t60 -44.17 -46.65 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -36.37 -39.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -68.87 -43.32 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 mm100 -68.8 -41.67 78.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.1 t -35.1 113.17 0.47 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -47.19 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -42.48 -37.16 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.456 HD13 ' CE2' ' A' ' 197' ' ' TYR . 8.4 tp -48.37 137.4 11.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.584 0.707 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 141.8 45.9 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.307 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.76 129.57 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.73 133.79 56.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.68 133.12 89.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.652 0.739 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -12.64 33.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -97.28 -8.89 28.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 50.26 50.37 18.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.7 p -70.72 -50.88 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 157.56 -34.87 0.54 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.504 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.466 HG13 ' CE1' ' A' ' 238' ' ' HIS . 7.3 p -41.45 -23.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.98 -98.46 2.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.7 p -115.61 147.59 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 231' ' ' ALA . 12.5 p -158.04 130.85 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.11 142.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -58.24 -41.72 84.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.53 -2.78 40.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.42 -17.37 15.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.609 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -57.35 -44.55 99.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.667 0.746 . . . . 0.0 110.977 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.95 -65.66 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.34 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.03 -23.86 57.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.466 ' CE1' HG13 ' A' ' 227' ' ' VAL . 14.1 t60 -74.05 -48.36 30.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 110.83 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.21 -13.1 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -66.87 -64.62 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 242' ' ' SER . 10.4 t70 -122.3 -53.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 241' ' ' ASP . 2.7 m -34.21 -69.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.1 t -49.86 176.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -148.59 164.2 34.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 48.9 p 45.74 42.13 8.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.58 88.39 3.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.098 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 8.8 tt -73.27 -50.6 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.853 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.2 t -61.3 -57.14 13.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.35 . . . . 0.0 110.841 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 186' ' ' GLY . 12.4 t -98.57 107.74 20.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.848 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 185' ' ' SER . . . 36.22 -126.92 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.1 m -113.24 127.44 56.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.904 0.383 . . . . 0.0 110.865 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 70.3 m 49.68 40.16 19.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.57 -40.35 2.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.462 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -61.84 108.53 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -78.35 170.71 16.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 77.3 p -122.2 148.79 44.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.477 ' NE2' ' CB ' ' A' ' 204' ' ' PHE . 7.2 pt20 -113.96 122.57 34.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.578 0.704 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 99.33 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.713 2.275 . . . . 0.0 112.311 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.0 t -51.08 143.78 10.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.6 m -87.27 -26.05 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.538 ' CE2' HD11 ' A' ' 217' ' ' LEU . 15.7 m-85 -72.52 -69.97 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.1 p -77.06 -3.22 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 46.7 p 52.09 31.48 8.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -114.7 177.09 4.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -106.74 126.95 52.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -138.45 151.98 47.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.434 ' CG1' HG21 ' A' ' 206' ' ' THR . 11.1 p -76.9 133.41 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.477 ' CB ' ' NE2' ' A' ' 193' ' ' GLN . 2.2 p90 -50.45 -21.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.16 -33.44 74.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 209' ' ' SER . 46.0 p -101.83 -38.16 7.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 206' ' ' THR . 2.8 tp -33.35 -38.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 206' ' ' THR . 29.4 mm100 -55.71 -49.74 72.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 206' ' ' THR . 69.4 p -83.26 -38.49 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 211' ' ' GLN . 8.8 t60 -53.98 -45.71 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 210' ' ' HIS . 5.5 mt-30 -38.34 -38.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -72.11 -52.72 15.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 214' ' ' CYS . 15.4 mm100 -57.46 -51.18 70.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.456 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.9 t -33.83 107.53 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -41.9 3.84 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -52.22 -38.26 57.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 197' ' ' TYR . 3.7 tp -38.91 129.08 1.19 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.584 0.707 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 134.23 27.63 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.713 2.276 . . . . 0.0 112.352 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 15.7 m -129.25 136.61 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.85 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.6 t -63.72 135.17 96.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.643 0.735 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -33.36 16.61 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -79.46 -20.67 46.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 61.96 54.63 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 10.7 p -75.42 -49.85 17.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 160.95 -38.47 0.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.518 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 226' ' ' GLY . 9.2 p -34.25 -39.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.47 -99.99 2.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -112.79 138.09 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 231' ' ' ALA . 14.8 p -150.13 134.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.3 143.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 46.8 ttt-85 -61.88 -39.86 93.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.49 2.38 29.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -110.81 -12.98 14.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.3 tp -60.99 -43.36 90.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.96 -65.65 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.351 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.53 -28.58 56.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -70.14 -56.33 7.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.822 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.41 -32.24 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -50.39 -66.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 27.6 t70 -124.05 -49.3 1.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.5 t -34.22 -68.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 6.2 t -49.93 108.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -132.23 81.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.3 t -80.43 -16.79 53.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -66.59 135.33 53.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.085 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 247' ' ' LEU . 4.4 mm? -86.28 47.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.93 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.866 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.1 t -123.03 120.28 32.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.853 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 42.1 t -104.61 -51.24 3.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.34 -128.43 8.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.0 t -70.76 109.36 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 110.856 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.4 t -50.88 155.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.837 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.51 171.9 50.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -129.42 107.16 9.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 74.6 mtm-85 -63.67 146.59 53.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.9 p -111.2 151.14 28.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -118.43 108.97 40.88 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 102.83 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 6.9 t -52.91 120.19 5.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.3 m -72.84 2.78 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.401 ' O ' ' CZ ' ' A' ' 216' ' ' ARG . 5.5 m-85 -101.38 -64.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.0 p -89.04 5.69 43.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p 45.87 35.07 2.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -98.24 -174.57 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -131.57 103.58 6.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.75 176.09 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 206' ' ' THR . 39.2 t -82.98 124.13 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -38.21 -29.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 203' ' ' VAL . 23.7 t0 -77.62 -42.21 35.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 203' ' ' VAL . 58.5 p -78.99 -50.81 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 206' ' ' THR . 2.3 tp -33.21 -42.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.151 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.412 ' N ' ' CG2' ' A' ' 207' ' ' ILE . 67.2 mm-40 -45.4 -57.42 4.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -71.32 -49.35 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 213' ' ' GLN . 14.2 t60 -40.52 -51.11 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.867 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.5 mt-30 -32.86 -38.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.7 m-85 -69.68 -49.04 57.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' HIS . 78.2 mm-40 -65.78 -45.46 82.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 213' ' ' GLN . 12.0 t -32.77 118.38 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.7 Cg_endo -69.79 -50.11 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.356 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 215' ' ' PRO . 24.7 mmm-85 -34.29 -37.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.9 tp -44.3 129.08 4.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.601 0.715 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 138.97 39.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.353 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.31 127.35 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.16 133.61 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.2 t -60.44 135.52 91.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -28.32 25.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -81.92 -7.81 59.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 48.39 53.42 12.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 9.4 p -72.79 -51.02 20.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 156.33 -35.15 0.6 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.536 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.471 HG12 ' CE1' ' A' ' 238' ' ' HIS . 6.7 p -37.68 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.148 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.85 -93.54 1.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.49 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.5 p -117.66 146.61 43.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.799 0.333 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.529 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 14.4 p -157.64 127.91 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -37.3 153.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -66.2 -43.83 85.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -78.47 7.15 7.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -14.32 11.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.4 tp -63.3 -43.58 80.41 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.599 0.714 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.5 Cg_exo -47.93 -65.44 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.729 2.286 . . . . 0.0 112.345 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.21 -25.63 57.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.471 ' CE1' HG12 ' A' ' 227' ' ' VAL . 7.8 t60 -72.57 -52.77 14.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 110.817 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.43 -18.71 12.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -69.98 -63.86 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 242' ' ' SER . 11.2 t0 -115.31 -56.35 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 241' ' ' ASP . 20.0 m -34.06 -69.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 3.0 t -56.79 150.24 16.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -133.37 178.68 6.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.8 t 40.04 40.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -110.97 140.5 45.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.11 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 14.5 tp -51.07 -43.45 61.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.859 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 t 49.69 42.41 23.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 110.845 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 56.0 p -115.11 132.23 56.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.76 -164.83 27.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.7 m -92.66 -48.37 6.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 110.781 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.4 t 40.15 41.96 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.67 146.77 5.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -123.66 131.48 53.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.703 0.287 . . . . 0.0 110.914 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -75.35 161.55 29.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 34.5 p -114.56 135.71 53.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 202' ' ' PHE . 29.9 tp60 -107.8 116.52 57.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.897 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 106.56 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.675 2.25 . . . . 0.0 112.315 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.17 138.44 56.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 196' ' ' THR . 4.8 m -86.25 -13.8 45.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.68 -64.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.914 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 p -85.93 -0.05 54.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 49.49 36.45 10.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -113.42 169.8 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -104.32 122.74 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 193' ' ' GLN . 73.1 m-85 -138.61 175.14 9.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.72 144.8 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -64.67 -27.96 69.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.07 -43.59 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 208' ' ' GLN . 52.8 p -73.97 -44.06 56.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.19 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 206' ' ' THR . 3.2 tp -33.67 -33.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 206' ' ' THR . 34.6 mm-40 -57.5 -58.43 8.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.7 m -77.45 -41.63 38.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 5.4 t60 -41.88 -46.43 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -38.52 -39.23 0.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -67.73 -39.76 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 55.3 mm-40 -73.8 -36.67 65.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.9 t -34.26 118.2 0.52 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.586 0.708 . . . . 0.0 110.903 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -24.43 29.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.327 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -84.4 25.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.4 tp -100.42 131.1 24.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.59 0.71 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 119.65 6.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.33 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.02 141.14 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.23 127.95 34.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.6 t -57.96 132.75 83.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.638 0.732 . . . . 0.0 110.928 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -12.14 32.13 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.698 2.265 . . . . 0.0 112.305 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -97.06 -8.42 30.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 47.71 53.06 11.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 4.2 p -73.12 -53.78 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 161.81 -32.13 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.4 p -44.54 -24.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 111.145 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.74 -81.05 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -132.55 148.75 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.467 ' CG1' HD13 ' A' ' 235' ' ' LEU . 12.9 p -156.41 136.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.69 147.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -65.26 -30.53 71.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -86.76 -1.69 57.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.87 -21.99 13.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 10.3 tp -56.32 -44.35 99.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.93 -65.63 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.686 2.257 . . . . 0.0 112.362 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.42 98.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 4.1 t60 -56.11 -49.24 74.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.0 mt -57.29 -27.4 62.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -55.58 -67.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.482 ' O ' ' C ' ' A' ' 242' ' ' SER . 5.6 p-10 -121.08 -52.02 2.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.1 t -31.54 -68.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.468 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.7 t -51.44 142.99 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -116.75 79.98 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.1 t -111.45 134.61 52.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -44.27 162.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.459 ' N ' HD23 ' A' ' 247' ' ' LEU . 4.3 mm? -51.79 155.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 96.8 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.0 p -153.38 162.58 41.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 42.2 m -137.24 148.06 46.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -144.8 49.97 0.66 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.0 p -80.11 163.1 24.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.884 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -109.61 89.42 3.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.4 -157.64 10.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -144.02 119.03 10.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.724 0.297 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -82.25 141.89 32.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.2 p -116.62 131.72 56.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -107.45 113.6 61.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 104.48 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.663 2.242 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.09 146.52 14.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.0 m -89.59 -26.44 20.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.18 -69.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.7 p -76.51 -4.2 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.0 p 49.57 39.13 16.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -121.31 164.59 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -93.97 128.04 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -137.92 160.59 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 20.9 t -69.21 138.18 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.12 -35.56 75.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -70.89 -15.92 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.3 p -107.94 -20.97 13.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 3.8 tp -50.56 -17.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -78.21 -42.19 32.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 93.6 p -85.06 -44.44 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.3 t60 -44.28 -47.84 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -34.88 -36.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 210' ' ' HIS . 17.4 m-85 -75.6 -45.34 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 36.5 mt-30 -64.71 -47.68 77.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' A' ' 213' ' ' GLN . 11.7 t -34.12 112.69 0.42 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.7 Cg_endo -69.8 -50.79 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.9 mmm-85 -38.06 -30.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 215' ' ' PRO . 5.1 tp -61.17 132.26 92.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.56 0.695 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 140.41 42.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.386 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.5 m -139.03 125.44 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.092 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.42 139.19 44.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.0 t -59.18 134.07 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.587 0.708 . . . . 0.0 110.93 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 1.13 4.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 224' ' ' GLN . 73.8 m-20 -121.3 9.0 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 223' ' ' ASN . 2.7 mp0 36.97 41.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 29.5 p -58.59 -47.41 84.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 151.46 -34.63 0.89 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 226' ' ' GLY . 11.8 p -37.14 -37.1 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.38 -102.37 2.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.524 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 35.5 p -118.22 123.29 45.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.429 HG21 ' N ' ' A' ' 231' ' ' ALA . 7.9 p -132.45 143.73 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.429 ' N ' HG21 ' A' ' 230' ' ' VAL . . . -52.69 137.65 30.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -49.73 -54.74 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.9 pm0 -66.06 -4.58 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -104.88 -13.79 15.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.631 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -61.07 -42.68 87.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.99 -64.06 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -56.4 -43.81 90.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -56.01 -56.22 23.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.9 mt -56.45 -14.29 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 1.3 tmmm? -64.88 -65.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 242' ' ' SER . 38.9 t0 -121.02 -51.75 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.2 m -35.46 -65.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 2.5 t -61.78 176.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -162.44 156.01 20.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 97.7 m -93.78 150.8 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . 45.95 43.55 10.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.9 tt -95.88 131.83 41.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 90.0 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.111 179.84 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 85.6 p -99.43 -24.39 14.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.341 . . . . 0.0 110.83 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 91.1 p -144.17 114.97 7.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 46.22 -116.77 2.38 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.453 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.1 t -65.77 171.78 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.883 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.6 t -54.62 115.12 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -55.32 -51.56 53.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 190' ' ' LYS . 3.6 mtmp? -104.23 156.59 17.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -94.04 166.06 12.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 p -138.6 136.16 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -113.91 106.52 53.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 101.56 0.93 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 29.8 t -54.94 142.08 31.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.5 m -89.56 -13.5 37.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.32 -65.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 24.4 p -82.3 -2.64 53.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 25.2 p 48.94 37.61 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -104.83 -174.86 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -130.19 102.63 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -119.85 173.64 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.5 t -73.1 144.09 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.422 ' O ' ' CG2' ' A' ' 207' ' ' ILE . 2.6 p90 -59.17 -34.45 72.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -69.0 -35.45 76.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 28.4 p -82.45 -32.15 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 204' ' ' PHE . 7.7 tp -48.87 -18.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -69.57 -47.9 62.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -88.29 -38.29 15.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 16.3 t60 -44.13 -51.29 8.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 51.8 mt-30 -34.3 -36.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 210' ' ' HIS . 28.2 m-85 -75.13 -46.31 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.5 mt-30 -62.9 -42.4 99.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.3 t -34.08 118.09 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.587 0.708 . . . . 0.0 110.889 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -49.44 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.266 . . . . 0.0 112.371 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -40.53 -37.76 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.6 tp -44.64 125.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 144.81 54.89 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.83 126.28 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.95 141.99 37.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.061 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.0 t -67.05 134.87 93.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -16.32 37.57 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -96.18 -6.7 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 48.04 53.81 11.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 4.5 p -72.33 -54.05 10.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 159.61 -24.46 0.31 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 p -48.67 -22.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.16 -89.3 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.9 p -124.92 145.78 49.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.18 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.8 p -153.79 134.79 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.22 152.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -70.11 -32.14 70.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.45 -1.8 58.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -114.18 -16.61 12.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 3.3 tp -61.76 -44.29 90.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 0.0 110.909 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.8 Cg_exo -48.01 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.667 2.244 . . . . 0.0 112.306 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.82 39.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.35 -51.1 56.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.71 -22.5 46.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -60.1 -63.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 242' ' ' SER . 17.0 t0 -125.3 -47.2 1.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.5 t -36.0 -66.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.2 t -52.12 -46.92 65.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -95.48 87.36 4.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 32.2 p -38.64 -53.95 1.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -103.28 89.54 3.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.114 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -123.13 -53.77 1.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 179.821 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 88.7 p -130.85 -48.99 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.876 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 1.6 t -61.2 135.95 57.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.63 -148.61 5.03 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.459 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.5 p 44.31 43.28 5.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 0.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.0 p -109.49 126.62 53.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -103.38 -52.84 0.9 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.54 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -54.28 130.11 37.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.87 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -76.51 168.94 19.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.2 p -126.84 143.84 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -119.52 116.87 33.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.598 0.713 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 96.93 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 30.1 t -51.42 135.14 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.2 m -83.77 -11.36 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -86.14 -69.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.4 p -79.17 -0.79 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p 47.81 42.56 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -125.34 159.79 30.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -90.61 129.38 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -138.63 171.24 14.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -76.16 159.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -77.16 -30.46 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.05 -20.01 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 30.6 p -104.77 -49.04 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 206' ' ' THR . 2.0 tp -33.35 -34.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 14.4 mm-40 -57.18 -56.63 19.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -77.79 -42.52 33.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.6 t60 -43.7 -46.72 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 210' ' ' HIS . 41.8 mt-30 -35.45 -35.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 m-85 -80.41 -42.96 21.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.8 t -33.29 123.5 0.44 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.59 0.71 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -44.2 2.17 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.331 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -45.27 -40.3 7.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 tp -39.21 128.82 1.29 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 123.4 10.05 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.37 140.39 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.03 135.21 50.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.069 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 29.9 t -61.99 134.65 94.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.726 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -30.64 21.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.705 2.27 . . . . 0.0 112.368 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -81.17 -9.68 59.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 49.04 52.93 13.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 11.2 p -71.38 -49.84 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 159.92 -39.14 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.538 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 238' ' ' HIS . 7.6 p -33.77 -38.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.26 -87.74 0.98 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.473 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 11.9 p -127.62 146.35 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.093 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 231' ' ' ALA . 7.9 p -158.08 132.43 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -37.47 141.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -38.49 68.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -80.45 -3.31 49.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -104.99 -16.79 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.9 tp -61.14 -42.69 87.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.726 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.97 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.731 2.287 . . . . 0.0 112.327 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.8 -23.88 59.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.474 ' CE1' HG12 ' A' ' 227' ' ' VAL . 10.5 t60 -73.76 -47.14 41.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.4 mt -62.4 -11.16 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -77.27 -64.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 242' ' ' SER . 20.0 t0 -108.58 -63.1 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.7 m -33.16 -71.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.434 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t -60.9 116.74 4.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -96.61 87.3 4.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.7 t -104.76 141.33 36.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.168 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . 46.82 27.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.3 mt -142.79 157.97 44.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 m -133.49 151.53 51.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 0.0 110.84 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 88.3 p -55.01 151.73 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.82 -98.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.4 m -155.49 115.61 3.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 0.0 110.86 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 93.3 p -112.14 41.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.11 -39.67 88.53 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.475 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -39.66 110.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.423 ' NH1' ' HB3' ' A' ' 191' ' ' ARG . 5.0 ptp180 -69.86 163.93 24.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.8 p -115.45 147.22 40.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.114 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -114.23 105.78 53.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.711 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 105.41 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.39 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 4.9 t -55.23 123.87 15.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.8 m -76.76 3.77 11.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.6 -63.96 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.53 9.15 21.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.7 p 39.7 42.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -108.68 -175.44 2.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.8 107.24 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -124.62 158.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 206' ' ' THR . 4.7 t -61.35 128.43 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -40.55 -32.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.8 -43.42 65.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 203' ' ' VAL . 46.9 p -72.23 -42.93 65.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.163 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.464 HG21 ' N ' ' A' ' 208' ' ' GLN . 3.6 tp -38.68 -29.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.464 ' N ' HG21 ' A' ' 207' ' ' ILE . 0.5 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -72.84 -37.7 67.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLN . 19.5 t60 -49.68 -50.4 43.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 19.2 mt-30 -34.32 -45.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.901 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -62.51 -45.81 91.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' HIS . 31.0 mm100 -67.86 -50.79 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -34.39 110.64 0.39 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.9 Cg_endo -69.8 -43.72 2.46 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 215' ' ' PRO . 15.5 mmm180 -34.46 -40.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.2 tp -40.29 127.3 1.73 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.592 0.711 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.42 33.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.73 135.99 54.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.35 57.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 38.7 t -58.93 131.51 86.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -3.57 12.25 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.252 . . . . 0.0 112.339 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -104.86 -11.54 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 53.44 53.18 12.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 6.3 p -76.21 -48.02 21.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 152.86 -30.09 0.82 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.48 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.3 p -42.94 -24.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.53 -91.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -120.14 150.13 41.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.47 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 12.5 p -158.25 133.9 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -44.23 142.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.49 -49.4 70.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.05 6.74 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -112.6 -14.73 13.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.1 tp -61.9 -43.56 87.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.544 0.688 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.99 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.27 . . . . 0.0 112.345 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.89 -34.83 61.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.558 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 18.4 t60 -65.6 -61.24 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.425 ' HA ' ' CB ' ' A' ' 243' ' ' CYS . 67.2 mt -49.07 -36.86 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -50.4 -67.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 7.8 p-10 -112.4 -57.2 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.448 ' HB3' ' CG ' ' A' ' 238' ' ' HIS . 5.5 t -33.81 -67.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.558 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t -66.47 167.07 11.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.848 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -108.96 103.68 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.3 p -120.05 112.53 19.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.55 41.05 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.408 HD22 ' C ' ' A' ' 247' ' ' LEU . 10.4 tt -97.42 -62.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.11 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.4 m -128.19 106.7 9.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.795 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 13.6 t -115.56 146.27 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.65 52.79 0.89 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.548 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.5 t -51.21 127.86 20.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 0.0 110.83 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.4 m -166.87 127.52 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.865 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -143.23 102.69 0.29 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.38 156.69 29.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.53 147.89 39.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 33.0 p -110.27 141.78 42.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -108.21 109.73 61.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.03 2.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.705 2.27 . . . . 0.0 112.301 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.56 148.36 49.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.6 m -90.23 -29.23 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.37 -69.65 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.52 -3.44 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 34.8 p 46.0 45.84 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -119.26 -175.36 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -119.74 123.4 43.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -138.62 160.66 39.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 204' ' ' PHE . 10.0 p -80.35 143.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.088 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.423 ' N ' HG23 ' A' ' 203' ' ' VAL . 2.0 p90 -51.86 -22.81 4.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 207' ' ' ILE . 76.7 p -99.29 -46.87 5.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.155 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.8 tp -33.29 -38.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 26.2 mt-30 -54.39 -55.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.08 -44.37 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 9.7 t60 -39.67 -50.65 2.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 210' ' ' HIS . 49.5 mm-40 -32.62 -39.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' HIS . 6.9 m-85 -75.84 -46.76 28.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.8 mm-40 -59.34 -43.93 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -33.94 113.8 0.43 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.586 0.708 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -47.58 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.386 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 11.9 mmm180 -38.32 -37.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 216' ' ' ARG . 7.7 tp -37.92 130.7 0.94 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.587 0.708 . . . . 0.0 110.964 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 125.86 12.66 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.351 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.9 m -122.29 136.02 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -67.29 139.54 57.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.34 130.61 94.23 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -12.46 32.85 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 0.0 112.321 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -96.46 -19.94 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 61.57 48.18 5.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.2 p -69.04 -52.11 32.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 162.83 -40.17 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 226' ' ' GLY . 11.5 p -36.03 -40.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.412 ' N ' HG13 ' A' ' 227' ' ' VAL . . . 95.56 -89.34 1.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.486 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 28.6 p -122.28 142.67 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.095 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.501 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 12.9 p -153.87 139.32 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -41.43 138.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -52.9 -41.15 64.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.425 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.8 pt-20 -78.93 -11.77 60.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.428 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 6.1 m-20 -92.24 -25.36 18.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.599 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.1 tp -54.16 -43.92 97.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.587 0.708 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -48.0 -60.36 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.222 . . . . 0.0 112.358 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -64.01 -31.92 82.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.414 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 5.7 t60 -65.36 -52.02 56.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.39 -33.04 58.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -48.95 -66.6 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.3 p30 -121.39 -52.04 2.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.3 t -32.51 -67.78 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.414 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.5 t -54.47 155.25 4.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -128.55 87.93 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.2 m -95.74 107.32 19.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -169.31 129.79 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.088 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.1 mt 53.98 41.82 31.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.164 179.79 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 71.2 p -103.79 97.65 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 0.0 110.85 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 68.2 m -104.84 -56.59 2.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -122.47 -80.28 0.52 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.6 t -133.94 124.75 26.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.819 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.3 m -66.92 150.82 48.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 116.19 73.6 0.52 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.98 156.35 18.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 110.901 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -68.13 171.78 6.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 42.5 p -138.99 138.32 37.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.122 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -110.46 106.25 57.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.873 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 99.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 48.4 t -53.67 142.41 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 79.5 m -89.4 -20.33 24.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.46 ' CE2' HD12 ' A' ' 217' ' ' LEU . 13.7 m-85 -76.47 -65.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.93 -2.26 56.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.3 p 49.83 37.03 12.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -107.34 -174.45 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -130.21 112.9 13.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.404 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 75.9 m-85 -121.7 177.34 5.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 206' ' ' THR . 60.4 t -80.27 123.11 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.424 ' C ' HG21 ' A' ' 207' ' ' ILE . 1.3 p90 -39.63 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 203' ' ' VAL . 6.5 t70 -80.41 -40.06 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 203' ' ' VAL . 81.8 p -79.64 -47.35 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 208' ' ' GLN . 2.1 tp -34.67 -31.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' THR . 32.8 mm-40 -53.12 -53.8 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -76.92 -47.39 21.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.2 t60 -40.93 -48.01 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 210' ' ' HIS . 9.3 mt-30 -33.73 -38.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 210' ' ' HIS . 10.6 m-85 -77.65 -44.92 26.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 210' ' ' HIS . 25.6 mm-40 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.467 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -32.65 116.5 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -46.42 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.627 2.218 . . . . 0.0 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.431 ' NH1' ' OE2' ' A' ' 233' ' ' GLU . 26.8 mmt-85 -41.28 -34.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.46 HD12 ' CE2' ' A' ' 197' ' ' TYR . 7.8 tp -55.54 136.52 70.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.565 0.698 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 153.94 68.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.45 131.38 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.161 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.12 135.89 57.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 47.3 t -59.48 134.25 88.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -17.51 37.55 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -94.69 -6.54 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 49.06 51.3 16.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 22.8 p -74.37 -48.26 29.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 154.91 -30.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.494 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.405 HG12 ' CE1' ' A' ' 238' ' ' HIS . 4.4 p -38.58 -26.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.18 -84.33 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.9 p -132.37 145.62 51.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.451 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 12.1 p -158.05 129.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.06 143.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -62.41 -44.7 95.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.431 ' OE2' ' NH1' ' A' ' 216' ' ' ARG . 16.4 pt-20 -70.04 -2.53 13.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.53 -12.54 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -58.17 -42.84 97.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.615 0.721 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.98 -65.83 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.49 -33.65 59.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 242' ' ' SER . 45.9 t60 -66.13 -50.16 64.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.5 mt -67.56 -25.51 65.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.988 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -56.39 -67.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.85 -32.38 0.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.456 ' O ' ' ND1' ' A' ' 238' ' ' HIS . 2.5 m -77.77 45.5 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 245' ' ' THR . 17.8 t -153.24 107.41 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -37.32 93.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 243' ' ' CYS . 24.6 p -146.5 133.18 19.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -117.28 92.34 3.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.1 148.04 22.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.117 179.844 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 185' ' ' SER . 26.3 m -120.99 139.56 53.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 184' ' ' SER . 19.8 m -35.48 142.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -140.76 -152.6 5.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 77.7 p -104.36 168.13 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 110.882 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.0 t -153.72 139.63 18.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -173.01 -156.69 13.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -95.87 120.73 36.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 110.879 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -60.59 152.28 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.9 p -123.39 132.07 53.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.145 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -107.43 103.92 50.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 100.58 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 51.5 t -52.26 149.62 5.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.4 m -90.59 -41.08 11.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.156 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.05 -70.12 0.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.5 p -75.26 -6.85 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.896 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.7 p 49.71 39.71 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -113.04 174.2 6.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.866 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -109.08 121.78 45.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.82 174.25 10.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.455 HG21 ' N ' ' A' ' 204' ' ' PHE . 14.6 p -97.91 144.14 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.13 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.455 ' N ' HG21 ' A' ' 203' ' ' VAL . 1.9 p90 -53.56 -21.94 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.28 -27.0 62.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 208' ' ' GLN . 64.7 p -102.39 -43.08 5.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 206' ' ' THR . 3.7 tp -35.94 -30.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.9 mt-30 -62.17 -52.96 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -81.94 -38.78 24.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' A' ' 213' ' ' GLN . 18.9 t60 -49.19 -51.05 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 210' ' ' HIS . 24.9 mt-30 -33.74 -38.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' HIS . 54.9 m-85 -72.95 -48.22 38.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.1 mt-30 -62.87 -50.2 71.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.2 t -34.15 113.7 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.629 0.728 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.67 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 15.5 mmm180 -43.29 -41.15 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 216' ' ' ARG . 11.8 tp -38.25 131.69 0.99 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 139.43 40.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.667 2.245 . . . . 0.0 112.3 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.3 134.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -64.44 127.87 33.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.9 t -58.21 131.45 84.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -12.42 32.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -95.19 -18.02 21.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 61.55 49.55 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 6.3 p -68.74 -52.07 34.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 155.71 -35.18 0.63 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.512 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.1 p -38.47 -26.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 111.141 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.71 -71.97 2.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 64.9 p -145.97 147.25 31.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.138 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 10.1 p -154.13 144.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -47.64 134.87 12.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -51.7 -36.57 47.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.42 ' OE1' ' C ' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.65 -17.05 58.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.825 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.451 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.2 m-20 -91.37 -25.5 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.571 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -48.27 -45.96 66.73 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.1 Cg_exo -47.94 -60.8 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 0.0 112.371 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -65.96 -20.72 69.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -76.84 -50.46 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 26.2 mt -53.88 -22.5 10.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -56.26 -67.2 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.6 m-20 -127.15 -49.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 241' ' ' ASP . 22.0 m -31.5 -64.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t -44.38 169.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -85.61 84.71 7.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.5 t -64.51 116.82 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.153 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -173.36 141.9 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.12 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.9 mp 49.06 43.22 22.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.861 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.6 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.696 0.284 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.425 ' O ' HD13 ' A' ' 207' ' ' ILE . 17.1 tm0? -114.12 117.97 42.88 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 104.85 1.38 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 12.5 t -57.52 135.47 56.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 196' ' ' THR . 81.9 m -82.4 -10.41 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -89.91 -69.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.0 p -79.67 4.33 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.8 p 42.76 37.06 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -118.51 160.62 21.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.37 130.85 37.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.98 170.12 16.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.81 127.76 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -46.13 -27.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.12 -35.0 66.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 207' ' ' ILE . 34.7 p -87.41 -50.71 6.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 208' ' ' GLN . 2.9 tp -33.54 -42.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 207' ' ' ILE . 92.7 mm-40 -49.76 -49.58 47.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.1 t -86.24 -45.3 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.484 ' O ' ' N ' ' A' ' 213' ' ' GLN . 11.0 t60 -45.28 -47.22 12.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mt-30 -34.74 -33.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.0 m-85 -78.91 -46.85 17.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mm-40 -63.15 -45.48 91.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.9 t -35.34 120.49 0.62 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.627 0.727 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -50.44 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.69 2.26 . . . . 0.0 112.338 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -43.62 -40.91 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 tp -39.69 127.29 1.49 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.615 0.722 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 141.95 46.56 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 230' ' ' VAL . 34.5 m -137.79 138.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -71.18 139.11 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.4 t -67.32 135.28 93.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -20.54 34.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -91.82 0.05 57.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 39.62 52.43 2.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.2 p -69.03 -51.53 38.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 159.12 -37.74 0.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.483 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.9 p -37.03 -33.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 90.99 -94.75 2.0 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.1 p -117.17 147.26 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 219' ' ' VAL . 11.6 p -157.14 131.77 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.63 146.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -58.92 -37.7 77.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.35 2.95 29.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.463 ' CB ' HG22 ' A' ' 230' ' ' VAL . 1.4 m-20 -109.24 -15.14 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.4 tp -65.17 -44.5 69.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.91 -62.68 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.327 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -61.02 -45.61 96.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -53.59 -48.28 69.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.358 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.1 mt -59.37 -17.34 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 32.8 ttmt -62.41 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 15.7 p-10 -128.2 -45.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.5 m -34.54 -64.98 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.752 0.31 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 30.5 mt-30 -107.81 103.86 51.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.2 Cg_endo -69.72 99.9 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.649 2.233 . . . . 0.0 112.338 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.16 140.7 15.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.4 m -87.21 -22.97 24.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -73.58 -69.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.1 p -77.78 -4.21 45.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 51.36 38.98 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -112.29 179.99 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -115.9 121.89 43.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -137.38 175.02 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.53 154.36 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -62.73 -25.26 68.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -68.47 -17.6 64.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 208' ' ' GLN . 55.5 p -112.38 -42.76 3.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.6 tp -33.73 -33.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 206' ' ' THR . 16.3 mm100 -62.34 -49.95 73.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 t -84.49 -44.5 13.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 213' ' ' GLN . 38.1 t60 -45.02 -50.87 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -33.03 -36.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 210' ' ' HIS . 14.9 m-85 -79.98 -48.3 13.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.5 mt-30 -57.29 -44.28 83.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.9 t -33.74 116.05 0.46 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.67 0.748 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -46.91 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.69 2.26 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -42.91 -25.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.18 132.23 31.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.575 0.702 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 137.45 35.49 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.26 . . . . 0.0 112.34 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 230' ' ' VAL . 17.0 m -136.1 140.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.37 132.32 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.56 136.89 96.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.653 0.739 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -32.8 18.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.703 2.269 . . . . 0.0 112.352 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -80.5 -4.15 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 45.05 47.89 9.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.549 ' SG ' HG12 ' A' ' 227' ' ' VAL . 13.4 p -64.93 -49.68 69.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 156.18 -37.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.549 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.5 p -34.34 -37.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.162 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.8 -75.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 81.7 p -136.4 150.58 48.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 219' ' ' VAL . 8.0 p -157.82 133.76 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.053 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.14 142.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ttt-85 -54.84 -43.94 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.21 6.55 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -113.96 -10.89 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.602 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 8.4 tp -66.41 -44.48 57.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.624 0.726 . . . . 0.0 110.914 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.98 -64.92 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -59.81 -47.79 89.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.439 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -51.09 -50.55 58.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.9 mt -59.92 -15.4 21.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 18.5 ttmt -69.64 -65.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' SER . 51.7 m-20 -123.34 -49.17 1.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.5 t -34.93 -69.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.729 0.3 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -107.65 105.21 55.54 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.606 0.717 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 102.69 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.5 t -52.54 145.69 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.9 m -90.09 -26.5 20.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -69.52 -73.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.57 -4.11 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.3 p 54.08 31.3 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -100.88 -176.59 3.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.27 121.91 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.546 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 68.5 m-85 -136.15 152.36 50.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.675 HG23 ' H ' ' A' ' 206' ' ' THR . 18.9 m -76.0 139.35 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.6 p90 -43.72 -23.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 203' ' ' VAL . 5.7 t70 -72.85 -44.01 61.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.675 ' H ' HG23 ' A' ' 203' ' ' VAL . 66.5 p -84.41 -45.71 12.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.3 tp -34.02 -34.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 206' ' ' THR . 21.7 mt-30 -58.37 -56.88 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.956 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.3 m -75.01 -37.92 61.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.546 ' CE1' ' CE2' ' A' ' 202' ' ' PHE . 36.0 t60 -44.85 -49.21 10.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -34.14 -34.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.9 m-85 -78.88 -47.08 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.5 mm-40 -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.8 t -34.41 109.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.4 Cg_endo -69.85 -50.64 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.273 . . . . 0.0 112.328 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 215' ' ' PRO . 12.7 mmt180 -36.79 -31.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.1 tp -52.23 135.88 40.36 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 138.34 37.74 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.361 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 219' ' ' VAL . 21.7 m -132.2 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.89 130.26 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.7 t -61.06 136.69 93.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.659 0.742 . . . . 0.0 110.834 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -29.6 23.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -83.68 -6.89 59.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 46.79 52.0 11.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.6 p -68.36 -51.54 43.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 161.2 -35.91 0.4 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.511 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.51 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.7 p -39.28 -26.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.143 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.43 -70.05 3.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 59.8 p -147.54 147.55 30.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.521 ' CG1' HD12 ' A' ' 235' ' ' LEU . 11.8 p -154.23 140.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -36.4 143.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.83 -39.14 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -81.88 3.22 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.677 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -115.54 -5.95 12.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.598 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.67 -44.51 80.64 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.586 0.708 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.99 -63.45 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.684 2.256 . . . . 0.0 112.3 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.05 -29.07 61.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.46 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' HIS . . . . . 0.408 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 15.9 t60 -70.05 -54.87 11.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.11 -14.2 2.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.65 -66.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 24.0 t0 -106.78 -62.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 241' ' ' ASP . 54.9 m -34.44 -66.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.768 0.318 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.687 ' O ' HD13 ' A' ' 207' ' ' ILE . 1.9 tp60 -117.21 115.69 37.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.731 . . . . 0.0 110.874 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 109.67 2.37 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.0 t -53.3 123.08 10.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 196' ' ' THR . 40.2 m -74.89 4.2 6.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -104.07 -59.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.3 7.73 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 38.8 p 41.46 46.69 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -120.63 155.07 34.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.95 115.07 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -135.8 145.29 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.2 t -47.83 149.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.681 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.7 p90 -69.17 -28.97 66.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.61 -36.67 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLN . 69.5 p -82.69 -44.59 15.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 193' ' ' GLN . 4.1 tp -33.54 -34.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.6 mt-30 -65.91 -50.4 64.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 75.0 p -73.82 -40.65 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.9 t60 -58.54 -50.14 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 210' ' ' HIS . 8.1 mm-40 -33.95 -36.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 210' ' ' HIS . 32.4 m-85 -70.93 -49.38 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 210' ' ' HIS . 51.6 mt-30 -65.08 -42.84 93.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -33.82 123.72 0.48 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -49.5 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -41.6 -38.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 tp -45.58 134.09 6.16 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.588 0.709 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.13 39.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 230' ' ' VAL . 17.8 m -134.53 133.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.76 143.68 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.093 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.29 134.62 89.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -23.31 30.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.09 2.7 53.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 37.97 50.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 9.1 p -67.4 -48.81 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 157.62 -41.86 0.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 226' ' ' GLY . 12.6 p -33.82 -38.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 111.162 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.0 -97.38 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 16.6 p -112.67 146.02 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.565 HG11 HD12 ' A' ' 235' ' ' LEU . 11.3 p -157.54 130.98 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.144 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.49 145.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.424 ' C ' ' HD3' ' A' ' 232' ' ' ARG . 3.5 tmt_? -62.08 -33.58 74.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.62 -4.28 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.553 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 4.4 m-20 -106.05 -8.57 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.622 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.9 tp -68.89 -43.1 25.98 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.625 0.726 . . . . 0.0 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.0 Cg_exo -47.94 -65.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.377 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.33 -33.72 71.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.89 -51.85 62.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 58.4 mt -57.43 -18.85 20.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -63.16 -66.71 0.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.4 m-20 -125.76 -46.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.1 m -35.02 -65.35 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.763 0.316 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 21.9 mm-40 -112.59 103.31 55.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.634 0.73 . . . . 0.0 110.944 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.1 Cg_endo -69.72 105.77 1.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.343 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.4 t -56.41 136.51 53.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -84.12 -17.15 41.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -78.97 -69.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.7 p -79.1 -2.64 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p 50.33 42.56 26.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -117.17 177.57 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -111.16 115.4 29.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -137.98 144.0 40.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.3 156.23 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.616 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.5 p90 -63.75 -24.85 67.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.77 -27.97 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.5 p -99.09 -37.62 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 204' ' ' PHE . 5.2 tp -38.61 -27.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 206' ' ' THR . 13.5 mm100 -63.6 -56.36 16.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -79.98 -42.46 23.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.9 t60 -41.16 -48.87 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.849 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -35.2 -38.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.38 -44.33 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.3 mt-30 -63.42 -47.89 80.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -34.57 107.29 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.727 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.65 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt-85 -41.8 -30.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.0 tp -52.6 135.41 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.585 0.707 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 141.91 46.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.38 136.58 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.48 134.98 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.0 t -66.68 135.28 94.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.619 0.723 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.02 29.02 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -85.96 -1.88 57.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 40.98 53.93 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.641 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.4 p -71.66 -52.0 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 154.39 -28.42 0.69 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.458 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.641 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.3 p -44.03 -24.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.52 -96.28 1.93 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.4 p -116.39 145.19 43.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 231' ' ' ALA . 12.0 p -155.51 128.08 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.45 145.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -59.82 -40.68 89.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -80.62 6.1 13.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 1.2 m-20 -115.07 -8.14 12.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.2 tp -69.88 -42.56 18.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 0.0 110.946 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.97 -64.3 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.35 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.35 -33.53 76.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.46 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' HIS . . . . . 0.403 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 15.0 t60 -64.25 -48.61 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.73 -19.62 51.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -62.24 -66.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' SER . 9.5 t0 -125.59 -45.41 1.78 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.7 t -35.63 -65.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.6 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.77 0.319 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.76 116.2 54.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.409 ' HB3' ' CD ' ' A' ' 201' ' ' GLU . 53.9 Cg_endo -69.74 98.03 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 34.5 t -50.97 142.83 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 196' ' ' THR . 74.3 m -88.28 -16.26 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -83.39 -69.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.1 p -78.06 -2.71 38.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.5 p 50.42 30.97 4.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 61.8 mttt -103.76 -174.73 2.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 194' ' ' PRO . 19.8 mm-40 -129.47 120.59 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.16 177.02 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.17 155.64 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.12 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.7 p90 -71.18 -31.15 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -26.72 59.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 209' ' ' SER . 70.2 p -91.27 -42.94 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 204' ' ' PHE . 4.3 tp -33.46 -38.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 206' ' ' THR . 56.7 mm-40 -56.95 -49.69 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' THR . 50.3 p -76.93 -37.34 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 213' ' ' GLN . 20.8 t60 -52.54 -48.49 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 77.7 mt-30 -34.36 -36.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 210' ' ' HIS . 15.8 m-85 -76.59 -47.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 210' ' ' HIS . 56.1 mm-40 -62.37 -47.88 82.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -34.94 102.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.638 0.733 . . . . 0.0 110.856 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -46.77 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 -45.37 -29.91 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -45.89 125.28 6.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.682 2.254 . . . . 0.0 112.351 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 219' ' ' VAL . 15.8 m -123.92 126.79 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.45 132.82 54.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.74 135.59 92.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -23.75 30.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -92.11 0.14 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 39.8 54.99 2.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.1 p -71.27 -51.04 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 163.67 -34.22 0.29 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.422 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 p -42.49 -26.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.31 -65.84 3.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 p -146.24 146.51 30.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.118 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 231' ' ' ALA . 14.8 p -157.77 135.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.12 142.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -56.11 -41.74 75.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -76.25 -10.47 59.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 35.1 m-20 -97.05 -13.59 22.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.851 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.608 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.42 -44.53 82.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.94 -64.62 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 0.0 112.345 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -60.78 -29.96 71.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -67.83 -44.65 76.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 47.0 mt -63.85 -15.9 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -65.64 -66.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.5 t70 -124.84 -46.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 241' ' ' ASP . 1.8 t -34.99 -69.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.71 0.291 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.586 ' OE1' HG21 ' A' ' 207' ' ' ILE . 2.2 pt20 -119.12 127.06 26.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.591 0.71 . . . . 0.0 110.972 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 102.38 1.01 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 31.4 t -50.62 143.99 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 196' ' ' THR . 17.0 m -86.58 -15.91 38.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -84.09 -70.49 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.9 p -77.2 -1.02 27.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.1 p 46.91 49.19 14.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -137.26 162.39 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.2 125.48 31.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -135.13 149.45 50.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 205' ' ' ASP . 16.8 t -62.08 144.39 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.0 p90 -66.82 -34.55 78.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.556 ' H ' HG12 ' A' ' 203' ' ' VAL . 37.7 t0 -73.24 -22.78 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.7 p -99.89 -25.33 14.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 204' ' ' PHE . 4.4 tp -52.45 -15.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.46 -47.52 32.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 m -86.83 -40.34 15.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 213' ' ' GLN . 10.7 t60 -44.42 -47.96 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 210' ' ' HIS . 18.1 mm-40 -35.96 -38.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -71.63 -44.97 63.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 210' ' ' HIS . 45.5 mt-30 -65.22 -40.66 94.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.8 t -34.65 112.33 0.43 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 214' ' ' CYS . 53.3 Cg_endo -69.83 -36.81 9.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.26 . . . . 0.0 112.28 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -55.62 -33.42 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tp -43.83 124.75 4.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 129.73 18.11 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.364 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.77 130.03 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.54 132.64 54.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.68 133.15 93.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -10.67 29.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.24 . . . . 0.0 112.345 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -98.84 -5.06 31.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 45.13 54.27 7.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.595 ' SG ' HG12 ' A' ' 227' ' ' VAL . 3.6 p -73.44 -53.95 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 162.03 -37.04 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.595 HG12 ' SG ' ' A' ' 225' ' ' CYS . 4.4 p -39.5 -27.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 0.0 111.142 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.34 -73.32 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.46 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.4 p -134.5 149.36 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.608 HG11 HD12 ' A' ' 235' ' ' LEU . 13.6 p -156.47 126.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.01 143.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.38 -46.77 73.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.8 6.79 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 1.0 OUTLIER -113.64 -11.09 13.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.608 HD12 HG11 ' A' ' 230' ' ' VAL . 10.0 tp -67.23 -44.24 47.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.581 0.705 . . . . 0.0 110.897 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.5 Cg_exo -48.03 -59.68 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -64.02 -46.98 89.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -52.0 -49.71 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 55.5 mt -54.38 -19.34 5.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 6.0 tmtm? -61.52 -65.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 241' ' ' ASP . 37.8 t0 -127.23 -44.62 1.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 241' ' ' ASP . 19.9 m -35.51 -64.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.968 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.1 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.733 0.301 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -121.01 119.77 29.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.574 0.702 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 100.94 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.304 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 7.9 t -51.29 119.89 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 196' ' ' THR . 6.9 m -72.17 1.27 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -99.04 -58.11 2.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.3 p -97.81 3.58 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.2 p 47.3 36.6 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -113.07 147.38 37.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -85.97 119.78 26.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.95 166.37 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.623 ' HB ' HG23 ' A' ' 206' ' ' THR . 20.5 t -71.16 145.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.803 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.7 OUTLIER -61.74 -31.19 71.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 203' ' ' VAL . 6.0 t70 -74.04 -31.66 62.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.623 HG23 ' HB ' ' A' ' 203' ' ' VAL . 27.2 p -82.99 -40.37 20.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.0 tp -43.1 -22.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 206' ' ' THR . 18.2 mt-30 -68.07 -50.28 56.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 -41.88 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.482 ' O ' ' N ' ' A' ' 213' ' ' GLN . 44.1 t60 -40.42 -52.54 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.2 mt-30 -32.7 -41.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.19 -49.86 63.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.5 mt-30 -63.97 -47.97 78.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.0 t -33.93 116.98 0.49 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.603 0.716 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -47.04 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ARG . . . . . 0.462 ' CD ' ' OE2' ' A' ' 233' ' ' GLU . 11.0 mmm180 -43.27 -37.47 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 tp -44.06 133.58 4.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.607 0.718 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 130.47 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 219' ' ' VAL . 30.9 m -126.86 126.11 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.183 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.39 132.65 48.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.19 131.69 95.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.65 0.738 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -21.15 33.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -86.56 -14.89 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 54.55 54.14 9.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.9 p -73.83 -49.21 26.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 158.25 -36.95 0.52 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.524 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -39.19 -32.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 111.106 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.45 -67.15 3.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.495 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 61.5 p -144.49 143.84 31.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.419 ' CG1' HD12 ' A' ' 235' ' ' LEU . 11.1 p -153.42 136.11 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.54 134.84 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -52.6 -41.58 63.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.462 ' OE2' ' CD ' ' A' ' 216' ' ' ARG . 21.8 pt-20 -69.25 -14.58 63.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -107.22 10.6 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.6 tp -76.44 -44.59 3.39 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.2 Cg_exo -47.99 -65.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.635 2.223 . . . . 0.0 112.385 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.39 58.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' HIS . . . . . 0.416 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 23.5 t60 -68.93 -56.22 8.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.84 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.4 mt -53.5 -29.29 35.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -66.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 242' ' ' SER . 2.8 m-20 -116.96 -58.38 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.5 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.0 t -29.38 -70.28 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.2 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.732 0.301 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -107.35 109.98 62.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 200' ' ' LYS . 53.6 Cg_endo -69.79 99.72 0.77 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.7 t -52.35 144.81 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.7 m -89.72 -25.33 21.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.96 -69.17 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.84 -5.91 52.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 56.8 p 50.74 42.5 27.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 25.0 mtmm -118.36 177.6 4.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -111.19 123.7 50.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -138.72 156.08 47.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 205' ' ' ASP . 9.5 p -76.31 140.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.682 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.0 p90 -53.11 -26.94 18.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 203' ' ' VAL . 16.5 t0 -65.43 -27.58 68.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 208' ' ' GLN . 71.3 p -104.17 -32.71 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.116 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 204' ' ' PHE . 8.8 tp -35.48 -30.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 206' ' ' THR . 27.6 mt-30 -66.48 -60.68 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.0 p -69.24 -43.53 73.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.0 t60 -40.57 -50.17 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 210' ' ' HIS . 32.9 mt-30 -32.67 -37.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.8 m-85 -79.23 -46.36 17.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 210' ' ' HIS . 73.5 mt-30 -59.73 -47.14 86.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' GLN . 6.2 t -34.04 117.93 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -50.9 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.34 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -39.05 -32.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.99 133.64 58.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.619 0.723 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 131.87 22.18 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.73 2.286 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.36 144.32 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -79.4 138.7 37.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 18.7 t -59.74 135.4 89.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.15 19.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -76.96 -20.22 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 60.15 53.7 4.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.475 ' SG ' HG12 ' A' ' 227' ' ' VAL . 7.9 p -76.44 -50.75 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 160.28 -31.61 0.39 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.475 HG12 ' SG ' ' A' ' 225' ' ' CYS . 5.9 p -39.41 -25.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.913 0.387 . . . . 0.0 111.177 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 79.96 -93.12 1.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.9 p -118.6 147.09 44.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.773 0.32 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.478 HG11 HD12 ' A' ' 235' ' ' LEU . 12.3 p -158.27 130.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.96 139.91 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.083 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -53.24 -44.72 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.61 -1.21 20.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 7.8 m-20 -106.0 -23.09 12.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.5 tp -54.55 -43.69 98.29 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.93 -62.38 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.676 2.251 . . . . 0.0 112.357 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.89 -30.67 70.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.526 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' HIS . . . . . 0.418 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 18.4 t60 -68.01 -54.26 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.2 mt -55.44 -29.74 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -53.46 -67.07 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 242' ' ' SER . 36.2 t70 -121.13 -51.29 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.1 t -32.76 -69.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.761 0.315 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.44 ' O ' HD13 ' A' ' 207' ' ' ILE . 0.5 OUTLIER -110.54 114.48 54.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 96.58 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 22.5 t -51.69 133.64 30.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 196' ' ' THR . 19.3 m -83.56 -10.86 58.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.179 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 217' ' ' LEU . 18.2 m-85 -86.3 -65.25 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 22.4 p -84.35 0.89 47.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.4 p 49.23 33.47 5.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 -174.84 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -127.91 125.96 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.41 170.86 15.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 205' ' ' ASP . 4.7 t -68.23 146.86 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.562 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.1 p90 -61.53 -25.78 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.435 ' H ' HG12 ' A' ' 203' ' ' VAL . 5.8 t70 -77.91 -43.7 29.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.6 p -73.7 -48.84 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 204' ' ' PHE . 2.8 tp -33.15 -35.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 23.7 mm100 -58.1 -54.58 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 m -78.76 -41.14 31.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.4 t60 -44.17 -46.65 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -36.37 -39.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -68.87 -43.32 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 mm100 -68.8 -41.67 78.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.1 t -35.1 113.17 0.47 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -47.19 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -42.48 -37.16 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 197' ' ' TYR . 8.4 tp -48.37 137.4 11.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.584 0.707 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.407 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.5 Cg_endo -69.84 141.8 45.9 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.307 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.76 129.57 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.73 133.79 56.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.68 133.12 89.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.652 0.739 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -12.64 33.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -97.28 -8.89 28.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 50.26 50.37 18.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.582 ' SG ' HG12 ' A' ' 227' ' ' VAL . 7.7 p -70.72 -50.88 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 157.56 -34.87 0.54 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.504 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.582 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -41.45 -23.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.98 -98.46 2.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.7 p -115.61 147.59 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 235' ' ' LEU . 12.5 p -158.04 130.85 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.11 142.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -58.24 -41.72 84.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.53 -2.78 40.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 16.1 m-20 -103.42 -17.37 15.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.609 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -57.35 -44.55 99.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.667 0.746 . . . . 0.0 110.977 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.95 -65.66 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.34 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.03 -23.86 57.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -74.05 -48.36 30.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 110.83 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.21 -13.1 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -66.87 -64.62 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 242' ' ' SER . 10.4 t70 -122.3 -53.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 241' ' ' ASP . 2.7 m -34.21 -69.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.794 0.331 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.521 ' NE2' HG12 ' A' ' 207' ' ' ILE . 12.9 pt20 -113.96 122.57 34.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.578 0.704 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 99.33 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.713 2.275 . . . . 0.0 112.311 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.0 t -51.08 143.78 10.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.6 m -87.27 -26.05 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.402 ' HB2' ' SG ' ' A' ' 214' ' ' CYS . 15.7 m-85 -72.52 -69.97 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.1 p -77.06 -3.22 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 46.7 p 52.09 31.48 8.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -114.7 177.09 4.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -106.74 126.95 52.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -138.45 151.98 47.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.737 HG22 ' H ' ' A' ' 205' ' ' ASP . 11.1 p -76.9 133.41 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -50.45 -21.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.737 ' H ' HG22 ' A' ' 203' ' ' VAL . 1.1 t70 -68.16 -33.44 74.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.462 ' H ' HG13 ' A' ' 203' ' ' VAL . 46.0 p -101.83 -38.16 7.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.521 HG12 ' NE2' ' A' ' 193' ' ' GLN . 2.8 tp -33.35 -38.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 206' ' ' THR . 29.4 mm100 -55.71 -49.74 72.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 206' ' ' THR . 69.4 p -83.26 -38.49 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 211' ' ' GLN . 8.8 t60 -53.98 -45.71 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 210' ' ' HIS . 5.5 mt-30 -38.34 -38.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -72.11 -52.72 15.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 214' ' ' CYS . 15.4 mm100 -57.46 -51.18 70.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.456 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.9 t -33.83 107.53 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -41.9 3.84 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -52.22 -38.26 57.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.567 HD12 ' HD2' ' A' ' 218' ' ' PRO . 3.7 tp -38.91 129.08 1.19 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.584 0.707 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.9 Cg_endo -69.69 134.23 27.63 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.713 2.276 . . . . 0.0 112.352 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 230' ' ' VAL . 15.7 m -129.25 136.61 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.85 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.6 t -63.72 135.17 96.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.643 0.735 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.529 ' HD3' HD21 ' A' ' 235' ' ' LEU . 53.7 Cg_endo -69.79 -33.36 16.61 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -79.46 -20.67 46.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 61.96 54.63 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 10.7 p -75.42 -49.85 17.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 160.95 -38.47 0.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.518 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 226' ' ' GLY . 9.2 p -34.25 -39.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 227' ' ' VAL . . . 95.47 -99.99 2.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.476 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -112.79 138.09 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 219' ' ' VAL . 14.8 p -150.13 134.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.3 143.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 46.8 ttt-85 -61.88 -39.86 93.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.49 2.38 29.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.605 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 30.5 m-20 -110.81 -12.98 14.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.3 tp -60.99 -43.36 90.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.96 -65.65 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.351 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.53 -28.58 56.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -70.14 -56.33 7.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.822 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.41 -32.24 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -50.39 -66.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 27.6 t70 -124.05 -49.3 1.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.5 t -34.22 -68.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.773 0.32 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.66 ' O ' HD13 ' A' ' 207' ' ' ILE . 19.7 tt0 -118.43 108.97 40.88 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 102.83 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 6.9 t -52.91 120.19 5.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 196' ' ' THR . 24.3 m -72.84 2.78 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.401 ' O ' ' CZ ' ' A' ' 216' ' ' ARG . 5.5 m-85 -101.38 -64.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.0 p -89.04 5.69 43.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p 45.87 35.07 2.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -98.24 -174.57 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -131.57 103.58 6.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.75 176.09 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 205' ' ' ASP . 39.2 t -82.98 124.13 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.6 p90 -38.21 -29.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.598 ' H ' HG12 ' A' ' 203' ' ' VAL . 23.7 t0 -77.62 -42.21 35.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 203' ' ' VAL . 58.5 p -78.99 -50.81 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.3 tp -33.21 -42.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.151 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.464 ' N ' HG23 ' A' ' 207' ' ' ILE . 67.2 mm-40 -45.4 -57.42 4.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -71.32 -49.35 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 213' ' ' GLN . 14.2 t60 -40.52 -51.11 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.867 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.5 mt-30 -32.86 -38.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.7 m-85 -69.68 -49.04 57.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' HIS . 78.2 mm-40 -65.78 -45.46 82.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 213' ' ' GLN . 12.0 t -32.77 118.38 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.7 Cg_endo -69.79 -50.11 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.356 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 215' ' ' PRO . 24.7 mmm-85 -34.29 -37.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.9 tp -44.3 129.08 4.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.601 0.715 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 138.97 39.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.353 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 219' ' ' VAL . 34.3 m -137.31 127.35 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.16 133.61 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.2 t -60.44 135.52 91.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -28.32 25.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -81.92 -7.81 59.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 48.39 53.42 12.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.613 ' SG ' HG12 ' A' ' 227' ' ' VAL . 9.4 p -72.79 -51.02 20.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 156.33 -35.15 0.6 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.536 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.613 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.7 p -37.68 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.148 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.85 -93.54 1.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.49 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.5 p -117.66 146.61 43.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.799 0.333 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 235' ' ' LEU . 14.4 p -157.64 127.91 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -37.3 153.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -66.2 -43.83 85.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -78.47 7.15 7.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -14.32 11.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.4 tp -63.3 -43.58 80.41 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.599 0.714 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.5 Cg_exo -47.93 -65.44 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.729 2.286 . . . . 0.0 112.345 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.21 -25.63 57.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' HIS . . . . . 0.438 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 7.8 t60 -72.57 -52.77 14.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 110.817 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.43 -18.71 12.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -69.98 -63.86 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 242' ' ' SER . 11.2 t0 -115.31 -56.35 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 241' ' ' ASP . 20.0 m -34.06 -69.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 3.0 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.755 0.312 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 202' ' ' PHE . 29.9 tp60 -107.8 116.52 57.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.897 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 106.56 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.675 2.25 . . . . 0.0 112.315 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.17 138.44 56.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 196' ' ' THR . 4.8 m -86.25 -13.8 45.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.68 -64.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.914 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 p -85.93 -0.05 54.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 49.49 36.45 10.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -113.42 169.8 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -104.32 122.74 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 193' ' ' GLN . 73.1 m-85 -138.61 175.14 9.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.719 HG12 ' H ' ' A' ' 205' ' ' ASP . 23.5 t -73.72 144.8 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.746 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.5 p90 -64.67 -27.96 69.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.719 ' H ' HG12 ' A' ' 203' ' ' VAL . 22.6 t70 -76.07 -43.59 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 208' ' ' GLN . 52.8 p -73.97 -44.06 56.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.19 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.2 tp -33.67 -33.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 206' ' ' THR . 34.6 mm-40 -57.5 -58.43 8.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.7 m -77.45 -41.63 38.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 5.4 t60 -41.88 -46.43 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -38.52 -39.23 0.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -67.73 -39.76 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 55.3 mm-40 -73.8 -36.67 65.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.9 t -34.26 118.2 0.52 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.586 0.708 . . . . 0.0 110.903 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -24.43 29.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.327 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -84.4 25.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 218' ' ' PRO . 5.4 tp -100.42 131.1 24.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.59 0.71 . . . . 0.0 110.923 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.532 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.8 Cg_endo -69.82 119.65 6.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.33 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.02 141.14 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.23 127.95 34.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.6 t -57.96 132.75 83.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.638 0.732 . . . . 0.0 110.928 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.505 ' HD3' HD21 ' A' ' 235' ' ' LEU . 53.4 Cg_endo -69.85 -12.14 32.13 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.698 2.265 . . . . 0.0 112.305 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -97.06 -8.42 30.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 47.71 53.06 11.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.407 ' SG ' HG12 ' A' ' 227' ' ' VAL . 4.2 p -73.12 -53.78 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 161.81 -32.13 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.407 HG12 ' SG ' ' A' ' 225' ' ' CYS . 11.4 p -44.54 -24.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 111.145 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.74 -81.05 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -132.55 148.75 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 231' ' ' ALA . 12.9 p -156.41 136.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.69 147.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -65.26 -30.53 71.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -86.76 -1.69 57.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.87 -21.99 13.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 10.3 tp -56.32 -44.35 99.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.93 -65.63 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.686 2.257 . . . . 0.0 112.362 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.42 98.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 4.1 t60 -56.11 -49.24 74.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.0 mt -57.29 -27.4 62.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -55.58 -67.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.482 ' O ' ' C ' ' A' ' 242' ' ' SER . 5.6 p-10 -121.08 -52.02 2.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.1 t -31.54 -68.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.468 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.7 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.744 0.307 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -107.45 113.6 61.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 104.48 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.663 2.242 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.09 146.52 14.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.0 m -89.59 -26.44 20.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.18 -69.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.7 p -76.51 -4.2 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.0 p 49.57 39.13 16.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -121.31 164.59 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -93.97 128.04 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -137.92 160.59 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 205' ' ' ASP . 20.9 t -69.21 138.18 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.759 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.9 p90 -60.12 -35.56 75.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.557 ' H ' HG12 ' A' ' 203' ' ' VAL . 7.3 t0 -70.89 -15.92 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 203' ' ' VAL . 29.3 p -107.94 -20.97 13.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.8 tp -50.56 -17.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -78.21 -42.19 32.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 93.6 p -85.06 -44.44 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.3 t60 -44.28 -47.84 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -34.88 -36.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 210' ' ' HIS . 17.4 m-85 -75.6 -45.34 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 36.5 mt-30 -64.71 -47.68 77.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' A' ' 213' ' ' GLN . 11.7 t -34.12 112.69 0.42 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.7 Cg_endo -69.8 -50.79 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.9 mmm-85 -38.06 -30.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 215' ' ' PRO . 5.1 tp -61.17 132.26 92.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.56 0.695 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 140.41 42.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.386 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 219' ' ' VAL . 32.5 m -139.03 125.44 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.092 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.42 139.19 44.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.0 t -59.18 134.07 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.587 0.708 . . . . 0.0 110.93 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 1.13 4.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 224' ' ' GLN . 73.8 m-20 -121.3 9.0 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 223' ' ' ASN . 2.7 mp0 36.97 41.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.454 ' SG ' HG12 ' A' ' 227' ' ' VAL . 29.5 p -58.59 -47.41 84.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 151.46 -34.63 0.89 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.454 HG12 ' SG ' ' A' ' 225' ' ' CYS . 11.8 p -37.14 -37.1 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.38 -102.37 2.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.524 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 35.5 p -118.22 123.29 45.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.45 143.73 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.595 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -52.69 137.65 30.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -49.73 -54.74 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.9 pm0 -66.06 -4.58 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.595 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 5.7 m-20 -104.88 -13.79 15.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.631 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -61.07 -42.68 87.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.99 -64.06 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -56.4 -43.81 90.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -56.01 -56.22 23.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.9 mt -56.45 -14.29 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 1.3 tmmm? -64.88 -65.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 242' ' ' SER . 38.9 t0 -121.02 -51.75 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.2 m -35.46 -65.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.74 0.305 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -113.91 106.52 53.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 101.56 0.93 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 29.8 t -54.94 142.08 31.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.419 ' O ' HG22 ' A' ' 196' ' ' THR . 58.5 m -89.56 -13.5 37.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.32 -65.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 24.4 p -82.3 -2.64 53.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 25.2 p 48.94 37.61 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -104.83 -174.86 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -130.19 102.63 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -119.85 173.64 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.46 ' HB ' HG23 ' A' ' 206' ' ' THR . 5.5 t -73.1 144.09 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.942 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.6 p90 -59.17 -34.45 72.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.405 ' H ' HG12 ' A' ' 203' ' ' VAL . 22.2 t0 -69.0 -35.45 76.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.46 HG23 ' HB ' ' A' ' 203' ' ' VAL . 28.4 p -82.45 -32.15 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.942 HG22 ' O ' ' A' ' 204' ' ' PHE . 7.7 tp -48.87 -18.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -69.57 -47.9 62.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -88.29 -38.29 15.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 16.3 t60 -44.13 -51.29 8.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 51.8 mt-30 -34.3 -36.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 210' ' ' HIS . 28.2 m-85 -75.13 -46.31 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.5 mt-30 -62.9 -42.4 99.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.3 t -34.08 118.09 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.587 0.708 . . . . 0.0 110.889 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -49.44 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.266 . . . . 0.0 112.371 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -40.53 -37.76 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.6 tp -44.64 125.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 144.81 54.89 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 219' ' ' VAL . 30.6 m -139.83 126.28 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.95 141.99 37.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.061 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.0 t -67.05 134.87 93.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -16.32 37.57 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -96.18 -6.7 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 48.04 53.81 11.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 4.5 p -72.33 -54.05 10.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 159.61 -24.46 0.31 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 p -48.67 -22.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.16 -89.3 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.9 p -124.92 145.78 49.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.18 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.8 p -153.79 134.79 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.433 ' HB3' ' OD2' ' A' ' 234' ' ' ASP . . . -39.22 152.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -70.11 -32.14 70.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.45 -1.8 58.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.433 ' OD2' ' HB3' ' A' ' 231' ' ' ALA . 68.5 m-20 -114.18 -16.61 12.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 3.3 tp -61.76 -44.29 90.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 0.0 110.909 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.8 Cg_exo -48.01 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.667 2.244 . . . . 0.0 112.306 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.82 39.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.35 -51.1 56.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 235' ' ' LEU . 76.1 mt -57.71 -22.5 46.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -60.1 -63.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 242' ' ' SER . 17.0 t0 -125.3 -47.2 1.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.5 t -36.0 -66.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.93 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.736 0.303 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.612 ' O ' HD13 ' A' ' 207' ' ' ILE . 68.4 mt-30 -119.52 116.87 33.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.598 0.713 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 96.93 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 30.1 t -51.42 135.14 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 196' ' ' THR . 54.2 m -83.77 -11.36 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -86.14 -69.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.4 p -79.17 -0.79 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p 47.81 42.56 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -125.34 159.79 30.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -90.61 129.38 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -138.63 171.24 14.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -76.16 159.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -77.16 -30.46 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.05 -20.01 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 30.6 p -104.77 -49.04 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.0 tp -33.35 -34.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 14.4 mm-40 -57.18 -56.63 19.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -77.79 -42.52 33.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.6 t60 -43.7 -46.72 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 210' ' ' HIS . 41.8 mt-30 -35.45 -35.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 m-85 -80.41 -42.96 21.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.8 t -33.29 123.5 0.44 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.59 0.71 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -44.2 2.17 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.331 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -45.27 -40.3 7.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 tp -39.21 128.82 1.29 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 123.4 10.05 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.37 140.39 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.03 135.21 50.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.069 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 29.9 t -61.99 134.65 94.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.726 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -30.64 21.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.705 2.27 . . . . 0.0 112.368 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -81.17 -9.68 59.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 49.04 52.93 13.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 227' ' ' VAL . 11.2 p -71.38 -49.84 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 159.92 -39.14 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.538 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.463 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.6 p -33.77 -38.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.26 -87.74 0.98 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.473 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 11.9 p -127.62 146.35 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.093 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 231' ' ' ALA . 7.9 p -158.08 132.43 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.47 141.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -38.49 68.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -80.45 -3.31 49.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 6.7 m-20 -104.99 -16.79 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.9 tp -61.14 -42.69 87.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.726 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.97 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.731 2.287 . . . . 0.0 112.327 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.8 -23.88 59.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' HIS . . . . . 0.437 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 10.5 t60 -73.76 -47.14 41.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.4 mt -62.4 -11.16 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -77.27 -64.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 242' ' ' SER . 20.0 t0 -108.58 -63.1 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.7 m -33.16 -71.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.777 0.322 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.649 ' O ' HD13 ' A' ' 207' ' ' ILE . 25.2 mm100 -114.23 105.78 53.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.711 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.4 Cg_endo -69.74 105.41 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.39 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 4.9 t -55.23 123.87 15.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 196' ' ' THR . 20.8 m -76.76 3.77 11.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.6 -63.96 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.53 9.15 21.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.7 p 39.7 42.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -108.68 -175.44 2.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.8 107.24 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -124.62 158.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 206' ' ' THR . 4.7 t -61.35 128.43 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.2 p90 -40.55 -32.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.8 -43.42 65.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 203' ' ' VAL . 46.9 p -72.23 -42.93 65.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.163 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.6 tp -38.68 -29.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 206' ' ' THR . 0.5 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -72.84 -37.7 67.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLN . 19.5 t60 -49.68 -50.4 43.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 19.2 mt-30 -34.32 -45.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.901 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -62.51 -45.81 91.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' HIS . 31.0 mm100 -67.86 -50.79 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -34.39 110.64 0.39 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.9 Cg_endo -69.8 -43.72 2.46 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 215' ' ' PRO . 15.5 mmm180 -34.46 -40.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.2 tp -40.29 127.3 1.73 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.592 0.711 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.42 33.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.73 135.99 54.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.35 57.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 38.7 t -58.93 131.51 86.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -3.57 12.25 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.252 . . . . 0.0 112.339 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -104.86 -11.54 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 53.44 53.18 12.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.573 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.3 p -76.21 -48.02 21.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 152.86 -30.09 0.82 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.48 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.573 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -42.94 -24.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.53 -91.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -120.14 150.13 41.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.631 HG11 HD12 ' A' ' 235' ' ' LEU . 12.5 p -158.25 133.9 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.653 ' HB3' ' OD2' ' A' ' 234' ' ' ASP . . . -44.23 142.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.49 -49.4 70.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.05 6.74 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.653 ' OD2' ' HB3' ' A' ' 231' ' ' ALA . 9.4 m-20 -112.6 -14.73 13.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.631 HD12 HG11 ' A' ' 230' ' ' VAL . 11.1 tp -61.9 -43.56 87.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.544 0.688 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.99 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.27 . . . . 0.0 112.345 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.89 -34.83 61.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' HIS . . . . . 0.559 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 18.4 t60 -65.6 -61.24 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 243' ' ' CYS . 67.2 mt -49.07 -36.86 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -50.4 -67.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 7.8 p-10 -112.4 -57.2 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.452 ' HB3' ' CG ' ' A' ' 238' ' ' HIS . 5.5 t -33.81 -67.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.559 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.78 0.324 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.52 ' O ' HD13 ' A' ' 207' ' ' ILE . 97.9 mm-40 -108.21 109.73 61.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.03 2.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.705 2.27 . . . . 0.0 112.301 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.56 148.36 49.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.6 m -90.23 -29.23 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.37 -69.65 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.52 -3.44 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 34.8 p 46.0 45.84 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -119.26 -175.36 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -119.74 123.4 43.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -138.62 160.66 39.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.681 HG22 ' H ' ' A' ' 205' ' ' ASP . 10.0 p -80.35 143.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.088 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -51.86 -22.81 4.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.681 ' H ' HG22 ' A' ' 203' ' ' VAL . 0.6 OUTLIER -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 207' ' ' ILE . 76.7 p -99.29 -46.87 5.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.155 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 193' ' ' GLN . 4.8 tp -33.29 -38.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 26.2 mt-30 -54.39 -55.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.08 -44.37 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 9.7 t60 -39.67 -50.65 2.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 210' ' ' HIS . 49.5 mm-40 -32.62 -39.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' HIS . 6.9 m-85 -75.84 -46.76 28.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.8 mm-40 -59.34 -43.93 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -33.94 113.8 0.43 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.586 0.708 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -47.58 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.386 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 11.9 mmm180 -38.32 -37.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 216' ' ' ARG . 7.7 tp -37.92 130.7 0.94 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.587 0.708 . . . . 0.0 110.964 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 125.86 12.66 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.351 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 230' ' ' VAL . 18.9 m -122.29 136.02 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -67.29 139.54 57.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.34 130.61 94.23 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -12.46 32.85 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 0.0 112.321 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -96.46 -19.94 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 61.57 48.18 5.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.2 p -69.04 -52.11 32.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 162.83 -40.17 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 228' ' ' GLY . 11.5 p -36.03 -40.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 227' ' ' VAL . . . 95.56 -89.34 1.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.486 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 28.6 p -122.28 142.67 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.095 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 235' ' ' LEU . 12.9 p -153.87 139.32 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -41.43 138.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -52.9 -41.15 64.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.436 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.8 pt-20 -78.93 -11.77 60.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 6.1 m-20 -92.24 -25.36 18.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.599 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.1 tp -54.16 -43.92 97.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.587 0.708 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -48.0 -60.36 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.222 . . . . 0.0 112.358 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -64.01 -31.92 82.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 5.7 t60 -65.36 -52.02 56.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.39 -33.04 58.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -48.95 -66.6 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.3 p30 -121.39 -52.04 2.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.3 t -32.51 -67.78 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.5 t . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 42.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.748 0.308 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.516 ' O ' HD13 ' A' ' 207' ' ' ILE . 15.3 mm-40 -110.46 106.25 57.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 99.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 48.4 t -53.67 142.41 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 79.5 m -89.4 -20.33 24.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.444 ' CE2' HD12 ' A' ' 217' ' ' LEU . 13.7 m-85 -76.47 -65.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.93 -2.26 56.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.3 p 49.83 37.03 12.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -107.34 -174.45 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -130.21 112.9 13.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.404 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 75.9 m-85 -121.7 177.34 5.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 205' ' ' ASP . 60.4 t -80.27 123.11 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.3 p90 -39.63 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.73 ' H ' HG12 ' A' ' 203' ' ' VAL . 6.5 t70 -80.41 -40.06 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 203' ' ' VAL . 81.8 p -79.64 -47.35 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.1 tp -34.67 -31.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' THR . 32.8 mm-40 -53.12 -53.8 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -76.92 -47.39 21.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.2 t60 -40.93 -48.01 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 210' ' ' HIS . 9.3 mt-30 -33.73 -38.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 210' ' ' HIS . 10.6 m-85 -77.65 -44.92 26.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 210' ' ' HIS . 25.6 mm-40 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.467 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -32.65 116.5 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -46.42 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.627 2.218 . . . . 0.0 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ARG . . . . . 0.431 ' NH1' ' OE2' ' A' ' 233' ' ' GLU . 26.8 mmt-85 -41.28 -34.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.444 HD12 ' CE2' ' A' ' 197' ' ' TYR . 7.8 tp -55.54 136.52 70.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.565 0.698 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 153.94 68.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.45 131.38 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.161 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.12 135.89 57.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 47.3 t -59.48 134.25 88.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -17.51 37.55 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -94.69 -6.54 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 49.06 51.3 16.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.547 ' SG ' HG12 ' A' ' 227' ' ' VAL . 22.8 p -74.37 -48.26 29.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 154.91 -30.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.494 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.547 HG12 ' SG ' ' A' ' 225' ' ' CYS . 4.4 p -38.58 -26.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.18 -84.33 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.9 p -132.37 145.62 51.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.459 ' CG1' HD12 ' A' ' 235' ' ' LEU . 12.1 p -158.05 129.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.06 143.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -62.41 -44.7 95.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.431 ' OE2' ' NH1' ' A' ' 216' ' ' ARG . 16.4 pt-20 -70.04 -2.53 13.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 4.5 m-20 -115.53 -12.54 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -58.17 -42.84 97.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.615 0.721 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.98 -65.83 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.49 -33.65 59.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 242' ' ' SER . 45.9 t60 -66.13 -50.16 64.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.5 mt -67.56 -25.51 65.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.988 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -56.39 -67.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.85 -32.38 0.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.456 ' O ' ' ND1' ' A' ' 238' ' ' HIS . 2.5 m -77.77 45.5 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 238' ' ' HIS . 17.8 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.753 0.311 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -107.43 103.92 50.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 100.58 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 199' ' ' THR . 51.5 t -52.26 149.62 5.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.4 m -90.59 -41.08 11.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.156 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.05 -70.12 0.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.5 p -75.26 -6.85 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.896 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' CYS . 22.7 p 49.71 39.71 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -113.04 174.2 6.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.866 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -109.08 121.78 45.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.82 174.25 10.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 205' ' ' ASP . 14.6 p -97.91 144.14 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.13 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -53.56 -21.94 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 203' ' ' VAL . 14.5 t70 -72.28 -27.0 62.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 208' ' ' GLN . 64.7 p -102.39 -43.08 5.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 206' ' ' THR . 3.7 tp -35.94 -30.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.9 mt-30 -62.17 -52.96 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -81.94 -38.78 24.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' A' ' 213' ' ' GLN . 18.9 t60 -49.19 -51.05 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.5 ' O ' HD22 ' A' ' 217' ' ' LEU . 24.9 mt-30 -33.74 -38.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' HIS . 54.9 m-85 -72.95 -48.22 38.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.1 mt-30 -62.87 -50.2 71.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.2 t -34.15 113.7 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.629 0.728 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.67 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 15.5 mmm180 -43.29 -41.15 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.7 HD12 ' HD2' ' A' ' 218' ' ' PRO . 11.8 tp -38.25 131.69 0.99 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.2 Cg_endo -69.79 139.43 40.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.667 2.245 . . . . 0.0 112.3 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.3 134.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -64.44 127.87 33.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.9 t -58.21 131.45 84.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -12.42 32.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -95.19 -18.02 21.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 61.55 49.55 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.68 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.3 p -68.74 -52.07 34.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 155.71 -35.18 0.63 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.512 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.68 HG12 ' SG ' ' A' ' 225' ' ' CYS . 5.1 p -38.47 -26.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 111.141 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.71 -71.97 2.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 64.9 p -145.97 147.25 31.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.138 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 10.1 p -154.13 144.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -47.64 134.87 12.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -51.7 -36.57 47.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.42 ' C ' ' OE1' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.65 -17.05 58.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.825 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.464 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.2 m-20 -91.37 -25.5 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.571 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -48.27 -45.96 66.73 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.1 Cg_exo -47.94 -60.8 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 0.0 112.371 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -65.96 -20.72 69.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -76.84 -50.46 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 26.2 mt -53.88 -22.5 10.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -56.26 -67.2 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.6 m-20 -127.15 -49.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 241' ' ' ASP . 22.0 m -31.5 -64.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.7 m 55.99 47.78 19.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 30.2 m 58.03 45.15 18.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -144.45 165.64 27.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 t -112.73 90.01 3.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.836 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.9 m -87.16 -59.05 2.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.44 97.7 2.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -96.22 106.09 18.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -65.06 157.12 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.6 p -115.2 141.6 47.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.425 ' O ' HD13 ' A' ' 207' ' ' ILE . 17.1 tm0? -114.12 117.97 42.88 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 104.85 1.38 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 12.5 t -57.52 135.47 56.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 196' ' ' THR . 81.9 m -82.4 -10.41 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -89.91 -69.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.0 p -79.67 4.33 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.8 p 42.76 37.06 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -118.51 160.62 21.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.37 130.85 37.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.98 170.12 16.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.81 127.76 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -46.13 -27.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.12 -35.0 66.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 207' ' ' ILE . 34.7 p -87.41 -50.71 6.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 208' ' ' GLN . 2.9 tp -33.54 -42.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 207' ' ' ILE . 92.7 mm-40 -49.76 -49.58 47.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.1 t -86.24 -45.3 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.484 ' O ' ' N ' ' A' ' 213' ' ' GLN . 11.0 t60 -45.28 -47.22 12.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mt-30 -34.74 -33.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.0 m-85 -78.91 -46.85 17.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mm-40 -63.15 -45.48 91.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.9 t -35.34 120.49 0.62 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.627 0.727 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -50.44 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.69 2.26 . . . . 0.0 112.338 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -43.62 -40.91 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 tp -39.69 127.29 1.49 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.615 0.722 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 141.95 46.56 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 230' ' ' VAL . 34.5 m -137.79 138.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -71.18 139.11 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.4 t -67.32 135.28 93.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -20.54 34.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -91.82 0.05 57.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 39.62 52.43 2.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.2 p -69.03 -51.53 38.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 159.12 -37.74 0.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.483 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.9 p -37.03 -33.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 90.99 -94.75 2.0 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.1 p -117.17 147.26 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 219' ' ' VAL . 11.6 p -157.14 131.77 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.63 146.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -58.92 -37.7 77.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.35 2.95 29.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.463 ' CB ' HG22 ' A' ' 230' ' ' VAL . 1.4 m-20 -109.24 -15.14 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.4 tp -65.17 -44.5 69.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.91 -62.68 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.327 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -61.02 -45.61 96.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -53.59 -48.28 69.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.358 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 247' ' ' LEU . 33.1 mt -59.37 -17.34 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 32.8 ttmt -62.41 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 15.7 p-10 -128.2 -45.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.5 m -34.54 -64.98 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t -45.44 155.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.81 -51.41 48.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 35.3 p -44.29 168.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -113.39 137.85 50.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 239' ' ' LEU . 56.0 mt -149.55 135.19 18.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 179.839 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 45.8 m -136.84 163.77 29.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 28.8 t -48.52 130.67 17.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -93.13 -112.66 2.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.9 m -105.46 91.26 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.85 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 92.7 p -104.5 162.4 13.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.811 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.03 -175.21 24.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -95.51 91.07 5.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.292 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.01 171.38 3.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.0 p -119.52 133.34 55.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 30.5 mt-30 -107.81 103.86 51.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.2 Cg_endo -69.72 99.9 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.649 2.233 . . . . 0.0 112.338 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.16 140.7 15.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.4 m -87.21 -22.97 24.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -73.58 -69.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.1 p -77.78 -4.21 45.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 51.36 38.98 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -112.29 179.99 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -115.9 121.89 43.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -137.38 175.02 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.53 154.36 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -62.73 -25.26 68.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -68.47 -17.6 64.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 208' ' ' GLN . 55.5 p -112.38 -42.76 3.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.6 tp -33.73 -33.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 206' ' ' THR . 16.3 mm100 -62.34 -49.95 73.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 t -84.49 -44.5 13.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 213' ' ' GLN . 38.1 t60 -45.02 -50.87 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -33.03 -36.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 210' ' ' HIS . 14.9 m-85 -79.98 -48.3 13.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.5 mt-30 -57.29 -44.28 83.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.9 t -33.74 116.05 0.46 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.67 0.748 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -46.91 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.69 2.26 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -42.91 -25.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.18 132.23 31.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.575 0.702 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 137.45 35.49 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.26 . . . . 0.0 112.34 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 230' ' ' VAL . 17.0 m -136.1 140.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.37 132.32 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.56 136.89 96.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.653 0.739 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -32.8 18.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.703 2.269 . . . . 0.0 112.352 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -80.5 -4.15 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 45.05 47.89 9.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.549 ' SG ' HG12 ' A' ' 227' ' ' VAL . 13.4 p -64.93 -49.68 69.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 156.18 -37.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.549 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.5 p -34.34 -37.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.162 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.8 -75.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 81.7 p -136.4 150.58 48.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 219' ' ' VAL . 8.0 p -157.82 133.76 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.053 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.14 142.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ttt-85 -54.84 -43.94 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.21 6.55 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -113.96 -10.89 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.602 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 8.4 tp -66.41 -44.48 57.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.624 0.726 . . . . 0.0 110.914 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.98 -64.92 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -59.81 -47.79 89.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.439 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -51.09 -50.55 58.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.9 mt -59.92 -15.4 21.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 18.5 ttmt -69.64 -65.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' SER . 51.7 m-20 -123.34 -49.17 1.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.5 t -34.93 -69.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.6 t -48.92 146.25 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -67.59 109.33 3.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 246' ' ' ALA . 28.8 p -38.92 105.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 245' ' ' THR . . . -35.16 132.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.2 tt -114.89 104.38 11.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.8 t -125.23 144.23 50.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.878 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.9 p -149.66 170.72 18.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -163.97 -99.43 0.14 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.515 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.9 m -83.39 104.12 13.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 m 45.35 39.08 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.797 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 190' ' ' LYS . . . 72.16 -81.34 0.58 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.457 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 189' ' ' GLY . 28.6 mttp -37.4 122.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.323 . . . . 0.0 110.886 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.6 mtp85 -62.43 157.47 20.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 7.6 p -141.68 123.8 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -107.65 105.21 55.54 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.606 0.717 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 102.69 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.5 t -52.54 145.69 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.9 m -90.09 -26.5 20.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -69.52 -73.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.57 -4.11 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.3 p 54.08 31.3 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -100.88 -176.59 3.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.27 121.91 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.546 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 68.5 m-85 -136.15 152.36 50.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.675 HG23 ' H ' ' A' ' 206' ' ' THR . 18.9 m -76.0 139.35 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.6 p90 -43.72 -23.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 203' ' ' VAL . 5.7 t70 -72.85 -44.01 61.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.675 ' H ' HG23 ' A' ' 203' ' ' VAL . 66.5 p -84.41 -45.71 12.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.3 tp -34.02 -34.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 206' ' ' THR . 21.7 mt-30 -58.37 -56.88 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.956 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.3 m -75.01 -37.92 61.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.546 ' CE1' ' CE2' ' A' ' 202' ' ' PHE . 36.0 t60 -44.85 -49.21 10.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -34.14 -34.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.9 m-85 -78.88 -47.08 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.5 mm-40 -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.8 t -34.41 109.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.4 Cg_endo -69.85 -50.64 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.273 . . . . 0.0 112.328 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 215' ' ' PRO . 12.7 mmt180 -36.79 -31.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.1 tp -52.23 135.88 40.36 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 138.34 37.74 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.361 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 219' ' ' VAL . 21.7 m -132.2 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.89 130.26 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.7 t -61.06 136.69 93.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.659 0.742 . . . . 0.0 110.834 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -29.6 23.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -83.68 -6.89 59.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 46.79 52.0 11.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.6 p -68.36 -51.54 43.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 161.2 -35.91 0.4 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.511 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.51 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.7 p -39.28 -26.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.143 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.43 -70.05 3.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 59.8 p -147.54 147.55 30.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.521 ' CG1' HD12 ' A' ' 235' ' ' LEU . 11.8 p -154.23 140.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -36.4 143.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.83 -39.14 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -81.88 3.22 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.677 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -115.54 -5.95 12.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.598 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.67 -44.51 80.64 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.586 0.708 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.99 -63.45 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.684 2.256 . . . . 0.0 112.3 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.05 -29.07 61.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.46 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' HIS . . . . . 0.408 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 15.9 t60 -70.05 -54.87 11.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.11 -14.2 2.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.65 -66.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 24.0 t0 -106.78 -62.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 241' ' ' ASP . 54.9 m -34.44 -66.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t -68.97 133.69 48.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -106.77 94.22 5.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 22.0 m -54.2 124.92 17.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -121.37 38.03 4.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.481 ' C ' HD12 ' A' ' 247' ' ' LEU . 4.0 pp -145.75 167.96 21.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.416 ' C ' HD12 ' A' ' 247' ' ' LEU . 33.7 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 72.9 m -154.7 165.16 37.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.367 . . . . 0.0 110.831 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.7 t -111.66 -51.88 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.911 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 145.17 -44.14 0.9 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.458 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.0 m -73.05 118.23 15.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 110.848 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.1 m 54.14 40.9 32.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.07 164.54 24.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -70.46 135.6 48.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.567 ' HB2' ' CD1' ' A' ' 204' ' ' PHE . 4.2 mtp-105 -79.09 155.23 28.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.0 p -130.39 129.8 43.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.687 ' O ' HD13 ' A' ' 207' ' ' ILE . 1.9 tp60 -117.21 115.69 37.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.731 . . . . 0.0 110.874 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 109.67 2.37 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.0 t -53.3 123.08 10.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 196' ' ' THR . 40.2 m -74.89 4.2 6.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -104.07 -59.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.3 7.73 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 38.8 p 41.46 46.69 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -120.63 155.07 34.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.95 115.07 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -135.8 145.29 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.2 t -47.83 149.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.681 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.7 p90 -69.17 -28.97 66.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.61 -36.67 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLN . 69.5 p -82.69 -44.59 15.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 193' ' ' GLN . 4.1 tp -33.54 -34.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.6 mt-30 -65.91 -50.4 64.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 75.0 p -73.82 -40.65 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.9 t60 -58.54 -50.14 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 210' ' ' HIS . 8.1 mm-40 -33.95 -36.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 210' ' ' HIS . 32.4 m-85 -70.93 -49.38 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 210' ' ' HIS . 51.6 mt-30 -65.08 -42.84 93.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -33.82 123.72 0.48 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -49.5 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -41.6 -38.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 tp -45.58 134.09 6.16 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.588 0.709 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.13 39.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 230' ' ' VAL . 17.8 m -134.53 133.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.76 143.68 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.093 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.29 134.62 89.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -23.31 30.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.09 2.7 53.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 37.97 50.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 9.1 p -67.4 -48.81 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 157.62 -41.86 0.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 226' ' ' GLY . 12.6 p -33.82 -38.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 111.162 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.0 -97.38 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 16.6 p -112.67 146.02 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.565 HG11 HD12 ' A' ' 235' ' ' LEU . 11.3 p -157.54 130.98 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.144 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.49 145.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.424 ' C ' ' HD3' ' A' ' 232' ' ' ARG . 3.5 tmt_? -62.08 -33.58 74.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.62 -4.28 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.553 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 4.4 m-20 -106.05 -8.57 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.622 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.9 tp -68.89 -43.1 25.98 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.625 0.726 . . . . 0.0 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.0 Cg_exo -47.94 -65.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.377 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.33 -33.72 71.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.89 -51.85 62.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 58.4 mt -57.43 -18.85 20.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -63.16 -66.71 0.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.4 m-20 -125.76 -46.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.1 m -35.02 -65.35 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.8 t -43.74 113.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.69 86.76 7.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -58.11 138.35 56.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -77.41 131.85 38.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.41 -43.41 75.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.093 179.863 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.0 p -55.54 -45.81 77.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.811 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 29.0 t -90.28 -46.78 8.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.03 -83.61 0.28 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.6 t -160.22 117.52 2.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 0.0 110.866 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.2 t -88.0 92.87 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 152.78 -48.52 0.54 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.497 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -131.19 139.36 49.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -108.31 161.15 15.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.4 p -110.35 138.98 46.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 21.9 mm-40 -112.59 103.31 55.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.634 0.73 . . . . 0.0 110.944 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.1 Cg_endo -69.72 105.77 1.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.343 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.4 t -56.41 136.51 53.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -84.12 -17.15 41.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -78.97 -69.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.7 p -79.1 -2.64 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p 50.33 42.56 26.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -117.17 177.57 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -111.16 115.4 29.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -137.98 144.0 40.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.3 156.23 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.616 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.5 p90 -63.75 -24.85 67.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.77 -27.97 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.5 p -99.09 -37.62 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 204' ' ' PHE . 5.2 tp -38.61 -27.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 206' ' ' THR . 13.5 mm100 -63.6 -56.36 16.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -79.98 -42.46 23.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.9 t60 -41.16 -48.87 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.849 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -35.2 -38.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.38 -44.33 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.3 mt-30 -63.42 -47.89 80.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -34.57 107.29 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.727 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.65 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt-85 -41.8 -30.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.0 tp -52.6 135.41 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.585 0.707 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 141.91 46.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.38 136.58 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.48 134.98 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.0 t -66.68 135.28 94.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.619 0.723 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.02 29.02 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.401 ' OD1' HG21 ' A' ' 245' ' ' THR . 40.0 m-80 -85.96 -1.88 57.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 40.98 53.93 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.641 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.4 p -71.66 -52.0 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 154.39 -28.42 0.69 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.458 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.641 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.3 p -44.03 -24.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.52 -96.28 1.93 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.4 p -116.39 145.19 43.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 231' ' ' ALA . 12.0 p -155.51 128.08 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.45 145.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -59.82 -40.68 89.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -80.62 6.1 13.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 1.2 m-20 -115.07 -8.14 12.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.2 tp -69.88 -42.56 18.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 0.0 110.946 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.97 -64.3 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.35 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.35 -33.53 76.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.46 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' HIS . . . . . 0.403 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 15.0 t60 -64.25 -48.61 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.73 -19.62 51.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -62.24 -66.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' SER . 9.5 t0 -125.59 -45.41 1.78 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.7 t -35.63 -65.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.5 t -54.62 103.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -97.44 47.77 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.401 HG21 ' OD1' ' A' ' 223' ' ' ASN . 11.2 t -87.54 130.86 34.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 247' ' ' LEU . . . -89.1 -44.27 10.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 246' ' ' ALA . 1.5 tt 36.36 53.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 179.859 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.5 p -124.39 117.22 23.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.883 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 26.9 m 59.29 43.42 16.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -92.01 70.45 1.79 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.0 m -106.09 175.59 5.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 110.824 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 94.3 p -114.4 126.9 55.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.818 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.31 -152.24 18.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.474 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm 59.71 54.16 4.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.5 ttt-85 -62.69 169.64 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.6 p -122.8 138.7 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.76 116.2 54.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.409 ' HB3' ' CD ' ' A' ' 201' ' ' GLU . 53.9 Cg_endo -69.74 98.03 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 34.5 t -50.97 142.83 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 196' ' ' THR . 74.3 m -88.28 -16.26 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -83.39 -69.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.1 p -78.06 -2.71 38.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.5 p 50.42 30.97 4.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 61.8 mttt -103.76 -174.73 2.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 194' ' ' PRO . 19.8 mm-40 -129.47 120.59 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.16 177.02 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.17 155.64 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.12 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.7 p90 -71.18 -31.15 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -26.72 59.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 209' ' ' SER . 70.2 p -91.27 -42.94 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 204' ' ' PHE . 4.3 tp -33.46 -38.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 206' ' ' THR . 56.7 mm-40 -56.95 -49.69 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' THR . 50.3 p -76.93 -37.34 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 213' ' ' GLN . 20.8 t60 -52.54 -48.49 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 77.7 mt-30 -34.36 -36.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 210' ' ' HIS . 15.8 m-85 -76.59 -47.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 210' ' ' HIS . 56.1 mm-40 -62.37 -47.88 82.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -34.94 102.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.638 0.733 . . . . 0.0 110.856 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -46.77 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 -45.37 -29.91 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -45.89 125.28 6.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.682 2.254 . . . . 0.0 112.351 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 219' ' ' VAL . 15.8 m -123.92 126.79 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.45 132.82 54.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.74 135.59 92.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -23.75 30.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -92.11 0.14 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 39.8 54.99 2.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.1 p -71.27 -51.04 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 163.67 -34.22 0.29 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.422 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 p -42.49 -26.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.31 -65.84 3.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 p -146.24 146.51 30.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.118 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 231' ' ' ALA . 14.8 p -157.77 135.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.12 142.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -56.11 -41.74 75.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -76.25 -10.47 59.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 35.1 m-20 -97.05 -13.59 22.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.851 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.608 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.42 -44.53 82.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.94 -64.62 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 0.0 112.345 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -60.78 -29.96 71.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -67.83 -44.65 76.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 47.0 mt -63.85 -15.9 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -65.64 -66.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.5 t70 -124.84 -46.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 241' ' ' ASP . 1.8 t -34.99 -69.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.5 t -45.91 162.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -121.03 127.18 51.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 87.2 m -127.53 139.06 53.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -129.08 -35.69 1.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.99 150.18 43.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.842 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 50.5 m -152.39 137.0 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 110.837 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 53.7 p -123.74 176.46 6.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 119.72 -99.73 0.76 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.8 t -82.24 141.72 32.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.872 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -72.9 170.35 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.887 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -109.28 -64.39 0.55 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -90.26 150.23 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.938 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.93 162.73 12.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 66.5 p -134.81 138.37 44.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.586 ' OE1' HG21 ' A' ' 207' ' ' ILE . 2.2 pt20 -119.12 127.06 26.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.591 0.71 . . . . 0.0 110.972 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 102.38 1.01 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 31.4 t -50.62 143.99 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 196' ' ' THR . 17.0 m -86.58 -15.91 38.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -84.09 -70.49 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.9 p -77.2 -1.02 27.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.1 p 46.91 49.19 14.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -137.26 162.39 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.2 125.48 31.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -135.13 149.45 50.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 205' ' ' ASP . 16.8 t -62.08 144.39 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.0 p90 -66.82 -34.55 78.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.556 ' H ' HG12 ' A' ' 203' ' ' VAL . 37.7 t0 -73.24 -22.78 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.7 p -99.89 -25.33 14.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 204' ' ' PHE . 4.4 tp -52.45 -15.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.46 -47.52 32.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 m -86.83 -40.34 15.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 213' ' ' GLN . 10.7 t60 -44.42 -47.96 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 210' ' ' HIS . 18.1 mm-40 -35.96 -38.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -71.63 -44.97 63.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 210' ' ' HIS . 45.5 mt-30 -65.22 -40.66 94.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.8 t -34.65 112.33 0.43 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 214' ' ' CYS . 53.3 Cg_endo -69.83 -36.81 9.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.26 . . . . 0.0 112.28 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -55.62 -33.42 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tp -43.83 124.75 4.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 129.73 18.11 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.364 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.77 130.03 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.54 132.64 54.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.68 133.15 93.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -10.67 29.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.24 . . . . 0.0 112.345 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -98.84 -5.06 31.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 45.13 54.27 7.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.595 ' SG ' HG12 ' A' ' 227' ' ' VAL . 3.6 p -73.44 -53.95 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 162.03 -37.04 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.595 HG12 ' SG ' ' A' ' 225' ' ' CYS . 4.4 p -39.5 -27.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 0.0 111.142 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.34 -73.32 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.46 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.4 p -134.5 149.36 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.608 HG11 HD12 ' A' ' 235' ' ' LEU . 13.6 p -156.47 126.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.01 143.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.38 -46.77 73.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.8 6.79 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 1.0 OUTLIER -113.64 -11.09 13.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.608 HD12 HG11 ' A' ' 230' ' ' VAL . 10.0 tp -67.23 -44.24 47.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.581 0.705 . . . . 0.0 110.897 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.5 Cg_exo -48.03 -59.68 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -64.02 -46.98 89.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -52.0 -49.71 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 55.5 mt -54.38 -19.34 5.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 6.0 tmtm? -61.52 -65.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 241' ' ' ASP . 37.8 t0 -127.23 -44.62 1.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 241' ' ' ASP . 19.9 m -35.51 -64.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.0 t -45.93 112.34 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -72.39 103.26 3.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 t -155.93 156.16 34.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.178 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 247' ' ' LEU . . . -62.94 104.92 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.677 HD12 ' H ' ' A' ' 247' ' ' LEU . 5.8 mp -35.91 -52.43 0.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.19 179.797 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.2 p -118.79 118.73 32.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.0 p -132.91 143.79 49.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -124.8 -88.35 0.77 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.514 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.8 p -132.42 -51.01 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.3 t -72.73 127.1 31.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -172.98 146.06 8.8 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.494 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -56.16 134.55 53.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -60.83 144.67 52.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.1 p -119.09 149.69 41.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -121.01 119.77 29.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.574 0.702 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 100.94 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.304 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 7.9 t -51.29 119.89 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 196' ' ' THR . 6.9 m -72.17 1.27 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -99.04 -58.11 2.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.3 p -97.81 3.58 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.2 p 47.3 36.6 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -113.07 147.38 37.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -85.97 119.78 26.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.95 166.37 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.623 ' HB ' HG23 ' A' ' 206' ' ' THR . 20.5 t -71.16 145.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.803 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.7 OUTLIER -61.74 -31.19 71.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 203' ' ' VAL . 6.0 t70 -74.04 -31.66 62.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.623 HG23 ' HB ' ' A' ' 203' ' ' VAL . 27.2 p -82.99 -40.37 20.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.0 tp -43.1 -22.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 206' ' ' THR . 18.2 mt-30 -68.07 -50.28 56.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 -41.88 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.482 ' O ' ' N ' ' A' ' 213' ' ' GLN . 44.1 t60 -40.42 -52.54 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.2 mt-30 -32.7 -41.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.19 -49.86 63.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.5 mt-30 -63.97 -47.97 78.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.0 t -33.93 116.98 0.49 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.603 0.716 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -47.04 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.462 ' CD ' ' OE2' ' A' ' 233' ' ' GLU . 11.0 mmm180 -43.27 -37.47 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 tp -44.06 133.58 4.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.607 0.718 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 130.47 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 219' ' ' VAL . 30.9 m -126.86 126.11 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.183 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.39 132.65 48.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.19 131.69 95.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.65 0.738 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -21.15 33.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -86.56 -14.89 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 54.55 54.14 9.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.9 p -73.83 -49.21 26.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 158.25 -36.95 0.52 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.524 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -39.19 -32.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 111.106 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.45 -67.15 3.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.495 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 61.5 p -144.49 143.84 31.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.419 ' CG1' HD12 ' A' ' 235' ' ' LEU . 11.1 p -153.42 136.11 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.54 134.84 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -52.6 -41.58 63.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.462 ' OE2' ' CD ' ' A' ' 216' ' ' ARG . 21.8 pt-20 -69.25 -14.58 63.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -107.22 10.6 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.6 tp -76.44 -44.59 3.39 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.2 Cg_exo -47.99 -65.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.635 2.223 . . . . 0.0 112.385 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.39 58.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' HIS . . . . . 0.416 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 23.5 t60 -68.93 -56.22 8.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.84 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.4 mt -53.5 -29.29 35.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -66.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 242' ' ' SER . 2.8 m-20 -116.96 -58.38 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.5 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.0 t -29.38 -70.28 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.2 t -51.76 129.12 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 39.6 m-20 -98.84 96.79 8.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -77.37 145.87 37.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -104.82 141.53 36.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.73 152.56 23.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 248' ' ' VAL . 47.4 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 2.0 m -47.69 146.05 2.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.903 0.382 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 95.3 p -97.34 173.67 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.8 64.65 1.2 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.468 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 89.7 p -52.08 -45.19 64.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.844 0.354 . . . . 0.0 110.856 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.9 p -113.68 177.71 4.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -63.19 -148.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.505 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -148.18 120.06 8.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.882 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -61.09 133.51 56.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.6 p -110.73 140.46 45.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -107.35 109.98 62.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 200' ' ' LYS . 53.6 Cg_endo -69.79 99.72 0.77 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.7 t -52.35 144.81 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.7 m -89.72 -25.33 21.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.96 -69.17 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.84 -5.91 52.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 56.8 p 50.74 42.5 27.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 25.0 mtmm -118.36 177.6 4.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -111.19 123.7 50.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -138.72 156.08 47.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 205' ' ' ASP . 9.5 p -76.31 140.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.682 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.0 p90 -53.11 -26.94 18.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 203' ' ' VAL . 16.5 t0 -65.43 -27.58 68.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 208' ' ' GLN . 71.3 p -104.17 -32.71 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.116 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 204' ' ' PHE . 8.8 tp -35.48 -30.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 206' ' ' THR . 27.6 mt-30 -66.48 -60.68 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.0 p -69.24 -43.53 73.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.0 t60 -40.57 -50.17 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 210' ' ' HIS . 32.9 mt-30 -32.67 -37.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.8 m-85 -79.23 -46.36 17.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 210' ' ' HIS . 73.5 mt-30 -59.73 -47.14 86.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' GLN . 6.2 t -34.04 117.93 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -50.9 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.34 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -39.05 -32.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.99 133.64 58.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.619 0.723 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 131.87 22.18 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.73 2.286 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.36 144.32 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -79.4 138.7 37.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 18.7 t -59.74 135.4 89.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.15 19.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -76.96 -20.22 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 60.15 53.7 4.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.475 ' SG ' HG12 ' A' ' 227' ' ' VAL . 7.9 p -76.44 -50.75 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 160.28 -31.61 0.39 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.475 HG12 ' SG ' ' A' ' 225' ' ' CYS . 5.9 p -39.41 -25.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.913 0.387 . . . . 0.0 111.177 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 79.96 -93.12 1.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.9 p -118.6 147.09 44.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.773 0.32 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.478 HG11 HD12 ' A' ' 235' ' ' LEU . 12.3 p -158.27 130.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.96 139.91 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.083 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -53.24 -44.72 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.61 -1.21 20.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 7.8 m-20 -106.0 -23.09 12.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.5 tp -54.55 -43.69 98.29 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.93 -62.38 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.676 2.251 . . . . 0.0 112.357 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.89 -30.67 70.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.526 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' HIS . . . . . 0.418 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 18.4 t60 -68.01 -54.26 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.2 mt -55.44 -29.74 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -53.46 -67.07 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 242' ' ' SER . 36.2 t70 -121.13 -51.29 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.1 t -32.76 -69.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.3 t -52.96 160.51 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -100.47 123.3 44.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 72.7 p -83.22 147.17 28.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.85 170.25 16.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.58 100.92 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.906 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 2.1 t -140.61 113.15 8.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 87.6 p -55.92 168.61 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 168.66 168.05 30.18 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.434 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 m -157.55 105.07 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.8 t -100.93 139.9 35.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -79.03 -104.83 0.22 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -109.33 114.39 28.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.752 0.31 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -68.49 136.07 52.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 22.9 p -116.96 145.44 43.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.15 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.44 ' O ' HD13 ' A' ' 207' ' ' ILE . 0.5 OUTLIER -110.54 114.48 54.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 96.58 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 22.5 t -51.69 133.64 30.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 196' ' ' THR . 19.3 m -83.56 -10.86 58.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.179 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 217' ' ' LEU . 18.2 m-85 -86.3 -65.25 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 22.4 p -84.35 0.89 47.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.4 p 49.23 33.47 5.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 -174.84 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -127.91 125.96 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.41 170.86 15.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 205' ' ' ASP . 4.7 t -68.23 146.86 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.562 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.1 p90 -61.53 -25.78 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.435 ' H ' HG12 ' A' ' 203' ' ' VAL . 5.8 t70 -77.91 -43.7 29.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.6 p -73.7 -48.84 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 204' ' ' PHE . 2.8 tp -33.15 -35.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 23.7 mm100 -58.1 -54.58 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 m -78.76 -41.14 31.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.4 t60 -44.17 -46.65 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -36.37 -39.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -68.87 -43.32 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 mm100 -68.8 -41.67 78.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.1 t -35.1 113.17 0.47 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -47.19 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -42.48 -37.16 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 197' ' ' TYR . 8.4 tp -48.37 137.4 11.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.584 0.707 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.407 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.5 Cg_endo -69.84 141.8 45.9 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.307 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.76 129.57 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.73 133.79 56.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.68 133.12 89.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.652 0.739 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -12.64 33.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -97.28 -8.89 28.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 50.26 50.37 18.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.582 ' SG ' HG12 ' A' ' 227' ' ' VAL . 7.7 p -70.72 -50.88 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 157.56 -34.87 0.54 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.504 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.582 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -41.45 -23.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.98 -98.46 2.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.7 p -115.61 147.59 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 235' ' ' LEU . 12.5 p -158.04 130.85 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.11 142.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -58.24 -41.72 84.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.53 -2.78 40.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 16.1 m-20 -103.42 -17.37 15.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.609 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -57.35 -44.55 99.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.667 0.746 . . . . 0.0 110.977 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.95 -65.66 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.34 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.03 -23.86 57.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -74.05 -48.36 30.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 110.83 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.21 -13.1 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -66.87 -64.62 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 242' ' ' SER . 10.4 t70 -122.3 -53.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 241' ' ' ASP . 2.7 m -34.21 -69.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.1 t -49.86 176.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -148.59 164.2 34.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 48.9 p 45.74 42.13 8.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.58 88.39 3.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.098 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 247' ' ' LEU . 8.8 tt -73.27 -50.6 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.853 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.2 t -61.3 -57.14 13.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.35 . . . . 0.0 110.841 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 186' ' ' GLY . 12.4 t -98.57 107.74 20.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.848 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 185' ' ' SER . . . 36.22 -126.92 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.1 m -113.24 127.44 56.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.904 0.383 . . . . 0.0 110.865 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 70.3 m 49.68 40.16 19.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.57 -40.35 2.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.462 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -61.84 108.53 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -78.35 170.71 16.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 77.3 p -122.2 148.79 44.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.521 ' NE2' HG12 ' A' ' 207' ' ' ILE . 12.9 pt20 -113.96 122.57 34.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.578 0.704 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 99.33 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.713 2.275 . . . . 0.0 112.311 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.0 t -51.08 143.78 10.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.6 m -87.27 -26.05 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.402 ' HB2' ' SG ' ' A' ' 214' ' ' CYS . 15.7 m-85 -72.52 -69.97 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.1 p -77.06 -3.22 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 46.7 p 52.09 31.48 8.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -114.7 177.09 4.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -106.74 126.95 52.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -138.45 151.98 47.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.737 HG22 ' H ' ' A' ' 205' ' ' ASP . 11.1 p -76.9 133.41 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -50.45 -21.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.737 ' H ' HG22 ' A' ' 203' ' ' VAL . 1.1 t70 -68.16 -33.44 74.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.462 ' H ' HG13 ' A' ' 203' ' ' VAL . 46.0 p -101.83 -38.16 7.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.521 HG12 ' NE2' ' A' ' 193' ' ' GLN . 2.8 tp -33.35 -38.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 206' ' ' THR . 29.4 mm100 -55.71 -49.74 72.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 206' ' ' THR . 69.4 p -83.26 -38.49 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 211' ' ' GLN . 8.8 t60 -53.98 -45.71 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 210' ' ' HIS . 5.5 mt-30 -38.34 -38.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -72.11 -52.72 15.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 214' ' ' CYS . 15.4 mm100 -57.46 -51.18 70.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.456 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.9 t -33.83 107.53 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -41.9 3.84 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -52.22 -38.26 57.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.567 HD12 ' HD2' ' A' ' 218' ' ' PRO . 3.7 tp -38.91 129.08 1.19 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.584 0.707 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.9 Cg_endo -69.69 134.23 27.63 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.713 2.276 . . . . 0.0 112.352 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 230' ' ' VAL . 15.7 m -129.25 136.61 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.85 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.6 t -63.72 135.17 96.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.643 0.735 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.529 ' HD3' HD21 ' A' ' 235' ' ' LEU . 53.7 Cg_endo -69.79 -33.36 16.61 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -79.46 -20.67 46.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 61.96 54.63 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 10.7 p -75.42 -49.85 17.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 160.95 -38.47 0.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.518 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 226' ' ' GLY . 9.2 p -34.25 -39.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 227' ' ' VAL . . . 95.47 -99.99 2.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.476 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -112.79 138.09 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 219' ' ' VAL . 14.8 p -150.13 134.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.3 143.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 46.8 ttt-85 -61.88 -39.86 93.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.49 2.38 29.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.605 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 30.5 m-20 -110.81 -12.98 14.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.3 tp -60.99 -43.36 90.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.96 -65.65 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.351 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.53 -28.58 56.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -70.14 -56.33 7.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.822 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.41 -32.24 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -50.39 -66.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 27.6 t70 -124.05 -49.3 1.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.5 t -34.22 -68.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 6.2 t -49.93 108.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -132.23 81.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.3 t -80.43 -16.79 53.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -66.59 135.33 53.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.085 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.28 47.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.866 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.1 t -123.03 120.28 32.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.853 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 42.1 t -104.61 -51.24 3.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.34 -128.43 8.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.0 t -70.76 109.36 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 110.856 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.4 t -50.88 155.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.837 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.51 171.9 50.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -129.42 107.16 9.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 74.6 mtm-85 -63.67 146.59 53.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.9 p -111.2 151.14 28.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.66 ' O ' HD13 ' A' ' 207' ' ' ILE . 19.7 tt0 -118.43 108.97 40.88 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 102.83 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 6.9 t -52.91 120.19 5.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 196' ' ' THR . 24.3 m -72.84 2.78 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.401 ' O ' ' CZ ' ' A' ' 216' ' ' ARG . 5.5 m-85 -101.38 -64.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.0 p -89.04 5.69 43.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p 45.87 35.07 2.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -98.24 -174.57 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -131.57 103.58 6.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.75 176.09 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 205' ' ' ASP . 39.2 t -82.98 124.13 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.6 p90 -38.21 -29.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.598 ' H ' HG12 ' A' ' 203' ' ' VAL . 23.7 t0 -77.62 -42.21 35.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 203' ' ' VAL . 58.5 p -78.99 -50.81 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.3 tp -33.21 -42.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.151 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.464 ' N ' HG23 ' A' ' 207' ' ' ILE . 67.2 mm-40 -45.4 -57.42 4.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -71.32 -49.35 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 213' ' ' GLN . 14.2 t60 -40.52 -51.11 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.867 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.5 mt-30 -32.86 -38.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.7 m-85 -69.68 -49.04 57.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' HIS . 78.2 mm-40 -65.78 -45.46 82.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 213' ' ' GLN . 12.0 t -32.77 118.38 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.7 Cg_endo -69.79 -50.11 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.356 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 215' ' ' PRO . 24.7 mmm-85 -34.29 -37.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.9 tp -44.3 129.08 4.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.601 0.715 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 138.97 39.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.353 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 219' ' ' VAL . 34.3 m -137.31 127.35 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.16 133.61 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.2 t -60.44 135.52 91.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -28.32 25.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -81.92 -7.81 59.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 48.39 53.42 12.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.613 ' SG ' HG12 ' A' ' 227' ' ' VAL . 9.4 p -72.79 -51.02 20.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 156.33 -35.15 0.6 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.536 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.613 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.7 p -37.68 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.148 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.85 -93.54 1.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.49 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.5 p -117.66 146.61 43.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.799 0.333 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 235' ' ' LEU . 14.4 p -157.64 127.91 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -37.3 153.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -66.2 -43.83 85.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -78.47 7.15 7.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -14.32 11.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.4 tp -63.3 -43.58 80.41 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.599 0.714 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.5 Cg_exo -47.93 -65.44 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.729 2.286 . . . . 0.0 112.345 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.21 -25.63 57.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' HIS . . . . . 0.438 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 7.8 t60 -72.57 -52.77 14.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 110.817 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.43 -18.71 12.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -69.98 -63.86 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 242' ' ' SER . 11.2 t0 -115.31 -56.35 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 241' ' ' ASP . 20.0 m -34.06 -69.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 3.0 t -56.79 150.24 16.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -133.37 178.68 6.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.8 t 40.04 40.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -110.97 140.5 45.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.11 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 14.5 tp -51.07 -43.45 61.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 248' ' ' VAL . 8.4 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 t 49.69 42.41 23.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 110.845 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 56.0 p -115.11 132.23 56.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.76 -164.83 27.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.7 m -92.66 -48.37 6.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 110.781 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.4 t 40.15 41.96 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.67 146.77 5.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -123.66 131.48 53.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.703 0.287 . . . . 0.0 110.914 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -75.35 161.55 29.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 34.5 p -114.56 135.71 53.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 202' ' ' PHE . 29.9 tp60 -107.8 116.52 57.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.897 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 106.56 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.675 2.25 . . . . 0.0 112.315 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.17 138.44 56.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 196' ' ' THR . 4.8 m -86.25 -13.8 45.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.68 -64.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.914 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 p -85.93 -0.05 54.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 49.49 36.45 10.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -113.42 169.8 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -104.32 122.74 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 193' ' ' GLN . 73.1 m-85 -138.61 175.14 9.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.719 HG12 ' H ' ' A' ' 205' ' ' ASP . 23.5 t -73.72 144.8 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.746 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.5 p90 -64.67 -27.96 69.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.719 ' H ' HG12 ' A' ' 203' ' ' VAL . 22.6 t70 -76.07 -43.59 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 208' ' ' GLN . 52.8 p -73.97 -44.06 56.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.19 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.2 tp -33.67 -33.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 206' ' ' THR . 34.6 mm-40 -57.5 -58.43 8.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.7 m -77.45 -41.63 38.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 5.4 t60 -41.88 -46.43 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -38.52 -39.23 0.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -67.73 -39.76 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 55.3 mm-40 -73.8 -36.67 65.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.9 t -34.26 118.2 0.52 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.586 0.708 . . . . 0.0 110.903 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -24.43 29.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.327 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -84.4 25.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 218' ' ' PRO . 5.4 tp -100.42 131.1 24.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.59 0.71 . . . . 0.0 110.923 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.532 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.8 Cg_endo -69.82 119.65 6.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.33 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.02 141.14 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.23 127.95 34.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.6 t -57.96 132.75 83.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.638 0.732 . . . . 0.0 110.928 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.505 ' HD3' HD21 ' A' ' 235' ' ' LEU . 53.4 Cg_endo -69.85 -12.14 32.13 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.698 2.265 . . . . 0.0 112.305 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -97.06 -8.42 30.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 47.71 53.06 11.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.407 ' SG ' HG12 ' A' ' 227' ' ' VAL . 4.2 p -73.12 -53.78 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 161.81 -32.13 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.407 HG12 ' SG ' ' A' ' 225' ' ' CYS . 11.4 p -44.54 -24.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 111.145 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.74 -81.05 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -132.55 148.75 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 231' ' ' ALA . 12.9 p -156.41 136.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.69 147.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -65.26 -30.53 71.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -86.76 -1.69 57.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.87 -21.99 13.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 10.3 tp -56.32 -44.35 99.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.93 -65.63 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.686 2.257 . . . . 0.0 112.362 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.42 98.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 4.1 t60 -56.11 -49.24 74.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.0 mt -57.29 -27.4 62.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -55.58 -67.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.482 ' O ' ' C ' ' A' ' 242' ' ' SER . 5.6 p-10 -121.08 -52.02 2.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.1 t -31.54 -68.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.468 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.7 t -51.44 142.99 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -116.75 79.98 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.1 t -111.45 134.61 52.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -44.27 162.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -51.79 155.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 96.8 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.0 p -153.38 162.58 41.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 42.2 m -137.24 148.06 46.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -144.8 49.97 0.66 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.0 p -80.11 163.1 24.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.884 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -109.61 89.42 3.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.4 -157.64 10.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -144.02 119.03 10.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.724 0.297 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -82.25 141.89 32.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.2 p -116.62 131.72 56.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -107.45 113.6 61.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 104.48 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.663 2.242 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.09 146.52 14.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.0 m -89.59 -26.44 20.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.18 -69.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.7 p -76.51 -4.2 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.0 p 49.57 39.13 16.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -121.31 164.59 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -93.97 128.04 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -137.92 160.59 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 205' ' ' ASP . 20.9 t -69.21 138.18 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.759 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.9 p90 -60.12 -35.56 75.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.557 ' H ' HG12 ' A' ' 203' ' ' VAL . 7.3 t0 -70.89 -15.92 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 203' ' ' VAL . 29.3 p -107.94 -20.97 13.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.8 tp -50.56 -17.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -78.21 -42.19 32.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 93.6 p -85.06 -44.44 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.3 t60 -44.28 -47.84 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -34.88 -36.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 210' ' ' HIS . 17.4 m-85 -75.6 -45.34 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 36.5 mt-30 -64.71 -47.68 77.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' A' ' 213' ' ' GLN . 11.7 t -34.12 112.69 0.42 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.7 Cg_endo -69.8 -50.79 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.9 mmm-85 -38.06 -30.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 215' ' ' PRO . 5.1 tp -61.17 132.26 92.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.56 0.695 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 140.41 42.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.386 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 219' ' ' VAL . 32.5 m -139.03 125.44 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.092 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.42 139.19 44.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.0 t -59.18 134.07 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.587 0.708 . . . . 0.0 110.93 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 1.13 4.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 224' ' ' GLN . 73.8 m-20 -121.3 9.0 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 223' ' ' ASN . 2.7 mp0 36.97 41.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.454 ' SG ' HG12 ' A' ' 227' ' ' VAL . 29.5 p -58.59 -47.41 84.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 151.46 -34.63 0.89 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.454 HG12 ' SG ' ' A' ' 225' ' ' CYS . 11.8 p -37.14 -37.1 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.38 -102.37 2.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.524 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 35.5 p -118.22 123.29 45.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.45 143.73 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.595 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -52.69 137.65 30.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -49.73 -54.74 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.9 pm0 -66.06 -4.58 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.595 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 5.7 m-20 -104.88 -13.79 15.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.631 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -61.07 -42.68 87.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.99 -64.06 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -56.4 -43.81 90.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -56.01 -56.22 23.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.9 mt -56.45 -14.29 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 1.3 tmmm? -64.88 -65.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 242' ' ' SER . 38.9 t0 -121.02 -51.75 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.2 m -35.46 -65.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 2.5 t -61.78 176.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -162.44 156.01 20.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 97.7 m -93.78 150.8 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . 45.95 43.55 10.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.573 ' C ' HD23 ' A' ' 247' ' ' LEU . 7.9 tt -95.88 131.83 41.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.436 ' N ' HD23 ' A' ' 247' ' ' LEU . 90.0 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.111 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 85.6 p -99.43 -24.39 14.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.341 . . . . 0.0 110.83 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 91.1 p -144.17 114.97 7.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 46.22 -116.77 2.38 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.453 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.1 t -65.77 171.78 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.883 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.6 t -54.62 115.12 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -55.32 -51.56 53.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -104.23 156.59 17.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -94.04 166.06 12.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 p -138.6 136.16 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -113.91 106.52 53.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 101.56 0.93 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 29.8 t -54.94 142.08 31.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.419 ' O ' HG22 ' A' ' 196' ' ' THR . 58.5 m -89.56 -13.5 37.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.32 -65.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 24.4 p -82.3 -2.64 53.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 25.2 p 48.94 37.61 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -104.83 -174.86 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -130.19 102.63 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -119.85 173.64 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.46 ' HB ' HG23 ' A' ' 206' ' ' THR . 5.5 t -73.1 144.09 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.942 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.6 p90 -59.17 -34.45 72.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.405 ' H ' HG12 ' A' ' 203' ' ' VAL . 22.2 t0 -69.0 -35.45 76.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.46 HG23 ' HB ' ' A' ' 203' ' ' VAL . 28.4 p -82.45 -32.15 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.942 HG22 ' O ' ' A' ' 204' ' ' PHE . 7.7 tp -48.87 -18.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -69.57 -47.9 62.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -88.29 -38.29 15.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 16.3 t60 -44.13 -51.29 8.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 51.8 mt-30 -34.3 -36.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 210' ' ' HIS . 28.2 m-85 -75.13 -46.31 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.5 mt-30 -62.9 -42.4 99.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.3 t -34.08 118.09 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.587 0.708 . . . . 0.0 110.889 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -49.44 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.266 . . . . 0.0 112.371 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -40.53 -37.76 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.6 tp -44.64 125.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 144.81 54.89 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 219' ' ' VAL . 30.6 m -139.83 126.28 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.95 141.99 37.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.061 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.0 t -67.05 134.87 93.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -16.32 37.57 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -96.18 -6.7 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 48.04 53.81 11.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 4.5 p -72.33 -54.05 10.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 159.61 -24.46 0.31 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 p -48.67 -22.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.16 -89.3 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.9 p -124.92 145.78 49.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.18 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.8 p -153.79 134.79 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.433 ' HB3' ' OD2' ' A' ' 234' ' ' ASP . . . -39.22 152.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -70.11 -32.14 70.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.45 -1.8 58.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.433 ' OD2' ' HB3' ' A' ' 231' ' ' ALA . 68.5 m-20 -114.18 -16.61 12.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 3.3 tp -61.76 -44.29 90.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 0.0 110.909 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.8 Cg_exo -48.01 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.667 2.244 . . . . 0.0 112.306 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.82 39.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.35 -51.1 56.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 235' ' ' LEU . 76.1 mt -57.71 -22.5 46.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -60.1 -63.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 242' ' ' SER . 17.0 t0 -125.3 -47.2 1.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.5 t -36.0 -66.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.2 t -52.12 -46.92 65.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -95.48 87.36 4.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 32.2 p -38.64 -53.95 1.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -103.28 89.54 3.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.114 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 247' ' ' LEU . 1.1 tm? -123.13 -53.77 1.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 179.821 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 88.7 p -130.85 -48.99 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.876 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 1.6 t -61.2 135.95 57.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.63 -148.61 5.03 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.459 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.5 p 44.31 43.28 5.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 0.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.0 p -109.49 126.62 53.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -103.38 -52.84 0.9 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.54 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -54.28 130.11 37.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.87 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -76.51 168.94 19.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.2 p -126.84 143.84 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.612 ' O ' HD13 ' A' ' 207' ' ' ILE . 68.4 mt-30 -119.52 116.87 33.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.598 0.713 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 96.93 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 30.1 t -51.42 135.14 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 196' ' ' THR . 54.2 m -83.77 -11.36 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -86.14 -69.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.4 p -79.17 -0.79 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p 47.81 42.56 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -125.34 159.79 30.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -90.61 129.38 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -138.63 171.24 14.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -76.16 159.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -77.16 -30.46 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.05 -20.01 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 30.6 p -104.77 -49.04 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.0 tp -33.35 -34.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 14.4 mm-40 -57.18 -56.63 19.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -77.79 -42.52 33.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.6 t60 -43.7 -46.72 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 210' ' ' HIS . 41.8 mt-30 -35.45 -35.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 m-85 -80.41 -42.96 21.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.8 t -33.29 123.5 0.44 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.59 0.71 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -44.2 2.17 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.331 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -45.27 -40.3 7.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 tp -39.21 128.82 1.29 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 123.4 10.05 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.37 140.39 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.03 135.21 50.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.069 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 29.9 t -61.99 134.65 94.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.726 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -30.64 21.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.705 2.27 . . . . 0.0 112.368 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -81.17 -9.68 59.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 49.04 52.93 13.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 227' ' ' VAL . 11.2 p -71.38 -49.84 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 159.92 -39.14 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.538 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.463 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.6 p -33.77 -38.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.26 -87.74 0.98 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.473 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 11.9 p -127.62 146.35 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.093 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 231' ' ' ALA . 7.9 p -158.08 132.43 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.47 141.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -38.49 68.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -80.45 -3.31 49.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 6.7 m-20 -104.99 -16.79 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.9 tp -61.14 -42.69 87.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.726 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.97 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.731 2.287 . . . . 0.0 112.327 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.8 -23.88 59.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' HIS . . . . . 0.437 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 10.5 t60 -73.76 -47.14 41.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.4 mt -62.4 -11.16 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -77.27 -64.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 242' ' ' SER . 20.0 t0 -108.58 -63.1 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.7 m -33.16 -71.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t -60.9 116.74 4.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -96.61 87.3 4.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.7 t -104.76 141.33 36.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.168 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . 46.82 27.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.3 mt -142.79 157.97 44.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 m -133.49 151.53 51.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 0.0 110.84 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 88.3 p -55.01 151.73 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.82 -98.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.4 m -155.49 115.61 3.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 0.0 110.86 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 93.3 p -112.14 41.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.11 -39.67 88.53 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.475 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -39.66 110.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.435 ' HB3' ' NH1' ' A' ' 191' ' ' ARG . 5.0 ptp180 -69.86 163.93 24.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.8 p -115.45 147.22 40.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.114 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.649 ' O ' HD13 ' A' ' 207' ' ' ILE . 25.2 mm100 -114.23 105.78 53.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.711 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.4 Cg_endo -69.74 105.41 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.39 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 4.9 t -55.23 123.87 15.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 196' ' ' THR . 20.8 m -76.76 3.77 11.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.6 -63.96 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.53 9.15 21.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.7 p 39.7 42.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -108.68 -175.44 2.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.8 107.24 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -124.62 158.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 206' ' ' THR . 4.7 t -61.35 128.43 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.2 p90 -40.55 -32.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.8 -43.42 65.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 203' ' ' VAL . 46.9 p -72.23 -42.93 65.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.163 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.6 tp -38.68 -29.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 206' ' ' THR . 0.5 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -72.84 -37.7 67.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLN . 19.5 t60 -49.68 -50.4 43.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 19.2 mt-30 -34.32 -45.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.901 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -62.51 -45.81 91.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' HIS . 31.0 mm100 -67.86 -50.79 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -34.39 110.64 0.39 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.9 Cg_endo -69.8 -43.72 2.46 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 215' ' ' PRO . 15.5 mmm180 -34.46 -40.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.2 tp -40.29 127.3 1.73 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.592 0.711 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.42 33.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.73 135.99 54.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.35 57.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 38.7 t -58.93 131.51 86.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -3.57 12.25 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.252 . . . . 0.0 112.339 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -104.86 -11.54 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 53.44 53.18 12.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.573 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.3 p -76.21 -48.02 21.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 152.86 -30.09 0.82 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.48 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.573 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -42.94 -24.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.53 -91.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -120.14 150.13 41.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.631 HG11 HD12 ' A' ' 235' ' ' LEU . 12.5 p -158.25 133.9 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.653 ' HB3' ' OD2' ' A' ' 234' ' ' ASP . . . -44.23 142.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.49 -49.4 70.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.05 6.74 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.653 ' OD2' ' HB3' ' A' ' 231' ' ' ALA . 9.4 m-20 -112.6 -14.73 13.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.631 HD12 HG11 ' A' ' 230' ' ' VAL . 11.1 tp -61.9 -43.56 87.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.544 0.688 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.99 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.27 . . . . 0.0 112.345 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.89 -34.83 61.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' HIS . . . . . 0.559 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 18.4 t60 -65.6 -61.24 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 243' ' ' CYS . 67.2 mt -49.07 -36.86 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -50.4 -67.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 7.8 p-10 -112.4 -57.2 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.452 ' HB3' ' CG ' ' A' ' 238' ' ' HIS . 5.5 t -33.81 -67.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.559 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t -66.47 167.07 11.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.848 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -108.96 103.68 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.3 p -120.05 112.53 19.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.55 41.05 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.4 tt -97.42 -62.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.11 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.4 m -128.19 106.7 9.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.795 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 13.6 t -115.56 146.27 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.65 52.79 0.89 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.548 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.5 t -51.21 127.86 20.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 0.0 110.83 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.4 m -166.87 127.52 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.865 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -143.23 102.69 0.29 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.38 156.69 29.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.53 147.89 39.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 33.0 p -110.27 141.78 42.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.52 ' O ' HD13 ' A' ' 207' ' ' ILE . 97.9 mm-40 -108.21 109.73 61.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.03 2.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.705 2.27 . . . . 0.0 112.301 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.56 148.36 49.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.6 m -90.23 -29.23 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.37 -69.65 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.52 -3.44 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 34.8 p 46.0 45.84 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -119.26 -175.36 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -119.74 123.4 43.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -138.62 160.66 39.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.681 HG22 ' H ' ' A' ' 205' ' ' ASP . 10.0 p -80.35 143.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.088 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -51.86 -22.81 4.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.681 ' H ' HG22 ' A' ' 203' ' ' VAL . 0.6 OUTLIER -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 207' ' ' ILE . 76.7 p -99.29 -46.87 5.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.155 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 193' ' ' GLN . 4.8 tp -33.29 -38.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 26.2 mt-30 -54.39 -55.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.08 -44.37 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 9.7 t60 -39.67 -50.65 2.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 210' ' ' HIS . 49.5 mm-40 -32.62 -39.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' HIS . 6.9 m-85 -75.84 -46.76 28.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.8 mm-40 -59.34 -43.93 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -33.94 113.8 0.43 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.586 0.708 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -47.58 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.386 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 11.9 mmm180 -38.32 -37.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 216' ' ' ARG . 7.7 tp -37.92 130.7 0.94 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.587 0.708 . . . . 0.0 110.964 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 125.86 12.66 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.351 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 230' ' ' VAL . 18.9 m -122.29 136.02 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -67.29 139.54 57.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.34 130.61 94.23 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -12.46 32.85 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 0.0 112.321 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -96.46 -19.94 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 61.57 48.18 5.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.2 p -69.04 -52.11 32.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 162.83 -40.17 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 228' ' ' GLY . 11.5 p -36.03 -40.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 227' ' ' VAL . . . 95.56 -89.34 1.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.486 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 28.6 p -122.28 142.67 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.095 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 235' ' ' LEU . 12.9 p -153.87 139.32 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -41.43 138.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -52.9 -41.15 64.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.436 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.8 pt-20 -78.93 -11.77 60.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 6.1 m-20 -92.24 -25.36 18.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.599 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.1 tp -54.16 -43.92 97.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.587 0.708 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -48.0 -60.36 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.222 . . . . 0.0 112.358 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -64.01 -31.92 82.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 5.7 t60 -65.36 -52.02 56.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.39 -33.04 58.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -48.95 -66.6 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.3 p30 -121.39 -52.04 2.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.3 t -32.51 -67.78 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.5 t -54.47 155.25 4.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -128.55 87.93 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.2 m -95.74 107.32 19.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -169.31 129.79 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.088 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.1 mt 53.98 41.82 31.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.164 179.79 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 71.2 p -103.79 97.65 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 0.0 110.85 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 68.2 m -104.84 -56.59 2.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -122.47 -80.28 0.52 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.6 t -133.94 124.75 26.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.819 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.3 m -66.92 150.82 48.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 116.19 73.6 0.52 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.98 156.35 18.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 110.901 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -68.13 171.78 6.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 42.5 p -138.99 138.32 37.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.122 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.516 ' O ' HD13 ' A' ' 207' ' ' ILE . 15.3 mm-40 -110.46 106.25 57.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 99.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 48.4 t -53.67 142.41 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 79.5 m -89.4 -20.33 24.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.444 ' CE2' HD12 ' A' ' 217' ' ' LEU . 13.7 m-85 -76.47 -65.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.93 -2.26 56.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.3 p 49.83 37.03 12.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -107.34 -174.45 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -130.21 112.9 13.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.404 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 75.9 m-85 -121.7 177.34 5.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 205' ' ' ASP . 60.4 t -80.27 123.11 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.3 p90 -39.63 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.73 ' H ' HG12 ' A' ' 203' ' ' VAL . 6.5 t70 -80.41 -40.06 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 203' ' ' VAL . 81.8 p -79.64 -47.35 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.1 tp -34.67 -31.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' THR . 32.8 mm-40 -53.12 -53.8 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -76.92 -47.39 21.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.2 t60 -40.93 -48.01 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 210' ' ' HIS . 9.3 mt-30 -33.73 -38.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 210' ' ' HIS . 10.6 m-85 -77.65 -44.92 26.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 210' ' ' HIS . 25.6 mm-40 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.467 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -32.65 116.5 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -46.42 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.627 2.218 . . . . 0.0 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.431 ' NH1' ' OE2' ' A' ' 233' ' ' GLU . 26.8 mmt-85 -41.28 -34.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.444 HD12 ' CE2' ' A' ' 197' ' ' TYR . 7.8 tp -55.54 136.52 70.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.565 0.698 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 153.94 68.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.45 131.38 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.161 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.12 135.89 57.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 47.3 t -59.48 134.25 88.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -17.51 37.55 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -94.69 -6.54 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 49.06 51.3 16.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.547 ' SG ' HG12 ' A' ' 227' ' ' VAL . 22.8 p -74.37 -48.26 29.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 154.91 -30.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.494 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.547 HG12 ' SG ' ' A' ' 225' ' ' CYS . 4.4 p -38.58 -26.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.18 -84.33 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.9 p -132.37 145.62 51.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.459 ' CG1' HD12 ' A' ' 235' ' ' LEU . 12.1 p -158.05 129.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.06 143.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -62.41 -44.7 95.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.431 ' OE2' ' NH1' ' A' ' 216' ' ' ARG . 16.4 pt-20 -70.04 -2.53 13.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 4.5 m-20 -115.53 -12.54 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -58.17 -42.84 97.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.615 0.721 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.98 -65.83 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.49 -33.65 59.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 242' ' ' SER . 45.9 t60 -66.13 -50.16 64.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.5 mt -67.56 -25.51 65.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.988 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -56.39 -67.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.85 -32.38 0.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.456 ' O ' ' ND1' ' A' ' 238' ' ' HIS . 2.5 m -77.77 45.5 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 245' ' ' THR . 17.8 t -153.24 107.41 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -37.32 93.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 243' ' ' CYS . 24.6 p -146.5 133.18 19.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -117.28 92.34 3.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.1 148.04 22.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.117 179.844 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 185' ' ' SER . 26.3 m -120.99 139.56 53.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 184' ' ' SER . 19.8 m -35.48 142.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -140.76 -152.6 5.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 77.7 p -104.36 168.13 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 110.882 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.0 t -153.72 139.63 18.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -173.01 -156.69 13.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -95.87 120.73 36.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 110.879 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -60.59 152.28 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.9 p -123.39 132.07 53.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.145 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -107.43 103.92 50.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 100.58 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 199' ' ' THR . 51.5 t -52.26 149.62 5.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.4 m -90.59 -41.08 11.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.156 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.05 -70.12 0.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.5 p -75.26 -6.85 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.896 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' CYS . 22.7 p 49.71 39.71 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -113.04 174.2 6.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.866 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -109.08 121.78 45.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.82 174.25 10.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 205' ' ' ASP . 14.6 p -97.91 144.14 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.13 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -53.56 -21.94 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 203' ' ' VAL . 14.5 t70 -72.28 -27.0 62.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 208' ' ' GLN . 64.7 p -102.39 -43.08 5.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 206' ' ' THR . 3.7 tp -35.94 -30.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.9 mt-30 -62.17 -52.96 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -81.94 -38.78 24.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' A' ' 213' ' ' GLN . 18.9 t60 -49.19 -51.05 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.5 ' O ' HD22 ' A' ' 217' ' ' LEU . 24.9 mt-30 -33.74 -38.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' HIS . 54.9 m-85 -72.95 -48.22 38.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.1 mt-30 -62.87 -50.2 71.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.2 t -34.15 113.7 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.629 0.728 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.67 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 15.5 mmm180 -43.29 -41.15 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.7 HD12 ' HD2' ' A' ' 218' ' ' PRO . 11.8 tp -38.25 131.69 0.99 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.2 Cg_endo -69.79 139.43 40.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.667 2.245 . . . . 0.0 112.3 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.3 134.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -64.44 127.87 33.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.9 t -58.21 131.45 84.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -12.42 32.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -95.19 -18.02 21.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 61.55 49.55 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.68 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.3 p -68.74 -52.07 34.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 155.71 -35.18 0.63 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.512 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.68 HG12 ' SG ' ' A' ' 225' ' ' CYS . 5.1 p -38.47 -26.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 111.141 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.71 -71.97 2.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 64.9 p -145.97 147.25 31.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.138 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 10.1 p -154.13 144.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -47.64 134.87 12.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -51.7 -36.57 47.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.42 ' C ' ' OE1' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.65 -17.05 58.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.825 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.464 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.2 m-20 -91.37 -25.5 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.571 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -48.27 -45.96 66.73 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.1 Cg_exo -47.94 -60.8 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 0.0 112.371 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -65.96 -20.72 69.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -76.84 -50.46 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 26.2 mt -53.88 -22.5 10.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -56.26 -67.2 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.6 m-20 -127.15 -49.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 241' ' ' ASP . 22.0 m -31.5 -64.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t -44.38 169.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -85.61 84.71 7.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 245' ' ' THR . 5.5 t -64.51 116.82 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.153 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 248' ' ' VAL . . . -173.36 141.9 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.12 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.9 mp 49.06 43.22 22.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 246' ' ' ALA . 91.4 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.6 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.696 0.284 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.425 ' O ' HD13 ' A' ' 207' ' ' ILE . 17.1 tm0? -114.12 117.97 42.88 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 104.85 1.38 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 12.5 t -57.52 135.47 56.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 196' ' ' THR . 81.9 m -82.4 -10.41 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -89.91 -69.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.0 p -79.67 4.33 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.8 p 42.76 37.06 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -118.51 160.62 21.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.37 130.85 37.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.98 170.12 16.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.81 127.76 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -46.13 -27.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.12 -35.0 66.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 207' ' ' ILE . 34.7 p -87.41 -50.71 6.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 208' ' ' GLN . 2.9 tp -33.54 -42.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 207' ' ' ILE . 92.7 mm-40 -49.76 -49.58 47.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.1 t -86.24 -45.3 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.484 ' O ' ' N ' ' A' ' 213' ' ' GLN . 11.0 t60 -45.28 -47.22 12.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mt-30 -34.74 -33.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.0 m-85 -78.91 -46.85 17.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mm-40 -63.15 -45.48 91.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.9 t -35.34 120.49 0.62 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.627 0.727 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -50.44 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.69 2.26 . . . . 0.0 112.338 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -43.62 -40.91 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 tp -39.69 127.29 1.49 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.615 0.722 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 141.95 46.56 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 230' ' ' VAL . 34.5 m -137.79 138.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -71.18 139.11 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.4 t -67.32 135.28 93.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -20.54 34.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -91.82 0.05 57.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 39.62 52.43 2.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.2 p -69.03 -51.53 38.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 159.12 -37.74 0.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.483 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.9 p -37.03 -33.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 90.99 -94.75 2.0 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.1 p -117.17 147.26 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 219' ' ' VAL . 11.6 p -157.14 131.77 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.63 146.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -58.92 -37.7 77.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.35 2.95 29.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.463 ' CB ' HG22 ' A' ' 230' ' ' VAL . 1.4 m-20 -109.24 -15.14 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.4 tp -65.17 -44.5 69.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.91 -62.68 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.327 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -61.02 -45.61 96.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -53.59 -48.28 69.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.358 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.1 mt -59.37 -17.34 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 32.8 ttmt -62.41 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 15.7 p-10 -128.2 -45.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.5 m -34.54 -64.98 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.752 0.31 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 30.5 mt-30 -107.81 103.86 51.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.2 Cg_endo -69.72 99.9 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.649 2.233 . . . . 0.0 112.338 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.16 140.7 15.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.4 m -87.21 -22.97 24.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -73.58 -69.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.1 p -77.78 -4.21 45.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 51.36 38.98 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -112.29 179.99 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -115.9 121.89 43.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -137.38 175.02 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.53 154.36 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -62.73 -25.26 68.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -68.47 -17.6 64.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 208' ' ' GLN . 55.5 p -112.38 -42.76 3.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.6 tp -33.73 -33.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 206' ' ' THR . 16.3 mm100 -62.34 -49.95 73.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 t -84.49 -44.5 13.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 213' ' ' GLN . 38.1 t60 -45.02 -50.87 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -33.03 -36.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 210' ' ' HIS . 14.9 m-85 -79.98 -48.3 13.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.5 mt-30 -57.29 -44.28 83.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.9 t -33.74 116.05 0.46 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.67 0.748 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -46.91 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.69 2.26 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -42.91 -25.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.18 132.23 31.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.575 0.702 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 137.45 35.49 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.26 . . . . 0.0 112.34 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 230' ' ' VAL . 17.0 m -136.1 140.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.37 132.32 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.56 136.89 96.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.653 0.739 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -32.8 18.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.703 2.269 . . . . 0.0 112.352 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -80.5 -4.15 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 45.05 47.89 9.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.549 ' SG ' HG12 ' A' ' 227' ' ' VAL . 13.4 p -64.93 -49.68 69.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 156.18 -37.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.549 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.5 p -34.34 -37.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.162 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.8 -75.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 81.7 p -136.4 150.58 48.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 219' ' ' VAL . 8.0 p -157.82 133.76 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.053 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.14 142.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ttt-85 -54.84 -43.94 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.21 6.55 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -113.96 -10.89 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.602 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 8.4 tp -66.41 -44.48 57.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.624 0.726 . . . . 0.0 110.914 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.98 -64.92 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -59.81 -47.79 89.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.439 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -51.09 -50.55 58.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.9 mt -59.92 -15.4 21.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 18.5 ttmt -69.64 -65.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' SER . 51.7 m-20 -123.34 -49.17 1.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.5 t -34.93 -69.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.729 0.3 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -107.65 105.21 55.54 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.606 0.717 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 102.69 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.5 t -52.54 145.69 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.9 m -90.09 -26.5 20.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -69.52 -73.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.57 -4.11 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.3 p 54.08 31.3 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -100.88 -176.59 3.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.27 121.91 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.546 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 68.5 m-85 -136.15 152.36 50.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.675 HG23 ' H ' ' A' ' 206' ' ' THR . 18.9 m -76.0 139.35 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.6 p90 -43.72 -23.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 203' ' ' VAL . 5.7 t70 -72.85 -44.01 61.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.675 ' H ' HG23 ' A' ' 203' ' ' VAL . 66.5 p -84.41 -45.71 12.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.3 tp -34.02 -34.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 206' ' ' THR . 21.7 mt-30 -58.37 -56.88 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.956 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.3 m -75.01 -37.92 61.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.546 ' CE1' ' CE2' ' A' ' 202' ' ' PHE . 36.0 t60 -44.85 -49.21 10.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -34.14 -34.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.9 m-85 -78.88 -47.08 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.5 mm-40 -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.8 t -34.41 109.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.4 Cg_endo -69.85 -50.64 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.273 . . . . 0.0 112.328 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 215' ' ' PRO . 12.7 mmt180 -36.79 -31.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.1 tp -52.23 135.88 40.36 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 138.34 37.74 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.361 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 219' ' ' VAL . 21.7 m -132.2 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.89 130.26 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.7 t -61.06 136.69 93.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.659 0.742 . . . . 0.0 110.834 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -29.6 23.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -83.68 -6.89 59.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 46.79 52.0 11.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.6 p -68.36 -51.54 43.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 161.2 -35.91 0.4 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.511 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.51 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.7 p -39.28 -26.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.143 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.43 -70.05 3.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 59.8 p -147.54 147.55 30.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.521 ' CG1' HD12 ' A' ' 235' ' ' LEU . 11.8 p -154.23 140.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -36.4 143.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.83 -39.14 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -81.88 3.22 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.677 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -115.54 -5.95 12.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.598 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.67 -44.51 80.64 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.586 0.708 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.99 -63.45 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.684 2.256 . . . . 0.0 112.3 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.05 -29.07 61.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.46 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . 0.408 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 15.9 t60 -70.05 -54.87 11.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.11 -14.2 2.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.65 -66.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 24.0 t0 -106.78 -62.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 241' ' ' ASP . 54.9 m -34.44 -66.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.768 0.318 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.687 ' O ' HD13 ' A' ' 207' ' ' ILE . 1.9 tp60 -117.21 115.69 37.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.731 . . . . 0.0 110.874 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 109.67 2.37 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.0 t -53.3 123.08 10.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 196' ' ' THR . 40.2 m -74.89 4.2 6.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -104.07 -59.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.3 7.73 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 38.8 p 41.46 46.69 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -120.63 155.07 34.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.95 115.07 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -135.8 145.29 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.2 t -47.83 149.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.681 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.7 p90 -69.17 -28.97 66.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.61 -36.67 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLN . 69.5 p -82.69 -44.59 15.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 193' ' ' GLN . 4.1 tp -33.54 -34.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.6 mt-30 -65.91 -50.4 64.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 75.0 p -73.82 -40.65 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.9 t60 -58.54 -50.14 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 210' ' ' HIS . 8.1 mm-40 -33.95 -36.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 210' ' ' HIS . 32.4 m-85 -70.93 -49.38 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 210' ' ' HIS . 51.6 mt-30 -65.08 -42.84 93.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -33.82 123.72 0.48 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -49.5 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -41.6 -38.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 tp -45.58 134.09 6.16 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.588 0.709 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.13 39.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 230' ' ' VAL . 17.8 m -134.53 133.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.76 143.68 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.093 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.29 134.62 89.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -23.31 30.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.09 2.7 53.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 37.97 50.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 9.1 p -67.4 -48.81 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 157.62 -41.86 0.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 226' ' ' GLY . 12.6 p -33.82 -38.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 111.162 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.0 -97.38 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 16.6 p -112.67 146.02 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.565 HG11 HD12 ' A' ' 235' ' ' LEU . 11.3 p -157.54 130.98 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.144 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.49 145.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.424 ' HD3' ' C ' ' A' ' 232' ' ' ARG . 3.5 tmt_? -62.08 -33.58 74.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.62 -4.28 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.553 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 4.4 m-20 -106.05 -8.57 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.622 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.9 tp -68.89 -43.1 25.98 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.625 0.726 . . . . 0.0 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.0 Cg_exo -47.94 -65.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.377 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.33 -33.72 71.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.89 -51.85 62.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 58.4 mt -57.43 -18.85 20.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -63.16 -66.71 0.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.4 m-20 -125.76 -46.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.1 m -35.02 -65.35 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.763 0.316 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 21.9 mm-40 -112.59 103.31 55.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.634 0.73 . . . . 0.0 110.944 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.1 Cg_endo -69.72 105.77 1.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.343 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.4 t -56.41 136.51 53.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -84.12 -17.15 41.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -78.97 -69.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.7 p -79.1 -2.64 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p 50.33 42.56 26.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -117.17 177.57 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -111.16 115.4 29.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -137.98 144.0 40.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.3 156.23 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.616 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.5 p90 -63.75 -24.85 67.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.77 -27.97 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.5 p -99.09 -37.62 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 204' ' ' PHE . 5.2 tp -38.61 -27.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 206' ' ' THR . 13.5 mm100 -63.6 -56.36 16.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -79.98 -42.46 23.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.9 t60 -41.16 -48.87 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.849 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -35.2 -38.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.38 -44.33 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.3 mt-30 -63.42 -47.89 80.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -34.57 107.29 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.727 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.65 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt-85 -41.8 -30.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.0 tp -52.6 135.41 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.585 0.707 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 141.91 46.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.38 136.58 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.48 134.98 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.0 t -66.68 135.28 94.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.619 0.723 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.02 29.02 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -85.96 -1.88 57.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 40.98 53.93 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.641 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.4 p -71.66 -52.0 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 154.39 -28.42 0.69 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.458 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.641 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.3 p -44.03 -24.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.52 -96.28 1.93 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.4 p -116.39 145.19 43.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 231' ' ' ALA . 12.0 p -155.51 128.08 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.45 145.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -59.82 -40.68 89.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -80.62 6.1 13.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 1.2 m-20 -115.07 -8.14 12.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.2 tp -69.88 -42.56 18.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 0.0 110.946 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.97 -64.3 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.35 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.35 -33.53 76.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.46 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . 0.403 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 15.0 t60 -64.25 -48.61 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.73 -19.62 51.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -62.24 -66.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' SER . 9.5 t0 -125.59 -45.41 1.78 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.7 t -35.63 -65.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.6 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.77 0.319 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.76 116.2 54.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.409 ' HB3' ' CD ' ' A' ' 201' ' ' GLU . 53.9 Cg_endo -69.74 98.03 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 34.5 t -50.97 142.83 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 196' ' ' THR . 74.3 m -88.28 -16.26 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -83.39 -69.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.1 p -78.06 -2.71 38.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.5 p 50.42 30.97 4.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 61.8 mttt -103.76 -174.73 2.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 194' ' ' PRO . 19.8 mm-40 -129.47 120.59 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.16 177.02 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.17 155.64 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.12 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.7 p90 -71.18 -31.15 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -26.72 59.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 209' ' ' SER . 70.2 p -91.27 -42.94 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 204' ' ' PHE . 4.3 tp -33.46 -38.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 206' ' ' THR . 56.7 mm-40 -56.95 -49.69 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' THR . 50.3 p -76.93 -37.34 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 213' ' ' GLN . 20.8 t60 -52.54 -48.49 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 77.7 mt-30 -34.36 -36.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 210' ' ' HIS . 15.8 m-85 -76.59 -47.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 210' ' ' HIS . 56.1 mm-40 -62.37 -47.88 82.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -34.94 102.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.638 0.733 . . . . 0.0 110.856 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -46.77 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 -45.37 -29.91 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -45.89 125.28 6.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.682 2.254 . . . . 0.0 112.351 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 219' ' ' VAL . 15.8 m -123.92 126.79 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.45 132.82 54.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.74 135.59 92.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -23.75 30.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -92.11 0.14 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 39.8 54.99 2.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.1 p -71.27 -51.04 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 163.67 -34.22 0.29 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.422 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 p -42.49 -26.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.31 -65.84 3.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 p -146.24 146.51 30.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.118 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 231' ' ' ALA . 14.8 p -157.77 135.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.12 142.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -56.11 -41.74 75.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -76.25 -10.47 59.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 35.1 m-20 -97.05 -13.59 22.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.851 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.608 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.42 -44.53 82.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.94 -64.62 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 0.0 112.345 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -60.78 -29.96 71.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -67.83 -44.65 76.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 47.0 mt -63.85 -15.9 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -65.64 -66.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.5 t70 -124.84 -46.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 241' ' ' ASP . 1.8 t -34.99 -69.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.71 0.291 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.586 ' OE1' HG21 ' A' ' 207' ' ' ILE . 2.2 pt20 -119.12 127.06 26.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.591 0.71 . . . . 0.0 110.972 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 102.38 1.01 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 31.4 t -50.62 143.99 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 196' ' ' THR . 17.0 m -86.58 -15.91 38.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -84.09 -70.49 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.9 p -77.2 -1.02 27.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.1 p 46.91 49.19 14.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -137.26 162.39 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.2 125.48 31.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -135.13 149.45 50.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 205' ' ' ASP . 16.8 t -62.08 144.39 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.0 p90 -66.82 -34.55 78.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.556 ' H ' HG12 ' A' ' 203' ' ' VAL . 37.7 t0 -73.24 -22.78 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.7 p -99.89 -25.33 14.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 204' ' ' PHE . 4.4 tp -52.45 -15.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.46 -47.52 32.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 m -86.83 -40.34 15.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 213' ' ' GLN . 10.7 t60 -44.42 -47.96 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 210' ' ' HIS . 18.1 mm-40 -35.96 -38.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -71.63 -44.97 63.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 210' ' ' HIS . 45.5 mt-30 -65.22 -40.66 94.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.8 t -34.65 112.33 0.43 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 214' ' ' CYS . 53.3 Cg_endo -69.83 -36.81 9.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.26 . . . . 0.0 112.28 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -55.62 -33.42 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tp -43.83 124.75 4.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 129.73 18.11 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.364 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.77 130.03 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.54 132.64 54.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.68 133.15 93.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -10.67 29.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.24 . . . . 0.0 112.345 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -98.84 -5.06 31.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 45.13 54.27 7.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.595 ' SG ' HG12 ' A' ' 227' ' ' VAL . 3.6 p -73.44 -53.95 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 162.03 -37.04 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.595 HG12 ' SG ' ' A' ' 225' ' ' CYS . 4.4 p -39.5 -27.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 0.0 111.142 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.34 -73.32 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.46 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.4 p -134.5 149.36 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.608 HG11 HD12 ' A' ' 235' ' ' LEU . 13.6 p -156.47 126.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.01 143.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.38 -46.77 73.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.8 6.79 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 1.0 OUTLIER -113.64 -11.09 13.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.608 HD12 HG11 ' A' ' 230' ' ' VAL . 10.0 tp -67.23 -44.24 47.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.581 0.705 . . . . 0.0 110.897 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.5 Cg_exo -48.03 -59.68 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -64.02 -46.98 89.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -52.0 -49.71 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 55.5 mt -54.38 -19.34 5.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 6.0 tmtm? -61.52 -65.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 241' ' ' ASP . 37.8 t0 -127.23 -44.62 1.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 241' ' ' ASP . 19.9 m -35.51 -64.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.968 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.1 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.733 0.301 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -121.01 119.77 29.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.574 0.702 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 100.94 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.304 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 7.9 t -51.29 119.89 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 196' ' ' THR . 6.9 m -72.17 1.27 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -99.04 -58.11 2.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.3 p -97.81 3.58 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.2 p 47.3 36.6 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -113.07 147.38 37.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -85.97 119.78 26.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.95 166.37 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.623 ' HB ' HG23 ' A' ' 206' ' ' THR . 20.5 t -71.16 145.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.803 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.7 OUTLIER -61.74 -31.19 71.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 203' ' ' VAL . 6.0 t70 -74.04 -31.66 62.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.623 HG23 ' HB ' ' A' ' 203' ' ' VAL . 27.2 p -82.99 -40.37 20.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.0 tp -43.1 -22.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 206' ' ' THR . 18.2 mt-30 -68.07 -50.28 56.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 -41.88 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.482 ' O ' ' N ' ' A' ' 213' ' ' GLN . 44.1 t60 -40.42 -52.54 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.2 mt-30 -32.7 -41.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.19 -49.86 63.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.5 mt-30 -63.97 -47.97 78.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.0 t -33.93 116.98 0.49 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.603 0.716 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -47.04 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . 0.462 ' CD ' ' OE2' ' A' ' 233' ' ' GLU . 11.0 mmm180 -43.27 -37.47 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 tp -44.06 133.58 4.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.607 0.718 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 130.47 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 219' ' ' VAL . 30.9 m -126.86 126.11 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.183 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.39 132.65 48.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.19 131.69 95.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.65 0.738 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -21.15 33.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -86.56 -14.89 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 54.55 54.14 9.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.9 p -73.83 -49.21 26.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 158.25 -36.95 0.52 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.524 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -39.19 -32.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 111.106 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.45 -67.15 3.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.495 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 61.5 p -144.49 143.84 31.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.419 ' CG1' HD12 ' A' ' 235' ' ' LEU . 11.1 p -153.42 136.11 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.54 134.84 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -52.6 -41.58 63.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.462 ' OE2' ' CD ' ' A' ' 216' ' ' ARG . 21.8 pt-20 -69.25 -14.58 63.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -107.22 10.6 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.6 tp -76.44 -44.59 3.39 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.2 Cg_exo -47.99 -65.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.635 2.223 . . . . 0.0 112.385 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.39 58.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . 0.416 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 23.5 t60 -68.93 -56.22 8.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.84 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.4 mt -53.5 -29.29 35.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -66.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 242' ' ' SER . 2.8 m-20 -116.96 -58.38 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.5 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.0 t -29.38 -70.28 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.2 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.732 0.301 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -107.35 109.98 62.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 200' ' ' LYS . 53.6 Cg_endo -69.79 99.72 0.77 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.7 t -52.35 144.81 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.7 m -89.72 -25.33 21.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.96 -69.17 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.84 -5.91 52.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 56.8 p 50.74 42.5 27.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 25.0 mtmm -118.36 177.6 4.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -111.19 123.7 50.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -138.72 156.08 47.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 205' ' ' ASP . 9.5 p -76.31 140.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.682 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.0 p90 -53.11 -26.94 18.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 203' ' ' VAL . 16.5 t0 -65.43 -27.58 68.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 208' ' ' GLN . 71.3 p -104.17 -32.71 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.116 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 204' ' ' PHE . 8.8 tp -35.48 -30.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 206' ' ' THR . 27.6 mt-30 -66.48 -60.68 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.0 p -69.24 -43.53 73.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.0 t60 -40.57 -50.17 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 210' ' ' HIS . 32.9 mt-30 -32.67 -37.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.8 m-85 -79.23 -46.36 17.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 210' ' ' HIS . 73.5 mt-30 -59.73 -47.14 86.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' GLN . 6.2 t -34.04 117.93 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -50.9 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.34 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -39.05 -32.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.99 133.64 58.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.619 0.723 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 131.87 22.18 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.73 2.286 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.36 144.32 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -79.4 138.7 37.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 18.7 t -59.74 135.4 89.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.15 19.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -76.96 -20.22 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 60.15 53.7 4.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.475 ' SG ' HG12 ' A' ' 227' ' ' VAL . 7.9 p -76.44 -50.75 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 160.28 -31.61 0.39 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.475 HG12 ' SG ' ' A' ' 225' ' ' CYS . 5.9 p -39.41 -25.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.913 0.387 . . . . 0.0 111.177 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 79.96 -93.12 1.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.9 p -118.6 147.09 44.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.773 0.32 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.478 HG11 HD12 ' A' ' 235' ' ' LEU . 12.3 p -158.27 130.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.96 139.91 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.083 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -53.24 -44.72 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.61 -1.21 20.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 7.8 m-20 -106.0 -23.09 12.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.5 tp -54.55 -43.69 98.29 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.93 -62.38 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.676 2.251 . . . . 0.0 112.357 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.89 -30.67 70.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.526 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . 0.418 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 18.4 t60 -68.01 -54.26 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.2 mt -55.44 -29.74 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -53.46 -67.07 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 242' ' ' SER . 36.2 t70 -121.13 -51.29 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.1 t -32.76 -69.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.761 0.315 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.44 ' O ' HD13 ' A' ' 207' ' ' ILE . 0.5 OUTLIER -110.54 114.48 54.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 96.58 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 22.5 t -51.69 133.64 30.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 196' ' ' THR . 19.3 m -83.56 -10.86 58.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.179 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 217' ' ' LEU . 18.2 m-85 -86.3 -65.25 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 22.4 p -84.35 0.89 47.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.4 p 49.23 33.47 5.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 -174.84 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -127.91 125.96 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.41 170.86 15.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 205' ' ' ASP . 4.7 t -68.23 146.86 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.562 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.1 p90 -61.53 -25.78 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.435 ' H ' HG12 ' A' ' 203' ' ' VAL . 5.8 t70 -77.91 -43.7 29.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.6 p -73.7 -48.84 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 204' ' ' PHE . 2.8 tp -33.15 -35.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 23.7 mm100 -58.1 -54.58 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 m -78.76 -41.14 31.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.4 t60 -44.17 -46.65 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -36.37 -39.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -68.87 -43.32 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 mm100 -68.8 -41.67 78.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.1 t -35.1 113.17 0.47 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -47.19 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -42.48 -37.16 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 197' ' ' TYR . 8.4 tp -48.37 137.4 11.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.584 0.707 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.407 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.5 Cg_endo -69.84 141.8 45.9 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.307 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.76 129.57 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.73 133.79 56.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.68 133.12 89.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.652 0.739 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -12.64 33.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -97.28 -8.89 28.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 50.26 50.37 18.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.582 ' SG ' HG12 ' A' ' 227' ' ' VAL . 7.7 p -70.72 -50.88 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 157.56 -34.87 0.54 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.504 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.582 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -41.45 -23.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.98 -98.46 2.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.7 p -115.61 147.59 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 235' ' ' LEU . 12.5 p -158.04 130.85 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.11 142.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -58.24 -41.72 84.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.53 -2.78 40.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 16.1 m-20 -103.42 -17.37 15.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.609 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -57.35 -44.55 99.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.667 0.746 . . . . 0.0 110.977 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.95 -65.66 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.34 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.03 -23.86 57.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -74.05 -48.36 30.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 110.83 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.21 -13.1 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -66.87 -64.62 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 242' ' ' SER . 10.4 t70 -122.3 -53.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 241' ' ' ASP . 2.7 m -34.21 -69.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.794 0.331 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.498 ' HG3' HD13 ' A' ' 207' ' ' ILE . 7.2 pt20 -113.96 122.57 34.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.578 0.704 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 99.33 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.713 2.275 . . . . 0.0 112.311 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.0 t -51.08 143.78 10.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.6 m -87.27 -26.05 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.402 ' HB2' ' SG ' ' A' ' 214' ' ' CYS . 15.7 m-85 -72.52 -69.97 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.1 p -77.06 -3.22 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 46.7 p 52.09 31.48 8.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -114.7 177.09 4.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -106.74 126.95 52.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -138.45 151.98 47.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.737 HG22 ' H ' ' A' ' 205' ' ' ASP . 11.1 p -76.9 133.41 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.477 ' CB ' ' NE2' ' A' ' 193' ' ' GLN . 2.2 p90 -50.45 -21.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.737 ' H ' HG22 ' A' ' 203' ' ' VAL . 1.1 t70 -68.16 -33.44 74.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.462 ' H ' HG13 ' A' ' 203' ' ' VAL . 46.0 p -101.83 -38.16 7.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.498 HD13 ' HG3' ' A' ' 193' ' ' GLN . 2.8 tp -33.35 -38.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 206' ' ' THR . 29.4 mm100 -55.71 -49.74 72.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 206' ' ' THR . 69.4 p -83.26 -38.49 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 211' ' ' GLN . 8.8 t60 -53.98 -45.71 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 210' ' ' HIS . 5.5 mt-30 -38.34 -38.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -72.11 -52.72 15.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 214' ' ' CYS . 15.4 mm100 -57.46 -51.18 70.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.456 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.9 t -33.83 107.53 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -41.9 3.84 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -52.22 -38.26 57.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.567 HD12 ' HD2' ' A' ' 218' ' ' PRO . 3.7 tp -38.91 129.08 1.19 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.584 0.707 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.9 Cg_endo -69.69 134.23 27.63 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.713 2.276 . . . . 0.0 112.352 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 230' ' ' VAL . 15.7 m -129.25 136.61 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.85 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.6 t -63.72 135.17 96.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.643 0.735 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.529 ' HD3' HD21 ' A' ' 235' ' ' LEU . 53.7 Cg_endo -69.79 -33.36 16.61 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -79.46 -20.67 46.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 61.96 54.63 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 10.7 p -75.42 -49.85 17.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 160.95 -38.47 0.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.518 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 226' ' ' GLY . 9.2 p -34.25 -39.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 227' ' ' VAL . . . 95.47 -99.99 2.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.476 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -112.79 138.09 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 219' ' ' VAL . 14.8 p -150.13 134.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.3 143.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 46.8 ttt-85 -61.88 -39.86 93.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.49 2.38 29.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.605 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 30.5 m-20 -110.81 -12.98 14.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.3 tp -60.99 -43.36 90.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.96 -65.65 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.351 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.53 -28.58 56.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -70.14 -56.33 7.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.822 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.41 -32.24 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -50.39 -66.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 27.6 t70 -124.05 -49.3 1.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.5 t -34.22 -68.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.773 0.32 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.66 ' O ' HD13 ' A' ' 207' ' ' ILE . 37.8 tt0 -118.43 108.97 40.88 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 102.83 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 6.9 t -52.91 120.19 5.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 196' ' ' THR . 24.3 m -72.84 2.78 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.401 ' O ' ' CZ ' ' A' ' 216' ' ' ARG . 5.5 m-85 -101.38 -64.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.0 p -89.04 5.69 43.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p 45.87 35.07 2.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -98.24 -174.57 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -131.57 103.58 6.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.75 176.09 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 205' ' ' ASP . 39.2 t -82.98 124.13 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.6 p90 -38.21 -29.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.598 ' H ' HG12 ' A' ' 203' ' ' VAL . 23.7 t0 -77.62 -42.21 35.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 203' ' ' VAL . 58.5 p -78.99 -50.81 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.3 tp -33.21 -42.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.151 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.464 ' N ' HG23 ' A' ' 207' ' ' ILE . 67.2 mm-40 -45.4 -57.42 4.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -71.32 -49.35 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 213' ' ' GLN . 14.2 t60 -40.52 -51.11 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.867 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.5 mt-30 -32.86 -38.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.7 m-85 -69.68 -49.04 57.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' HIS . 78.2 mm-40 -65.78 -45.46 82.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 213' ' ' GLN . 12.0 t -32.77 118.38 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.7 Cg_endo -69.79 -50.11 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.356 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 215' ' ' PRO . 24.7 mmm-85 -34.29 -37.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.9 tp -44.3 129.08 4.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.601 0.715 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 138.97 39.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.353 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 219' ' ' VAL . 34.3 m -137.31 127.35 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.16 133.61 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.2 t -60.44 135.52 91.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -28.32 25.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -81.92 -7.81 59.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 48.39 53.42 12.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.613 ' SG ' HG12 ' A' ' 227' ' ' VAL . 9.4 p -72.79 -51.02 20.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 156.33 -35.15 0.6 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.536 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.613 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.7 p -37.68 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.148 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.85 -93.54 1.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.49 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.5 p -117.66 146.61 43.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.799 0.333 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 235' ' ' LEU . 14.4 p -157.64 127.91 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -37.3 153.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -66.2 -43.83 85.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -78.47 7.15 7.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -14.32 11.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.4 tp -63.3 -43.58 80.41 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.599 0.714 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.5 Cg_exo -47.93 -65.44 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.729 2.286 . . . . 0.0 112.345 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.21 -25.63 57.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . 0.438 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 7.8 t60 -72.57 -52.77 14.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 110.817 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.43 -18.71 12.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -69.98 -63.86 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 242' ' ' SER . 11.2 t0 -115.31 -56.35 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 241' ' ' ASP . 20.0 m -34.06 -69.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 3.0 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.755 0.312 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 202' ' ' PHE . 29.9 tp60 -107.8 116.52 57.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.897 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 106.56 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.675 2.25 . . . . 0.0 112.315 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.17 138.44 56.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 196' ' ' THR . 4.8 m -86.25 -13.8 45.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.68 -64.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.914 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 p -85.93 -0.05 54.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 49.49 36.45 10.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -113.42 169.8 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -104.32 122.74 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 193' ' ' GLN . 73.1 m-85 -138.61 175.14 9.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.719 HG12 ' H ' ' A' ' 205' ' ' ASP . 23.5 t -73.72 144.8 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.746 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.5 p90 -64.67 -27.96 69.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.719 ' H ' HG12 ' A' ' 203' ' ' VAL . 22.6 t70 -76.07 -43.59 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 208' ' ' GLN . 52.8 p -73.97 -44.06 56.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.19 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.2 tp -33.67 -33.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 206' ' ' THR . 34.6 mm-40 -57.5 -58.43 8.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.7 m -77.45 -41.63 38.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 5.4 t60 -41.88 -46.43 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -38.52 -39.23 0.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -67.73 -39.76 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 55.3 mm-40 -73.8 -36.67 65.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.9 t -34.26 118.2 0.52 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.586 0.708 . . . . 0.0 110.903 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -24.43 29.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.327 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -84.4 25.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 218' ' ' PRO . 5.4 tp -100.42 131.1 24.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.59 0.71 . . . . 0.0 110.923 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.532 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.8 Cg_endo -69.82 119.65 6.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.33 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.02 141.14 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.23 127.95 34.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.6 t -57.96 132.75 83.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.638 0.732 . . . . 0.0 110.928 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.505 ' HD3' HD21 ' A' ' 235' ' ' LEU . 53.4 Cg_endo -69.85 -12.14 32.13 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.698 2.265 . . . . 0.0 112.305 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -97.06 -8.42 30.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 47.71 53.06 11.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.407 ' SG ' HG12 ' A' ' 227' ' ' VAL . 4.2 p -73.12 -53.78 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 161.81 -32.13 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.407 HG12 ' SG ' ' A' ' 225' ' ' CYS . 11.4 p -44.54 -24.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 111.145 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.74 -81.05 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -132.55 148.75 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 231' ' ' ALA . 12.9 p -156.41 136.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.69 147.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -65.26 -30.53 71.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -86.76 -1.69 57.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.87 -21.99 13.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 10.3 tp -56.32 -44.35 99.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.93 -65.63 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.686 2.257 . . . . 0.0 112.362 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.42 98.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 4.1 t60 -56.11 -49.24 74.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.0 mt -57.29 -27.4 62.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -55.58 -67.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.482 ' O ' ' C ' ' A' ' 242' ' ' SER . 5.6 p-10 -121.08 -52.02 2.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.1 t -31.54 -68.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.468 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.7 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.744 0.307 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -107.45 113.6 61.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 104.48 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.663 2.242 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.09 146.52 14.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.0 m -89.59 -26.44 20.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.18 -69.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.7 p -76.51 -4.2 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.0 p 49.57 39.13 16.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -121.31 164.59 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -93.97 128.04 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -137.92 160.59 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 205' ' ' ASP . 20.9 t -69.21 138.18 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.759 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.9 p90 -60.12 -35.56 75.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.557 ' H ' HG12 ' A' ' 203' ' ' VAL . 7.3 t0 -70.89 -15.92 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 203' ' ' VAL . 29.3 p -107.94 -20.97 13.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.8 tp -50.56 -17.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -78.21 -42.19 32.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 93.6 p -85.06 -44.44 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.3 t60 -44.28 -47.84 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -34.88 -36.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 210' ' ' HIS . 17.4 m-85 -75.6 -45.34 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 36.5 mt-30 -64.71 -47.68 77.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' A' ' 213' ' ' GLN . 11.7 t -34.12 112.69 0.42 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.7 Cg_endo -69.8 -50.79 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.9 mmm-85 -38.06 -30.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 215' ' ' PRO . 5.1 tp -61.17 132.26 92.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.56 0.695 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 140.41 42.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.386 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 219' ' ' VAL . 32.5 m -139.03 125.44 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.092 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.42 139.19 44.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.0 t -59.18 134.07 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.587 0.708 . . . . 0.0 110.93 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 1.13 4.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 224' ' ' GLN . 73.8 m-20 -121.3 9.0 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 223' ' ' ASN . 2.7 mp0 36.97 41.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.454 ' SG ' HG12 ' A' ' 227' ' ' VAL . 29.5 p -58.59 -47.41 84.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 151.46 -34.63 0.89 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.454 HG12 ' SG ' ' A' ' 225' ' ' CYS . 11.8 p -37.14 -37.1 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.38 -102.37 2.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.524 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 35.5 p -118.22 123.29 45.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.45 143.73 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.595 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -52.69 137.65 30.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -49.73 -54.74 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.9 pm0 -66.06 -4.58 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.595 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 5.7 m-20 -104.88 -13.79 15.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.631 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -61.07 -42.68 87.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.99 -64.06 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -56.4 -43.81 90.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -56.01 -56.22 23.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.9 mt -56.45 -14.29 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 1.3 tmmm? -64.88 -65.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 242' ' ' SER . 38.9 t0 -121.02 -51.75 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.2 m -35.46 -65.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.74 0.305 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -113.91 106.52 53.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 101.56 0.93 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 29.8 t -54.94 142.08 31.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.419 ' O ' HG22 ' A' ' 196' ' ' THR . 58.5 m -89.56 -13.5 37.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.32 -65.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 24.4 p -82.3 -2.64 53.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 25.2 p 48.94 37.61 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -104.83 -174.86 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -130.19 102.63 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -119.85 173.64 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.46 ' HB ' HG23 ' A' ' 206' ' ' THR . 5.5 t -73.1 144.09 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.942 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.6 p90 -59.17 -34.45 72.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.405 ' H ' HG12 ' A' ' 203' ' ' VAL . 22.2 t0 -69.0 -35.45 76.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.46 HG23 ' HB ' ' A' ' 203' ' ' VAL . 28.4 p -82.45 -32.15 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.942 HG22 ' O ' ' A' ' 204' ' ' PHE . 7.7 tp -48.87 -18.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -69.57 -47.9 62.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -88.29 -38.29 15.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 16.3 t60 -44.13 -51.29 8.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 51.8 mt-30 -34.3 -36.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 210' ' ' HIS . 28.2 m-85 -75.13 -46.31 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.5 mt-30 -62.9 -42.4 99.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.3 t -34.08 118.09 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.587 0.708 . . . . 0.0 110.889 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -49.44 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.266 . . . . 0.0 112.371 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -40.53 -37.76 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.6 tp -44.64 125.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 144.81 54.89 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 219' ' ' VAL . 30.6 m -139.83 126.28 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.95 141.99 37.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.061 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.0 t -67.05 134.87 93.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -16.32 37.57 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -96.18 -6.7 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 48.04 53.81 11.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 4.5 p -72.33 -54.05 10.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 159.61 -24.46 0.31 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 p -48.67 -22.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.16 -89.3 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.9 p -124.92 145.78 49.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.18 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.8 p -153.79 134.79 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.433 ' HB3' ' OD2' ' A' ' 234' ' ' ASP . . . -39.22 152.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -70.11 -32.14 70.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.45 -1.8 58.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.433 ' OD2' ' HB3' ' A' ' 231' ' ' ALA . 68.5 m-20 -114.18 -16.61 12.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 3.3 tp -61.76 -44.29 90.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 0.0 110.909 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.8 Cg_exo -48.01 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.667 2.244 . . . . 0.0 112.306 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.82 39.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.35 -51.1 56.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 235' ' ' LEU . 76.1 mt -57.71 -22.5 46.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -60.1 -63.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 242' ' ' SER . 17.0 t0 -125.3 -47.2 1.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.5 t -36.0 -66.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.93 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.736 0.303 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.612 ' O ' HD13 ' A' ' 207' ' ' ILE . 68.4 mt-30 -119.52 116.87 33.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.598 0.713 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 96.93 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 30.1 t -51.42 135.14 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 196' ' ' THR . 54.2 m -83.77 -11.36 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -86.14 -69.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.4 p -79.17 -0.79 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p 47.81 42.56 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -125.34 159.79 30.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -90.61 129.38 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -138.63 171.24 14.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -76.16 159.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -77.16 -30.46 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.05 -20.01 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 30.6 p -104.77 -49.04 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.0 tp -33.35 -34.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 14.4 mm-40 -57.18 -56.63 19.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -77.79 -42.52 33.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.6 t60 -43.7 -46.72 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 210' ' ' HIS . 41.8 mt-30 -35.45 -35.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 m-85 -80.41 -42.96 21.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.8 t -33.29 123.5 0.44 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.59 0.71 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -44.2 2.17 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.331 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -45.27 -40.3 7.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 tp -39.21 128.82 1.29 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 123.4 10.05 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.37 140.39 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.03 135.21 50.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.069 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 29.9 t -61.99 134.65 94.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.726 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -30.64 21.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.705 2.27 . . . . 0.0 112.368 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -81.17 -9.68 59.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 49.04 52.93 13.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 227' ' ' VAL . 11.2 p -71.38 -49.84 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 159.92 -39.14 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.538 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.463 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.6 p -33.77 -38.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.26 -87.74 0.98 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.473 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 11.9 p -127.62 146.35 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.093 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 231' ' ' ALA . 7.9 p -158.08 132.43 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.47 141.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -38.49 68.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -80.45 -3.31 49.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 6.7 m-20 -104.99 -16.79 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.9 tp -61.14 -42.69 87.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.726 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.97 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.731 2.287 . . . . 0.0 112.327 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.8 -23.88 59.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . 0.437 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 10.5 t60 -73.76 -47.14 41.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.4 mt -62.4 -11.16 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -77.27 -64.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 242' ' ' SER . 20.0 t0 -108.58 -63.1 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.7 m -33.16 -71.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.777 0.322 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.649 ' O ' HD13 ' A' ' 207' ' ' ILE . 25.2 mm100 -114.23 105.78 53.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.711 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.4 Cg_endo -69.74 105.41 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.39 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 4.9 t -55.23 123.87 15.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 196' ' ' THR . 20.8 m -76.76 3.77 11.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.6 -63.96 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.53 9.15 21.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.7 p 39.7 42.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -108.68 -175.44 2.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.8 107.24 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -124.62 158.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 206' ' ' THR . 4.7 t -61.35 128.43 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.2 p90 -40.55 -32.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.8 -43.42 65.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 203' ' ' VAL . 46.9 p -72.23 -42.93 65.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.163 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.6 tp -38.68 -29.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 206' ' ' THR . 0.5 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -72.84 -37.7 67.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLN . 19.5 t60 -49.68 -50.4 43.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 19.2 mt-30 -34.32 -45.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.901 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -62.51 -45.81 91.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' HIS . 31.0 mm100 -67.86 -50.79 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -34.39 110.64 0.39 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.9 Cg_endo -69.8 -43.72 2.46 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 215' ' ' PRO . 15.5 mmm180 -34.46 -40.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.2 tp -40.29 127.3 1.73 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.592 0.711 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.42 33.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.73 135.99 54.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.35 57.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 38.7 t -58.93 131.51 86.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -3.57 12.25 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.252 . . . . 0.0 112.339 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -104.86 -11.54 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 53.44 53.18 12.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.573 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.3 p -76.21 -48.02 21.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 152.86 -30.09 0.82 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.48 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.573 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -42.94 -24.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.53 -91.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -120.14 150.13 41.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.631 HG11 HD12 ' A' ' 235' ' ' LEU . 12.5 p -158.25 133.9 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.653 ' HB3' ' OD2' ' A' ' 234' ' ' ASP . . . -44.23 142.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.49 -49.4 70.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.05 6.74 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.653 ' OD2' ' HB3' ' A' ' 231' ' ' ALA . 9.4 m-20 -112.6 -14.73 13.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.631 HD12 HG11 ' A' ' 230' ' ' VAL . 11.1 tp -61.9 -43.56 87.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.544 0.688 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.99 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.27 . . . . 0.0 112.345 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.89 -34.83 61.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . 0.559 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 18.4 t60 -65.6 -61.24 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 243' ' ' CYS . 67.2 mt -49.07 -36.86 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -50.4 -67.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 7.8 p-10 -112.4 -57.2 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.452 ' HB3' ' CG ' ' A' ' 238' ' ' HIS . 5.5 t -33.81 -67.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.559 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.78 0.324 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.52 ' O ' HD13 ' A' ' 207' ' ' ILE . 97.9 mm-40 -108.21 109.73 61.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.03 2.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.705 2.27 . . . . 0.0 112.301 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.56 148.36 49.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.6 m -90.23 -29.23 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.37 -69.65 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.52 -3.44 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 34.8 p 46.0 45.84 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -119.26 -175.36 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -119.74 123.4 43.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -138.62 160.66 39.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.681 HG22 ' H ' ' A' ' 205' ' ' ASP . 10.0 p -80.35 143.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.088 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -51.86 -22.81 4.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.681 ' H ' HG22 ' A' ' 203' ' ' VAL . 0.6 OUTLIER -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 207' ' ' ILE . 76.7 p -99.29 -46.87 5.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.155 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 193' ' ' GLN . 4.8 tp -33.29 -38.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 26.2 mt-30 -54.39 -55.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.08 -44.37 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 9.7 t60 -39.67 -50.65 2.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 210' ' ' HIS . 49.5 mm-40 -32.62 -39.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' HIS . 6.9 m-85 -75.84 -46.76 28.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.8 mm-40 -59.34 -43.93 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -33.94 113.8 0.43 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.586 0.708 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -47.58 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.386 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 11.9 mmm180 -38.32 -37.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 216' ' ' ARG . 7.7 tp -37.92 130.7 0.94 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.587 0.708 . . . . 0.0 110.964 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 125.86 12.66 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.351 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 230' ' ' VAL . 18.9 m -122.29 136.02 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -67.29 139.54 57.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.34 130.61 94.23 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -12.46 32.85 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 0.0 112.321 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -96.46 -19.94 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 61.57 48.18 5.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.2 p -69.04 -52.11 32.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 162.83 -40.17 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 228' ' ' GLY . 11.5 p -36.03 -40.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 227' ' ' VAL . . . 95.56 -89.34 1.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.486 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 28.6 p -122.28 142.67 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.095 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 235' ' ' LEU . 12.9 p -153.87 139.32 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -41.43 138.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -52.9 -41.15 64.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.436 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.8 pt-20 -78.93 -11.77 60.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 6.1 m-20 -92.24 -25.36 18.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.599 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.1 tp -54.16 -43.92 97.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.587 0.708 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -48.0 -60.36 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.222 . . . . 0.0 112.358 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -64.01 -31.92 82.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 5.7 t60 -65.36 -52.02 56.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.39 -33.04 58.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -48.95 -66.6 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.3 p30 -121.39 -52.04 2.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.3 t -32.51 -67.78 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.5 t . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 42.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.748 0.308 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.516 ' O ' HD13 ' A' ' 207' ' ' ILE . 15.3 mm-40 -110.46 106.25 57.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 99.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 48.4 t -53.67 142.41 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 79.5 m -89.4 -20.33 24.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.444 ' CE2' HD12 ' A' ' 217' ' ' LEU . 13.7 m-85 -76.47 -65.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.93 -2.26 56.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.3 p 49.83 37.03 12.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -107.34 -174.45 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -130.21 112.9 13.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.404 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 75.9 m-85 -121.7 177.34 5.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 205' ' ' ASP . 60.4 t -80.27 123.11 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.3 p90 -39.63 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.73 ' H ' HG12 ' A' ' 203' ' ' VAL . 6.5 t70 -80.41 -40.06 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 203' ' ' VAL . 81.8 p -79.64 -47.35 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.1 tp -34.67 -31.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' THR . 32.8 mm-40 -53.12 -53.8 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -76.92 -47.39 21.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.2 t60 -40.93 -48.01 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 210' ' ' HIS . 9.3 mt-30 -33.73 -38.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 210' ' ' HIS . 10.6 m-85 -77.65 -44.92 26.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 210' ' ' HIS . 25.6 mm-40 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.467 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -32.65 116.5 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -46.42 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.627 2.218 . . . . 0.0 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . 0.431 ' NH1' ' OE2' ' A' ' 233' ' ' GLU . 26.8 mmt-85 -41.28 -34.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.444 HD12 ' CE2' ' A' ' 197' ' ' TYR . 7.8 tp -55.54 136.52 70.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.565 0.698 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 153.94 68.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.45 131.38 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.161 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.12 135.89 57.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 47.3 t -59.48 134.25 88.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -17.51 37.55 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -94.69 -6.54 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 49.06 51.3 16.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.547 ' SG ' HG12 ' A' ' 227' ' ' VAL . 22.8 p -74.37 -48.26 29.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 154.91 -30.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.494 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.547 HG12 ' SG ' ' A' ' 225' ' ' CYS . 4.4 p -38.58 -26.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.18 -84.33 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.9 p -132.37 145.62 51.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.459 ' CG1' HD12 ' A' ' 235' ' ' LEU . 12.1 p -158.05 129.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.06 143.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -62.41 -44.7 95.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.431 ' OE2' ' NH1' ' A' ' 216' ' ' ARG . 16.4 pt-20 -70.04 -2.53 13.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 4.5 m-20 -115.53 -12.54 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -58.17 -42.84 97.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.615 0.721 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.98 -65.83 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.49 -33.65 59.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 242' ' ' SER . 45.9 t60 -66.13 -50.16 64.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.5 mt -67.56 -25.51 65.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.988 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -56.39 -67.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.85 -32.38 0.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.456 ' O ' ' ND1' ' A' ' 238' ' ' HIS . 2.5 m -77.77 45.5 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 238' ' ' HIS . 17.8 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.753 0.311 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -107.43 103.92 50.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 100.58 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 199' ' ' THR . 51.5 t -52.26 149.62 5.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.4 m -90.59 -41.08 11.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.156 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.05 -70.12 0.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.5 p -75.26 -6.85 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.896 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' CYS . 22.7 p 49.71 39.71 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -113.04 174.2 6.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.866 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -109.08 121.78 45.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.82 174.25 10.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 205' ' ' ASP . 14.6 p -97.91 144.14 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.13 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -53.56 -21.94 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 203' ' ' VAL . 14.5 t70 -72.28 -27.0 62.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 208' ' ' GLN . 64.7 p -102.39 -43.08 5.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 206' ' ' THR . 3.7 tp -35.94 -30.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.9 mt-30 -62.17 -52.96 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -81.94 -38.78 24.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' A' ' 213' ' ' GLN . 18.9 t60 -49.19 -51.05 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.5 ' O ' HD22 ' A' ' 217' ' ' LEU . 24.9 mt-30 -33.74 -38.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' HIS . 54.9 m-85 -72.95 -48.22 38.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.1 mt-30 -62.87 -50.2 71.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.2 t -34.15 113.7 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.629 0.728 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.67 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 15.5 mmm180 -43.29 -41.15 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.7 HD12 ' HD2' ' A' ' 218' ' ' PRO . 11.8 tp -38.25 131.69 0.99 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.2 Cg_endo -69.79 139.43 40.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.667 2.245 . . . . 0.0 112.3 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.3 134.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -64.44 127.87 33.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.9 t -58.21 131.45 84.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -12.42 32.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -95.19 -18.02 21.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 61.55 49.55 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.68 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.3 p -68.74 -52.07 34.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 155.71 -35.18 0.63 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.512 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.68 HG12 ' SG ' ' A' ' 225' ' ' CYS . 5.1 p -38.47 -26.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 111.141 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.71 -71.97 2.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 64.9 p -145.97 147.25 31.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.138 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 10.1 p -154.13 144.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -47.64 134.87 12.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -51.7 -36.57 47.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.42 ' C ' ' OE1' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.65 -17.05 58.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.825 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.464 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.2 m-20 -91.37 -25.5 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.571 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -48.27 -45.96 66.73 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.1 Cg_exo -47.94 -60.8 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 0.0 112.371 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -65.96 -20.72 69.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -76.84 -50.46 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 26.2 mt -53.88 -22.5 10.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -56.26 -67.2 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.6 m-20 -127.15 -49.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 241' ' ' ASP . 22.0 m -31.5 -64.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.7 m 55.99 47.78 19.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 30.2 m 58.03 45.15 18.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -144.45 165.64 27.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 t -112.73 90.01 3.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.836 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.9 m -87.16 -59.05 2.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.44 97.7 2.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -96.22 106.09 18.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -65.06 157.12 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 38.6 p -115.2 141.6 47.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.425 ' O ' HD13 ' A' ' 207' ' ' ILE . 17.1 tm0? -114.12 117.97 42.88 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 104.85 1.38 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 12.5 t -57.52 135.47 56.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 196' ' ' THR . 81.9 m -82.4 -10.41 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -89.91 -69.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.0 p -79.67 4.33 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.8 p 42.76 37.06 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -118.51 160.62 21.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.37 130.85 37.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.98 170.12 16.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.81 127.76 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -46.13 -27.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.12 -35.0 66.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 207' ' ' ILE . 34.7 p -87.41 -50.71 6.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 208' ' ' GLN . 2.9 tp -33.54 -42.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 207' ' ' ILE . 92.7 mm-40 -49.76 -49.58 47.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.1 t -86.24 -45.3 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.484 ' O ' ' N ' ' A' ' 213' ' ' GLN . 11.0 t60 -45.28 -47.22 12.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mt-30 -34.74 -33.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.0 m-85 -78.91 -46.85 17.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.3 mm-40 -63.15 -45.48 91.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.435 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.9 t -35.34 120.49 0.62 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.627 0.727 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -50.44 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.69 2.26 . . . . 0.0 112.338 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -43.62 -40.91 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 tp -39.69 127.29 1.49 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.615 0.722 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 141.95 46.56 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.25 . . . . 0.0 112.345 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 230' ' ' VAL . 34.5 m -137.79 138.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -71.18 139.11 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.4 t -67.32 135.28 93.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.646 0.736 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -20.54 34.9 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -91.82 0.05 57.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 39.62 52.43 2.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.2 p -69.03 -51.53 38.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 159.12 -37.74 0.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.483 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.9 p -37.03 -33.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 90.99 -94.75 2.0 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 41.1 p -117.17 147.26 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 219' ' ' VAL . 11.6 p -157.14 131.77 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.63 146.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -58.92 -37.7 77.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.35 2.95 29.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.463 ' CB ' HG22 ' A' ' 230' ' ' VAL . 1.4 m-20 -109.24 -15.14 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.4 tp -65.17 -44.5 69.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.91 -62.68 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.327 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -61.02 -45.61 96.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -53.59 -48.28 69.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.358 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 247' ' ' LEU . 33.1 mt -59.37 -17.34 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 32.8 ttmt -62.41 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 15.7 p-10 -128.2 -45.97 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.5 m -34.54 -64.98 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t -45.44 155.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.81 -51.41 48.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 35.3 p -44.29 168.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -113.39 137.85 50.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 239' ' ' LEU . 56.0 mt -149.55 135.19 18.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 179.839 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 45.8 m -136.84 163.77 29.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 28.8 t -48.52 130.67 17.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -93.13 -112.66 2.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.9 m -105.46 91.26 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.85 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 92.7 p -104.5 162.4 13.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.811 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.03 -175.21 24.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -95.51 91.07 5.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.292 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.01 171.38 3.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 20.0 p -119.52 133.34 55.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 30.5 mt-30 -107.81 103.86 51.07 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.2 Cg_endo -69.72 99.9 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.649 2.233 . . . . 0.0 112.338 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.16 140.7 15.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.4 m -87.21 -22.97 24.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -73.58 -69.82 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.1 p -77.78 -4.21 45.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 51.36 38.98 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -112.29 179.99 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -115.9 121.89 43.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -137.38 175.02 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.53 154.36 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -62.73 -25.26 68.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -68.47 -17.6 64.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 208' ' ' GLN . 55.5 p -112.38 -42.76 3.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 206' ' ' THR . 4.6 tp -33.73 -33.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 206' ' ' THR . 16.3 mm100 -62.34 -49.95 73.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 t -84.49 -44.5 13.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 213' ' ' GLN . 38.1 t60 -45.02 -50.87 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -33.03 -36.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 210' ' ' HIS . 14.9 m-85 -79.98 -48.3 13.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.5 mt-30 -57.29 -44.28 83.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.9 t -33.74 116.05 0.46 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.67 0.748 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -46.91 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.69 2.26 . . . . 0.0 112.354 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -42.91 -25.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.18 132.23 31.88 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.575 0.702 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 137.45 35.49 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.689 2.26 . . . . 0.0 112.34 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 230' ' ' VAL . 17.0 m -136.1 140.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.37 132.32 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.107 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.56 136.89 96.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.653 0.739 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -32.8 18.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.703 2.269 . . . . 0.0 112.352 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -80.5 -4.15 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 45.05 47.89 9.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.549 ' SG ' HG12 ' A' ' 227' ' ' VAL . 13.4 p -64.93 -49.68 69.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 156.18 -37.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.549 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.5 p -34.34 -37.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.162 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.8 -75.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 81.7 p -136.4 150.58 48.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 219' ' ' VAL . 8.0 p -157.82 133.76 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.053 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.14 142.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ttt-85 -54.84 -43.94 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.21 6.55 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -113.96 -10.89 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.602 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 8.4 tp -66.41 -44.48 57.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.624 0.726 . . . . 0.0 110.914 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.98 -64.92 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -59.81 -47.79 89.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.439 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -51.09 -50.55 58.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.9 mt -59.92 -15.4 21.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 18.5 ttmt -69.64 -65.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' SER . 51.7 m-20 -123.34 -49.17 1.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.5 t -34.93 -69.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.6 t -48.92 146.25 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -67.59 109.33 3.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 246' ' ' ALA . 28.8 p -38.92 105.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 245' ' ' THR . . . -35.16 132.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.2 tt -114.89 104.38 11.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.8 t -125.23 144.23 50.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.878 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.9 p -149.66 170.72 18.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -163.97 -99.43 0.14 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.515 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.9 m -83.39 104.12 13.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 m 45.35 39.08 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.797 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 190' ' ' LYS . . . 72.16 -81.34 0.58 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.457 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 189' ' ' GLY . 28.6 mttp -37.4 122.37 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.323 . . . . 0.0 110.886 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 24.6 mtp85 -62.43 157.47 20.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 7.6 p -141.68 123.8 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -107.65 105.21 55.54 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.606 0.717 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 102.69 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.5 t -52.54 145.69 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.9 m -90.09 -26.5 20.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -69.52 -73.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.57 -4.11 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.3 p 54.08 31.3 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -100.88 -176.59 3.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -124.27 121.91 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.546 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 68.5 m-85 -136.15 152.36 50.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.675 HG23 ' H ' ' A' ' 206' ' ' THR . 18.9 m -76.0 139.35 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.6 p90 -43.72 -23.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 203' ' ' VAL . 5.7 t70 -72.85 -44.01 61.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.675 ' H ' HG23 ' A' ' 203' ' ' VAL . 66.5 p -84.41 -45.71 12.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.3 tp -34.02 -34.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 206' ' ' THR . 21.7 mt-30 -58.37 -56.88 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.956 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.3 m -75.01 -37.92 61.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.546 ' CE1' ' CE2' ' A' ' 202' ' ' PHE . 36.0 t60 -44.85 -49.21 10.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -34.14 -34.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.9 m-85 -78.88 -47.08 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 210' ' ' HIS . 13.5 mm-40 -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.8 t -34.41 109.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.4 Cg_endo -69.85 -50.64 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.273 . . . . 0.0 112.328 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 215' ' ' PRO . 12.7 mmt180 -36.79 -31.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.1 tp -52.23 135.88 40.36 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 138.34 37.74 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.361 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 219' ' ' VAL . 21.7 m -132.2 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.89 130.26 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.7 t -61.06 136.69 93.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.659 0.742 . . . . 0.0 110.834 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -29.6 23.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -83.68 -6.89 59.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 46.79 52.0 11.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.6 p -68.36 -51.54 43.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 161.2 -35.91 0.4 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.511 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.51 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.7 p -39.28 -26.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 111.143 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.43 -70.05 3.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 59.8 p -147.54 147.55 30.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.521 ' CG1' HD12 ' A' ' 235' ' ' LEU . 11.8 p -154.23 140.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -36.4 143.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.088 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.83 -39.14 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -81.88 3.22 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.677 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -115.54 -5.95 12.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.598 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.67 -44.51 80.64 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.586 0.708 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.99 -63.45 0.31 Allowed 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.684 2.256 . . . . 0.0 112.3 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.05 -29.07 61.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.46 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . 0.408 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 15.9 t60 -70.05 -54.87 11.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.886 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.11 -14.2 2.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.65 -66.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 24.0 t0 -106.78 -62.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 241' ' ' ASP . 54.9 m -34.44 -66.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t -68.97 133.69 48.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -106.77 94.22 5.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 22.0 m -54.2 124.92 17.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -121.37 38.03 4.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.481 ' C ' HD12 ' A' ' 247' ' ' LEU . 4.0 pp -145.75 167.96 21.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.416 ' C ' HD12 ' A' ' 247' ' ' LEU . 33.7 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 72.9 m -154.7 165.16 37.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.367 . . . . 0.0 110.831 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.7 t -111.66 -51.88 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.911 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 145.17 -44.14 0.9 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.458 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.0 m -73.05 118.23 15.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 110.848 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.1 m 54.14 40.9 32.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.07 164.54 24.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -70.46 135.6 48.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.567 ' HB2' ' CD1' ' A' ' 204' ' ' PHE . 4.2 mtp-105 -79.09 155.23 28.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.0 p -130.39 129.8 43.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.687 ' O ' HD13 ' A' ' 207' ' ' ILE . 1.9 tp60 -117.21 115.69 37.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.731 . . . . 0.0 110.874 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 109.67 2.37 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.0 t -53.3 123.08 10.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 196' ' ' THR . 40.2 m -74.89 4.2 6.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -104.07 -59.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.3 7.73 44.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 38.8 p 41.46 46.69 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -120.63 155.07 34.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.95 115.07 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -135.8 145.29 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.2 t -47.83 149.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.681 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.7 p90 -69.17 -28.97 66.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.61 -36.67 62.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLN . 69.5 p -82.69 -44.59 15.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 193' ' ' GLN . 4.1 tp -33.54 -34.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.6 mt-30 -65.91 -50.4 64.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 206' ' ' THR . 75.0 p -73.82 -40.65 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.9 t60 -58.54 -50.14 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 210' ' ' HIS . 8.1 mm-40 -33.95 -36.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 210' ' ' HIS . 32.4 m-85 -70.93 -49.38 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 210' ' ' HIS . 51.6 mt-30 -65.08 -42.84 93.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -33.82 123.72 0.48 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -49.5 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 0.0 112.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -41.6 -38.03 1.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 tp -45.58 134.09 6.16 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.588 0.709 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.13 39.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 0.0 112.328 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 230' ' ' VAL . 17.8 m -134.53 133.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.76 143.68 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.093 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.6 t -69.29 134.62 89.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.891 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -23.31 30.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.09 2.7 53.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 37.97 50.84 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 9.1 p -67.4 -48.81 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 157.62 -41.86 0.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 226' ' ' GLY . 12.6 p -33.82 -38.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 111.162 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.0 -97.38 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 16.6 p -112.67 146.02 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 0.0 111.195 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.565 HG11 HD12 ' A' ' 235' ' ' LEU . 11.3 p -157.54 130.98 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.144 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.49 145.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.424 ' HD3' ' C ' ' A' ' 232' ' ' ARG . 3.5 tmt_? -62.08 -33.58 74.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.62 -4.28 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.553 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 4.4 m-20 -106.05 -8.57 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.622 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.9 tp -68.89 -43.1 25.98 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.625 0.726 . . . . 0.0 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.0 Cg_exo -47.94 -65.34 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.377 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.33 -33.72 71.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.89 -51.85 62.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 58.4 mt -57.43 -18.85 20.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -63.16 -66.71 0.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.4 m-20 -125.76 -46.49 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 241' ' ' ASP . 17.1 m -35.02 -65.35 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.865 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.8 t -43.74 113.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.69 86.76 7.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -58.11 138.35 56.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -77.41 131.85 38.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.41 -43.41 75.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.093 179.863 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.0 p -55.54 -45.81 77.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.811 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 29.0 t -90.28 -46.78 8.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.03 -83.61 0.28 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.6 t -160.22 117.52 2.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 0.0 110.866 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.2 t -88.0 92.87 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 152.78 -48.52 0.54 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.497 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -131.19 139.36 49.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.81 0.338 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -108.31 161.15 15.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.4 p -110.35 138.98 46.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 21.9 mm-40 -112.59 103.31 55.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.634 0.73 . . . . 0.0 110.944 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.1 Cg_endo -69.72 105.77 1.54 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.343 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.4 t -56.41 136.51 53.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 m -84.12 -17.15 41.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -78.97 -69.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.7 p -79.1 -2.64 41.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p 50.33 42.56 26.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.173 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -117.17 177.57 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -111.16 115.4 29.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -137.98 144.0 40.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.3 156.23 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.616 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.5 p90 -63.75 -24.85 67.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.77 -27.97 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.5 p -99.09 -37.62 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 204' ' ' PHE . 5.2 tp -38.61 -27.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 206' ' ' THR . 13.5 mm100 -63.6 -56.36 16.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -79.98 -42.46 23.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.9 t60 -41.16 -48.87 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.849 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 35.8 mt-30 -35.2 -38.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.38 -44.33 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.3 mt-30 -63.42 -47.89 80.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -34.57 107.29 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.628 0.727 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.65 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.364 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt-85 -41.8 -30.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.0 tp -52.6 135.41 44.34 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.585 0.707 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 141.91 46.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.349 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.38 136.58 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.48 134.98 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.0 t -66.68 135.28 94.4 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.619 0.723 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.02 29.02 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.401 ' OD1' HG21 ' A' ' 245' ' ' THR . 40.0 m-80 -85.96 -1.88 57.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 40.98 53.93 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.641 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.4 p -71.66 -52.0 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 154.39 -28.42 0.69 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.458 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.641 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.3 p -44.03 -24.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.52 -96.28 1.93 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.4 p -116.39 145.19 43.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 231' ' ' ALA . 12.0 p -155.51 128.08 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.45 145.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -59.82 -40.68 89.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -80.62 6.1 13.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 1.2 m-20 -115.07 -8.14 12.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.629 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.2 tp -69.88 -42.56 18.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 0.0 110.946 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.3 Cg_exo -47.97 -64.3 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.35 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.35 -33.53 76.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.46 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . 0.403 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 15.0 t60 -64.25 -48.61 75.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.73 -19.62 51.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -62.24 -66.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' SER . 9.5 t0 -125.59 -45.41 1.78 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.7 t -35.63 -65.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.5 t -54.62 103.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -97.44 47.77 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.401 HG21 ' OD1' ' A' ' 223' ' ' ASN . 11.2 t -87.54 130.86 34.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 247' ' ' LEU . . . -89.1 -44.27 10.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 246' ' ' ALA . 1.5 tt 36.36 53.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 179.859 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.5 p -124.39 117.22 23.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.883 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 26.9 m 59.29 43.42 16.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -92.01 70.45 1.79 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.0 m -106.09 175.59 5.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 110.824 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 94.3 p -114.4 126.9 55.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.818 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.31 -152.24 18.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.474 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm 59.71 54.16 4.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 10.5 ttt-85 -62.69 169.64 3.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 18.6 p -122.8 138.7 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.76 116.2 54.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.409 ' HB3' ' CD ' ' A' ' 201' ' ' GLU . 53.9 Cg_endo -69.74 98.03 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 34.5 t -50.97 142.83 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 196' ' ' THR . 74.3 m -88.28 -16.26 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.164 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -83.39 -69.74 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.1 p -78.06 -2.71 38.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.5 p 50.42 30.97 4.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 61.8 mttt -103.76 -174.73 2.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 194' ' ' PRO . 19.8 mm-40 -129.47 120.59 25.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.16 177.02 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.17 155.64 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.12 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.7 p90 -71.18 -31.15 67.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -26.72 59.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 209' ' ' SER . 70.2 p -91.27 -42.94 10.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 204' ' ' PHE . 4.3 tp -33.46 -38.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 206' ' ' THR . 56.7 mm-40 -56.95 -49.69 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 206' ' ' THR . 50.3 p -76.93 -37.34 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 213' ' ' GLN . 20.8 t60 -52.54 -48.49 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 77.7 mt-30 -34.36 -36.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 210' ' ' HIS . 15.8 m-85 -76.59 -47.02 23.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 210' ' ' HIS . 56.1 mm-40 -62.37 -47.88 82.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -34.94 102.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.638 0.733 . . . . 0.0 110.856 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -46.77 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 -45.37 -29.91 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -45.89 125.28 6.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.682 2.254 . . . . 0.0 112.351 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 219' ' ' VAL . 15.8 m -123.92 126.79 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.45 132.82 54.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.74 135.59 92.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -23.75 30.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 0.0 112.372 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -92.11 0.14 57.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 39.8 54.99 2.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.1 p -71.27 -51.04 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 163.67 -34.22 0.29 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.422 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 p -42.49 -26.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.31 -65.84 3.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.468 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.5 p -146.24 146.51 30.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.87 0.367 . . . . 0.0 111.118 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 231' ' ' ALA . 14.8 p -157.77 135.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.12 142.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -56.11 -41.74 75.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -76.25 -10.47 59.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 35.1 m-20 -97.05 -13.59 22.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.851 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.608 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.7 tp -63.42 -44.53 82.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.94 -64.62 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 0.0 112.345 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -60.78 -29.96 71.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -67.83 -44.65 76.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 47.0 mt -63.85 -15.9 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -65.64 -66.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.5 t70 -124.84 -46.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 241' ' ' ASP . 1.8 t -34.99 -69.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.5 t -45.91 162.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -121.03 127.18 51.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 87.2 m -127.53 139.06 53.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -129.08 -35.69 1.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.99 150.18 43.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.11 179.842 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 50.5 m -152.39 137.0 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 110.837 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 53.7 p -123.74 176.46 6.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 119.72 -99.73 0.76 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.8 t -82.24 141.72 32.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.872 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -72.9 170.35 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.887 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -109.28 -64.39 0.55 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -90.26 150.23 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.938 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.93 162.73 12.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 66.5 p -134.81 138.37 44.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.586 ' OE1' HG21 ' A' ' 207' ' ' ILE . 2.2 pt20 -119.12 127.06 26.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.591 0.71 . . . . 0.0 110.972 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 102.38 1.01 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 31.4 t -50.62 143.99 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 196' ' ' THR . 17.0 m -86.58 -15.91 38.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -84.09 -70.49 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.9 p -77.2 -1.02 27.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.1 p 46.91 49.19 14.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -137.26 162.39 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.2 125.48 31.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -135.13 149.45 50.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 205' ' ' ASP . 16.8 t -62.08 144.39 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.0 p90 -66.82 -34.55 78.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.556 ' H ' HG12 ' A' ' 203' ' ' VAL . 37.7 t0 -73.24 -22.78 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.7 p -99.89 -25.33 14.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 204' ' ' PHE . 4.4 tp -52.45 -15.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.46 -47.52 32.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 m -86.83 -40.34 15.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 213' ' ' GLN . 10.7 t60 -44.42 -47.96 9.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 210' ' ' HIS . 18.1 mm-40 -35.96 -38.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -71.63 -44.97 63.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 210' ' ' HIS . 45.5 mt-30 -65.22 -40.66 94.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.8 t -34.65 112.33 0.43 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 214' ' ' CYS . 53.3 Cg_endo -69.83 -36.81 9.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.26 . . . . 0.0 112.28 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -55.62 -33.42 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tp -43.83 124.75 4.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.597 0.713 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 129.73 18.11 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.673 2.249 . . . . 0.0 112.364 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.77 130.03 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.54 132.64 54.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.68 133.15 93.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.578 0.704 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -10.67 29.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.24 . . . . 0.0 112.345 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -98.84 -5.06 31.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 45.13 54.27 7.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.595 ' SG ' HG12 ' A' ' 227' ' ' VAL . 3.6 p -73.44 -53.95 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 162.03 -37.04 0.37 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.595 HG12 ' SG ' ' A' ' 225' ' ' CYS . 4.4 p -39.5 -27.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 0.0 111.142 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 85.34 -73.32 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.46 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.4 p -134.5 149.36 50.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 111.135 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.608 HG11 HD12 ' A' ' 235' ' ' LEU . 13.6 p -156.47 126.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.01 143.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.38 -46.77 73.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.8 6.79 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 1.0 OUTLIER -113.64 -11.09 13.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.608 HD12 HG11 ' A' ' 230' ' ' VAL . 10.0 tp -67.23 -44.24 47.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.581 0.705 . . . . 0.0 110.897 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.5 Cg_exo -48.03 -59.68 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.693 2.262 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -64.02 -46.98 89.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -52.0 -49.71 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 55.5 mt -54.38 -19.34 5.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 6.0 tmtm? -61.52 -65.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 241' ' ' ASP . 37.8 t0 -127.23 -44.62 1.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 241' ' ' ASP . 19.9 m -35.51 -64.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.0 t -45.93 112.34 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -72.39 103.26 3.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 t -155.93 156.16 34.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.178 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 247' ' ' LEU . . . -62.94 104.92 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.677 ' H ' HD12 ' A' ' 247' ' ' LEU . 5.8 mp -35.91 -52.43 0.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.19 179.797 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.2 p -118.79 118.73 32.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.0 p -132.91 143.79 49.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -124.8 -88.35 0.77 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.514 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.8 p -132.42 -51.01 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.3 t -72.73 127.1 31.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -172.98 146.06 8.8 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.494 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -56.16 134.55 53.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -60.83 144.67 52.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.1 p -119.09 149.69 41.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -121.01 119.77 29.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.574 0.702 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 100.94 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.304 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 7.9 t -51.29 119.89 4.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 196' ' ' THR . 6.9 m -72.17 1.27 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -99.04 -58.11 2.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 18.3 p -97.81 3.58 49.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 58.2 p 47.3 36.6 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -113.07 147.38 37.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -85.97 119.78 26.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -132.95 166.37 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.623 ' HB ' HG23 ' A' ' 206' ' ' THR . 20.5 t -71.16 145.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.803 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.7 OUTLIER -61.74 -31.19 71.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 203' ' ' VAL . 6.0 t70 -74.04 -31.66 62.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.623 HG23 ' HB ' ' A' ' 203' ' ' VAL . 27.2 p -82.99 -40.37 20.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.0 tp -43.1 -22.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 206' ' ' THR . 18.2 mt-30 -68.07 -50.28 56.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 -41.88 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.482 ' O ' ' N ' ' A' ' 213' ' ' GLN . 44.1 t60 -40.42 -52.54 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.2 mt-30 -32.7 -41.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.19 -49.86 63.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.5 mt-30 -63.97 -47.97 78.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.451 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.0 t -33.93 116.98 0.49 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.603 0.716 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -47.04 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.462 ' CD ' ' OE2' ' A' ' 233' ' ' GLU . 11.0 mmm180 -43.27 -37.47 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 tp -44.06 133.58 4.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.607 0.718 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 130.47 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 219' ' ' VAL . 30.9 m -126.86 126.11 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.183 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.39 132.65 48.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.19 131.69 95.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.65 0.738 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -21.15 33.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.659 2.239 . . . . 0.0 112.337 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -86.56 -14.89 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 54.55 54.14 9.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 227' ' ' VAL . 5.9 p -73.83 -49.21 26.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 158.25 -36.95 0.52 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.524 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -39.19 -32.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 111.106 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.45 -67.15 3.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.495 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 61.5 p -144.49 143.84 31.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 111.118 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.419 ' CG1' HD12 ' A' ' 235' ' ' LEU . 11.1 p -153.42 136.11 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -45.54 134.84 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.108 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -52.6 -41.58 63.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.462 ' OE2' ' CD ' ' A' ' 216' ' ' ARG . 21.8 pt-20 -69.25 -14.58 63.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -107.22 10.6 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.6 tp -76.44 -44.59 3.39 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.2 Cg_exo -47.99 -65.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.635 2.223 . . . . 0.0 112.385 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.8 -29.39 58.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . 0.416 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 23.5 t60 -68.93 -56.22 8.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.84 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 51.4 mt -53.5 -29.29 35.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -66.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 242' ' ' SER . 2.8 m-20 -116.96 -58.38 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.5 ' C ' ' O ' ' A' ' 241' ' ' ASP . 6.0 t -29.38 -70.28 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.2 t -51.76 129.12 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 39.6 m-20 -98.84 96.79 8.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -77.37 145.87 37.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -104.82 141.53 36.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.73 152.56 23.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 248' ' ' VAL . 47.4 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 2.0 m -47.69 146.05 2.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.903 0.382 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 95.3 p -97.34 173.67 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 90.8 64.65 1.2 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.468 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 89.7 p -52.08 -45.19 64.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.844 0.354 . . . . 0.0 110.856 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.9 p -113.68 177.71 4.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -63.19 -148.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.505 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -148.18 120.06 8.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.882 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -61.09 133.51 56.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.6 p -110.73 140.46 45.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -107.35 109.98 62.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 200' ' ' LYS . 53.6 Cg_endo -69.79 99.72 0.77 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.7 t -52.35 144.81 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.7 m -89.72 -25.33 21.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.96 -69.17 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.84 -5.91 52.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 56.8 p 50.74 42.5 27.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 194' ' ' PRO . 25.0 mtmm -118.36 177.6 4.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -111.19 123.7 50.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -138.72 156.08 47.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 205' ' ' ASP . 9.5 p -76.31 140.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.682 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.0 p90 -53.11 -26.94 18.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 203' ' ' VAL . 16.5 t0 -65.43 -27.58 68.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 208' ' ' GLN . 71.3 p -104.17 -32.71 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.116 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 204' ' ' PHE . 8.8 tp -35.48 -30.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 206' ' ' THR . 27.6 mt-30 -66.48 -60.68 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 80.0 p -69.24 -43.53 73.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 213' ' ' GLN . 36.0 t60 -40.57 -50.17 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 210' ' ' HIS . 32.9 mt-30 -32.67 -37.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.8 m-85 -79.23 -46.36 17.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 210' ' ' HIS . 73.5 mt-30 -59.73 -47.14 86.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.446 ' C ' ' O ' ' A' ' 213' ' ' GLN . 6.2 t -34.04 117.93 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 110.925 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -50.9 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.34 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -39.05 -32.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.99 133.64 58.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.619 0.723 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 131.87 22.18 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.73 2.286 . . . . 0.0 112.347 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.36 144.32 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -79.4 138.7 37.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 18.7 t -59.74 135.4 89.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 0.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.15 19.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.327 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -76.96 -20.22 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 60.15 53.7 4.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.475 ' SG ' HG12 ' A' ' 227' ' ' VAL . 7.9 p -76.44 -50.75 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 160.28 -31.61 0.39 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.475 HG12 ' SG ' ' A' ' 225' ' ' CYS . 5.9 p -39.41 -25.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.913 0.387 . . . . 0.0 111.177 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 79.96 -93.12 1.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 39.9 p -118.6 147.09 44.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.773 0.32 . . . . 0.0 111.183 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.478 HG11 HD12 ' A' ' 235' ' ' LEU . 12.3 p -158.27 130.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -39.96 139.91 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.083 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -53.24 -44.72 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.61 -1.21 20.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 7.8 m-20 -106.0 -23.09 12.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.856 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.5 tp -54.55 -43.69 98.29 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.93 -62.38 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.676 2.251 . . . . 0.0 112.357 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.89 -30.67 70.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.526 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . 0.418 ' ND1' ' HB3' ' A' ' 242' ' ' SER . 18.4 t60 -68.01 -54.26 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.835 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 66.2 mt -55.44 -29.74 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -53.46 -67.07 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 242' ' ' SER . 36.2 t70 -121.13 -51.29 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.1 t -32.76 -69.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.3 t -52.96 160.51 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -100.47 123.3 44.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 72.7 p -83.22 147.17 28.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.85 170.25 16.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.58 100.92 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.085 179.906 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 2.1 t -140.61 113.15 8.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 87.6 p -55.92 168.61 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 168.66 168.05 30.18 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.434 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 m -157.55 105.07 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.8 t -100.93 139.9 35.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -79.03 -104.83 0.22 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -109.33 114.39 28.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.752 0.31 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -68.49 136.07 52.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 22.9 p -116.96 145.44 43.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.15 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.44 ' O ' HD13 ' A' ' 207' ' ' ILE . 0.5 OUTLIER -110.54 114.48 54.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 96.58 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 22.5 t -51.69 133.64 30.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 196' ' ' THR . 19.3 m -83.56 -10.86 58.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.179 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 217' ' ' LEU . 18.2 m-85 -86.3 -65.25 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 22.4 p -84.35 0.89 47.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 70.4 p 49.23 33.47 5.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 -174.84 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -127.91 125.96 40.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.41 170.86 15.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 205' ' ' ASP . 4.7 t -68.23 146.86 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.562 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.1 p90 -61.53 -25.78 67.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.435 ' H ' HG12 ' A' ' 203' ' ' VAL . 5.8 t70 -77.91 -43.7 29.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 70.6 p -73.7 -48.84 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 204' ' ' PHE . 2.8 tp -33.15 -35.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 23.7 mm100 -58.1 -54.58 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 206' ' ' THR . 1.7 m -78.76 -41.14 31.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.4 t60 -44.17 -46.65 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -36.37 -39.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -68.87 -43.32 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 mm100 -68.8 -41.67 78.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.1 t -35.1 113.17 0.47 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -47.19 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 0.0 112.369 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -42.48 -37.16 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 197' ' ' TYR . 8.4 tp -48.37 137.4 11.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.584 0.707 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.407 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.5 Cg_endo -69.84 141.8 45.9 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.307 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.76 129.57 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.135 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.73 133.79 56.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.68 133.12 89.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.652 0.739 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -12.64 33.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.224 . . . . 0.0 112.357 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -97.28 -8.89 28.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 50.26 50.37 18.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.582 ' SG ' HG12 ' A' ' 227' ' ' VAL . 7.7 p -70.72 -50.88 31.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 157.56 -34.87 0.54 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.504 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.582 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -41.45 -23.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.98 -98.46 2.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.7 p -115.61 147.59 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 111.1 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 235' ' ' LEU . 12.5 p -158.04 130.85 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.11 142.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -58.24 -41.72 84.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.53 -2.78 40.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 16.1 m-20 -103.42 -17.37 15.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.609 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -57.35 -44.55 99.69 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.667 0.746 . . . . 0.0 110.977 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.95 -65.66 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.677 2.251 . . . . 0.0 112.34 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.03 -23.86 57.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -74.05 -48.36 30.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 110.83 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.21 -13.1 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -66.87 -64.62 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 242' ' ' SER . 10.4 t70 -122.3 -53.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 241' ' ' ASP . 2.7 m -34.21 -69.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 3.1 t -49.86 176.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -148.59 164.2 34.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 48.9 p 45.74 42.13 8.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.58 88.39 3.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.098 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 247' ' ' LEU . 8.8 tt -73.27 -50.6 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.853 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.2 t -61.3 -57.14 13.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.35 . . . . 0.0 110.841 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 186' ' ' GLY . 12.4 t -98.57 107.74 20.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.848 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 185' ' ' SER . . . 36.22 -126.92 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.1 m -113.24 127.44 56.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.904 0.383 . . . . 0.0 110.865 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 70.3 m 49.68 40.16 19.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.57 -40.35 2.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.462 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -61.84 108.53 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -78.35 170.71 16.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 77.3 p -122.2 148.79 44.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.498 ' HG3' HD13 ' A' ' 207' ' ' ILE . 7.2 pt20 -113.96 122.57 34.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.578 0.704 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 99.33 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.713 2.275 . . . . 0.0 112.311 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 49.0 t -51.08 143.78 10.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.6 m -87.27 -26.05 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.402 ' HB2' ' SG ' ' A' ' 214' ' ' CYS . 15.7 m-85 -72.52 -69.97 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.1 p -77.06 -3.22 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 46.7 p 52.09 31.48 8.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -114.7 177.09 4.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -106.74 126.95 52.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -138.45 151.98 47.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.737 HG22 ' H ' ' A' ' 205' ' ' ASP . 11.1 p -76.9 133.41 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.477 ' CB ' ' NE2' ' A' ' 193' ' ' GLN . 2.2 p90 -50.45 -21.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.737 ' H ' HG22 ' A' ' 203' ' ' VAL . 1.1 t70 -68.16 -33.44 74.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.462 ' H ' HG13 ' A' ' 203' ' ' VAL . 46.0 p -101.83 -38.16 7.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.498 HD13 ' HG3' ' A' ' 193' ' ' GLN . 2.8 tp -33.35 -38.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 206' ' ' THR . 29.4 mm100 -55.71 -49.74 72.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 206' ' ' THR . 69.4 p -83.26 -38.49 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 211' ' ' GLN . 8.8 t60 -53.98 -45.71 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 210' ' ' HIS . 5.5 mt-30 -38.34 -38.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -72.11 -52.72 15.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 214' ' ' CYS . 15.4 mm100 -57.46 -51.18 70.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.456 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.9 t -33.83 107.53 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -41.9 3.84 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.689 2.259 . . . . 0.0 112.332 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -52.22 -38.26 57.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.567 HD12 ' HD2' ' A' ' 218' ' ' PRO . 3.7 tp -38.91 129.08 1.19 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.584 0.707 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.9 Cg_endo -69.69 134.23 27.63 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.713 2.276 . . . . 0.0 112.352 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 230' ' ' VAL . 15.7 m -129.25 136.61 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.85 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.6 t -63.72 135.17 96.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.643 0.735 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.529 ' HD3' HD21 ' A' ' 235' ' ' LEU . 53.7 Cg_endo -69.79 -33.36 16.61 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.33 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -79.46 -20.67 46.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 61.96 54.63 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 10.7 p -75.42 -49.85 17.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 160.95 -38.47 0.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.518 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 226' ' ' GLY . 9.2 p -34.25 -39.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 227' ' ' VAL . . . 95.47 -99.99 2.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.476 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -112.79 138.09 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 219' ' ' VAL . 14.8 p -150.13 134.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -35.3 143.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 46.8 ttt-85 -61.88 -39.86 93.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.49 2.38 29.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.605 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 30.5 m-20 -110.81 -12.98 14.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.3 tp -60.99 -43.36 90.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.96 -65.65 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.351 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -56.53 -28.58 56.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -70.14 -56.33 7.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.822 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.41 -32.24 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -50.39 -66.51 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 242' ' ' SER . 27.6 t70 -124.05 -49.3 1.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 241' ' ' ASP . 5.5 t -34.22 -68.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 6.2 t -49.93 108.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -132.23 81.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.3 t -80.43 -16.79 53.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -66.59 135.33 53.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.085 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.28 47.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.866 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.1 t -123.03 120.28 32.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.853 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 42.1 t -104.61 -51.24 3.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.34 -128.43 8.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.0 t -70.76 109.36 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 110.856 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.4 t -50.88 155.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.837 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.51 171.9 50.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -129.42 107.16 9.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 74.6 mtm-85 -63.67 146.59 53.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.9 p -111.2 151.14 28.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.66 ' O ' HD13 ' A' ' 207' ' ' ILE . 37.8 tt0 -118.43 108.97 40.88 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 0.0 110.922 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 102.83 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 6.9 t -52.91 120.19 5.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 196' ' ' THR . 24.3 m -72.84 2.78 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.401 ' O ' ' CZ ' ' A' ' 216' ' ' ARG . 5.5 m-85 -101.38 -64.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.951 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.0 p -89.04 5.69 43.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p 45.87 35.07 2.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -98.24 -174.57 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -131.57 103.58 6.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.75 176.09 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 205' ' ' ASP . 39.2 t -82.98 124.13 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.6 p90 -38.21 -29.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.598 ' H ' HG12 ' A' ' 203' ' ' VAL . 23.7 t0 -77.62 -42.21 35.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 203' ' ' VAL . 58.5 p -78.99 -50.81 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.3 tp -33.21 -42.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.151 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.464 ' N ' HG23 ' A' ' 207' ' ' ILE . 67.2 mm-40 -45.4 -57.42 4.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -71.32 -49.35 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 213' ' ' GLN . 14.2 t60 -40.52 -51.11 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.867 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 210' ' ' HIS . 46.5 mt-30 -32.86 -38.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 210' ' ' HIS . 19.7 m-85 -69.68 -49.04 57.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' HIS . 78.2 mm-40 -65.78 -45.46 82.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 213' ' ' GLN . 12.0 t -32.77 118.38 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.831 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.7 Cg_endo -69.79 -50.11 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.651 2.234 . . . . 0.0 112.356 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 215' ' ' PRO . 24.7 mmm-85 -34.29 -37.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 215' ' ' PRO . 6.9 tp -44.3 129.08 4.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.601 0.715 . . . . 0.0 110.901 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 138.97 39.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.353 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 219' ' ' VAL . 34.3 m -137.31 127.35 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.16 133.61 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 44.2 t -60.44 135.52 91.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -28.32 25.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -81.92 -7.81 59.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 48.39 53.42 12.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.613 ' SG ' HG12 ' A' ' 227' ' ' VAL . 9.4 p -72.79 -51.02 20.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 156.33 -35.15 0.6 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.536 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.613 HG12 ' SG ' ' A' ' 225' ' ' CYS . 6.7 p -37.68 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.148 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.85 -93.54 1.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.49 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 33.5 p -117.66 146.61 43.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.799 0.333 . . . . 0.0 111.126 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 235' ' ' LEU . 14.4 p -157.64 127.91 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -37.3 153.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -66.2 -43.83 85.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -78.47 7.15 7.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -14.32 11.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.62 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.4 tp -63.3 -43.58 80.41 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.599 0.714 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.5 Cg_exo -47.93 -65.44 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.729 2.286 . . . . 0.0 112.345 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.21 -25.63 57.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . 0.438 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 7.8 t60 -72.57 -52.77 14.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 110.817 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.43 -18.71 12.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -69.98 -63.86 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 242' ' ' SER . 11.2 t0 -115.31 -56.35 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 241' ' ' ASP . 20.0 m -34.06 -69.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 3.0 t -56.79 150.24 16.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -133.37 178.68 6.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.8 t 40.04 40.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -110.97 140.5 45.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.11 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 14.5 tp -51.07 -43.45 61.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 248' ' ' VAL . 8.4 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 t 49.69 42.41 23.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 110.845 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 56.0 p -115.11 132.23 56.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.76 -164.83 27.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.7 m -92.66 -48.37 6.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 110.781 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.4 t 40.15 41.96 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.67 146.77 5.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -123.66 131.48 53.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.703 0.287 . . . . 0.0 110.914 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -75.35 161.55 29.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 34.5 p -114.56 135.71 53.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 202' ' ' PHE . 29.9 tp60 -107.8 116.52 57.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.897 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 106.56 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.675 2.25 . . . . 0.0 112.315 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.17 138.44 56.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 196' ' ' THR . 4.8 m -86.25 -13.8 45.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.15 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.68 -64.38 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.914 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 14.2 p -85.93 -0.05 54.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 62.0 p 49.49 36.45 10.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -113.42 169.8 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -104.32 122.74 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 193' ' ' GLN . 73.1 m-85 -138.61 175.14 9.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.719 HG12 ' H ' ' A' ' 205' ' ' ASP . 23.5 t -73.72 144.8 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.746 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.5 p90 -64.67 -27.96 69.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.719 ' H ' HG12 ' A' ' 203' ' ' VAL . 22.6 t70 -76.07 -43.59 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 208' ' ' GLN . 52.8 p -73.97 -44.06 56.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.19 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.2 tp -33.67 -33.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 206' ' ' THR . 34.6 mm-40 -57.5 -58.43 8.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.7 m -77.45 -41.63 38.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 5.4 t60 -41.88 -46.43 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -38.52 -39.23 0.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -67.73 -39.76 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 55.3 mm-40 -73.8 -36.67 65.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 1.9 t -34.26 118.2 0.52 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.586 0.708 . . . . 0.0 110.903 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -24.43 29.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.657 2.238 . . . . 0.0 112.327 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -84.4 25.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 218' ' ' PRO . 5.4 tp -100.42 131.1 24.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.59 0.71 . . . . 0.0 110.923 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.532 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.8 Cg_endo -69.82 119.65 6.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.33 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.02 141.14 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.23 127.95 34.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 43.6 t -57.96 132.75 83.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.638 0.732 . . . . 0.0 110.928 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.505 ' HD3' HD21 ' A' ' 235' ' ' LEU . 53.4 Cg_endo -69.85 -12.14 32.13 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.698 2.265 . . . . 0.0 112.305 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -97.06 -8.42 30.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 47.71 53.06 11.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.407 ' SG ' HG12 ' A' ' 227' ' ' VAL . 4.2 p -73.12 -53.78 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 161.81 -32.13 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.407 HG12 ' SG ' ' A' ' 225' ' ' CYS . 11.4 p -44.54 -24.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 111.145 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.74 -81.05 1.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -132.55 148.75 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 231' ' ' ALA . 12.9 p -156.41 136.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -36.69 147.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -65.26 -30.53 71.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -86.76 -1.69 57.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.87 -21.99 13.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 10.3 tp -56.32 -44.35 99.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.0 Cg_exo -47.93 -65.63 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.686 2.257 . . . . 0.0 112.362 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.42 98.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 4.1 t60 -56.11 -49.24 74.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 19.0 mt -57.29 -27.4 62.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -55.58 -67.11 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.482 ' O ' ' C ' ' A' ' 242' ' ' SER . 5.6 p-10 -121.08 -52.02 2.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.1 t -31.54 -68.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.468 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.7 t -51.44 142.99 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -116.75 79.98 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.1 t -111.45 134.61 52.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.162 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -44.27 162.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.103 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -51.79 155.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 96.8 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.0 p -153.38 162.58 41.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.93 0.395 . . . . 0.0 110.825 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 42.2 m -137.24 148.06 46.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -144.8 49.97 0.66 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.0 p -80.11 163.1 24.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.884 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -109.61 89.42 3.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.4 -157.64 10.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -144.02 119.03 10.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.724 0.297 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -82.25 141.89 32.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.2 p -116.62 131.72 56.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -107.45 113.6 61.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 104.48 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.663 2.242 . . . . 0.0 112.356 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 43.1 t -54.09 146.52 14.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.0 m -89.59 -26.44 20.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.18 -69.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.7 p -76.51 -4.2 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 69.0 p 49.57 39.13 16.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -121.31 164.59 16.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.891 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -93.97 128.04 40.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -137.92 160.59 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 205' ' ' ASP . 20.9 t -69.21 138.18 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.759 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.9 p90 -60.12 -35.56 75.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.557 ' H ' HG12 ' A' ' 203' ' ' VAL . 7.3 t0 -70.89 -15.92 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 203' ' ' VAL . 29.3 p -107.94 -20.97 13.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.8 tp -50.56 -17.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -78.21 -42.19 32.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 93.6 p -85.06 -44.44 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.3 t60 -44.28 -47.84 9.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 210' ' ' HIS . 28.0 mt-30 -34.88 -36.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 210' ' ' HIS . 17.4 m-85 -75.6 -45.34 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 36.5 mt-30 -64.71 -47.68 77.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' A' ' 213' ' ' GLN . 11.7 t -34.12 112.69 0.42 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 217' ' ' LEU . 53.7 Cg_endo -69.8 -50.79 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.9 mmm-85 -38.06 -30.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 215' ' ' PRO . 5.1 tp -61.17 132.26 92.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.56 0.695 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 140.41 42.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.386 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 219' ' ' VAL . 32.5 m -139.03 125.44 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.092 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.42 139.19 44.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.0 t -59.18 134.07 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.587 0.708 . . . . 0.0 110.93 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 1.13 4.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 224' ' ' GLN . 73.8 m-20 -121.3 9.0 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 223' ' ' ASN . 2.7 mp0 36.97 41.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.454 ' SG ' HG12 ' A' ' 227' ' ' VAL . 29.5 p -58.59 -47.41 84.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 151.46 -34.63 0.89 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.454 HG12 ' SG ' ' A' ' 225' ' ' CYS . 11.8 p -37.14 -37.1 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.38 -102.37 2.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.524 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 35.5 p -118.22 123.29 45.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.45 143.73 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.595 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -52.69 137.65 30.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -49.73 -54.74 17.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 24.9 pm0 -66.06 -4.58 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.595 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 5.7 m-20 -104.88 -13.79 15.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.631 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -61.07 -42.68 87.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.628 0.728 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.9 Cg_exo -47.99 -64.06 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 240' ' ' LYS . . . -56.4 -43.81 90.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -56.01 -56.22 23.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.356 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.9 mt -56.45 -14.29 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 237' ' ' GLY . 1.3 tmmm? -64.88 -65.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 242' ' ' SER . 38.9 t0 -121.02 -51.75 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.2 m -35.46 -65.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 2.5 t -61.78 176.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -162.44 156.01 20.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 97.7 m -93.78 150.8 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . 45.95 43.55 10.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.573 HD23 ' C ' ' A' ' 247' ' ' LEU . 7.9 tt -95.88 131.83 41.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.436 ' N ' HD23 ' A' ' 247' ' ' LEU . 90.0 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.111 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 85.6 p -99.43 -24.39 14.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.341 . . . . 0.0 110.83 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 91.1 p -144.17 114.97 7.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 46.22 -116.77 2.38 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.453 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.1 t -65.77 171.78 4.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.883 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.6 t -54.62 115.12 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -55.32 -51.56 53.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -104.23 156.59 17.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -94.04 166.06 12.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 p -138.6 136.16 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -113.91 106.52 53.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 0.0 110.945 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 101.56 0.93 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.719 2.279 . . . . 0.0 112.312 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 29.8 t -54.94 142.08 31.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.419 ' O ' HG22 ' A' ' 196' ' ' THR . 58.5 m -89.56 -13.5 37.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.32 -65.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 24.4 p -82.3 -2.64 53.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 25.2 p 48.94 37.61 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -104.83 -174.86 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -130.19 102.63 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -119.85 173.64 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.46 ' HB ' HG23 ' A' ' 206' ' ' THR . 5.5 t -73.1 144.09 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.942 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.6 p90 -59.17 -34.45 72.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.405 ' H ' HG12 ' A' ' 203' ' ' VAL . 22.2 t0 -69.0 -35.45 76.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.46 HG23 ' HB ' ' A' ' 203' ' ' VAL . 28.4 p -82.45 -32.15 29.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.942 HG22 ' O ' ' A' ' 204' ' ' PHE . 7.7 tp -48.87 -18.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -69.57 -47.9 62.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -88.29 -38.29 15.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 213' ' ' GLN . 16.3 t60 -44.13 -51.29 8.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 210' ' ' HIS . 51.8 mt-30 -34.3 -36.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 210' ' ' HIS . 28.2 m-85 -75.13 -46.31 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.5 mt-30 -62.9 -42.4 99.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 213' ' ' GLN . 3.3 t -34.08 118.09 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.587 0.708 . . . . 0.0 110.889 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -49.44 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.266 . . . . 0.0 112.371 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -40.53 -37.76 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.6 tp -44.64 125.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 144.81 54.89 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.684 2.256 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 219' ' ' VAL . 30.6 m -139.83 126.28 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.95 141.99 37.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.061 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.0 t -67.05 134.87 93.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -16.32 37.57 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -96.18 -6.7 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 48.04 53.81 11.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 4.5 p -72.33 -54.05 10.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 159.61 -24.46 0.31 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 p -48.67 -22.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.16 -89.3 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.9 p -124.92 145.78 49.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.788 0.328 . . . . 0.0 111.18 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.8 p -153.79 134.79 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.433 ' HB3' ' OD2' ' A' ' 234' ' ' ASP . . . -39.22 152.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -70.11 -32.14 70.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.45 -1.8 58.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.433 ' OD2' ' HB3' ' A' ' 231' ' ' ALA . 68.5 m-20 -114.18 -16.61 12.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.606 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 3.3 tp -61.76 -44.29 90.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 0.0 110.909 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 66.8 Cg_exo -48.01 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.667 2.244 . . . . 0.0 112.306 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.82 39.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.35 -51.1 56.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 235' ' ' LEU . 76.1 mt -57.71 -22.5 46.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -60.1 -63.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 242' ' ' SER . 17.0 t0 -125.3 -47.2 1.75 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.5 t -36.0 -66.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.2 t -52.12 -46.92 65.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -95.48 87.36 4.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 32.2 p -38.64 -53.95 1.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -103.28 89.54 3.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.114 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 247' ' ' LEU . 1.1 tm? -123.13 -53.77 1.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 179.821 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 88.7 p -130.85 -48.99 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.876 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 1.6 t -61.2 135.95 57.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.63 -148.61 5.03 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.459 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.5 p 44.31 43.28 5.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 0.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.0 p -109.49 126.62 53.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -103.38 -52.84 0.9 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.54 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -54.28 130.11 37.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.87 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -76.51 168.94 19.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 39.2 p -126.84 143.84 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.612 ' O ' HD13 ' A' ' 207' ' ' ILE . 68.4 mt-30 -119.52 116.87 33.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.598 0.713 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 96.93 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 30.1 t -51.42 135.14 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 196' ' ' THR . 54.2 m -83.77 -11.36 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -86.14 -69.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 26.4 p -79.17 -0.79 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p 47.81 42.56 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.174 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -125.34 159.79 30.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -90.61 129.38 36.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -138.63 171.24 14.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -76.16 159.2 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -77.16 -30.46 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.917 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.05 -20.01 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 208' ' ' GLN . 30.6 p -104.77 -49.04 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.0 tp -33.35 -34.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 206' ' ' THR . 14.4 mm-40 -57.18 -56.63 19.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.95 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -77.79 -42.52 33.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 213' ' ' GLN . 12.6 t60 -43.7 -46.72 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 210' ' ' HIS . 41.8 mt-30 -35.45 -35.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 210' ' ' HIS . 11.6 m-85 -80.41 -42.96 21.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 210' ' ' HIS . 35.1 mt-30 -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.8 t -33.29 123.5 0.44 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.59 0.71 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -44.2 2.17 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.331 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -45.27 -40.3 7.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 tp -39.21 128.82 1.29 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 123.4 10.05 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.37 140.39 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.03 135.21 50.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.069 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 29.9 t -61.99 134.65 94.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.726 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -30.64 21.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.705 2.27 . . . . 0.0 112.368 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -81.17 -9.68 59.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 49.04 52.93 13.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 227' ' ' VAL . 11.2 p -71.38 -49.84 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 159.92 -39.14 0.46 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.538 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.463 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.6 p -33.77 -38.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 96.26 -87.74 0.98 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.473 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 11.9 p -127.62 146.35 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.093 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 231' ' ' ALA . 7.9 p -158.08 132.43 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -37.47 141.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -38.49 68.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -80.45 -3.31 49.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 6.7 m-20 -104.99 -16.79 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.637 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 12.9 tp -61.14 -42.69 87.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.726 . . . . 0.0 110.91 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -47.97 -65.71 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.731 2.287 . . . . 0.0 112.327 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -59.8 -23.88 59.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . 0.437 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 10.5 t60 -73.76 -47.14 41.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 41.4 mt -62.4 -11.16 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -77.27 -64.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 242' ' ' SER . 20.0 t0 -108.58 -63.1 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 241' ' ' ASP . 4.7 m -33.16 -71.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t -60.9 116.74 4.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -96.61 87.3 4.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.7 t -104.76 141.33 36.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.168 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . 46.82 27.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.3 mt -142.79 157.97 44.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 m -133.49 151.53 51.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 0.0 110.84 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 88.3 p -55.01 151.73 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.82 -98.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.4 m -155.49 115.61 3.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 0.0 110.86 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 93.3 p -112.14 41.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.11 -39.67 88.53 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.475 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -39.66 110.33 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.435 ' HB3' ' NH1' ' A' ' 191' ' ' ARG . 5.0 ptp180 -69.86 163.93 24.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 40.8 p -115.45 147.22 40.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.114 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.649 ' O ' HD13 ' A' ' 207' ' ' ILE . 25.2 mm100 -114.23 105.78 53.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.711 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.4 Cg_endo -69.74 105.41 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.39 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 4.9 t -55.23 123.87 15.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 196' ' ' THR . 20.8 m -76.76 3.77 11.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.6 -63.96 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.53 9.15 21.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.7 p 39.7 42.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -108.68 -175.44 2.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.8 107.24 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -124.62 158.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 206' ' ' THR . 4.7 t -61.35 128.43 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 207' ' ' ILE . 2.2 p90 -40.55 -32.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.8 -43.42 65.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 203' ' ' VAL . 46.9 p -72.23 -42.93 65.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.163 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 204' ' ' PHE . 3.6 tp -38.68 -29.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 206' ' ' THR . 0.5 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -72.84 -37.7 67.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLN . 19.5 t60 -49.68 -50.4 43.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 210' ' ' HIS . 19.2 mt-30 -34.32 -45.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.901 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -62.51 -45.81 91.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' HIS . 31.0 mm100 -67.86 -50.79 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.438 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.5 t -34.39 110.64 0.39 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 216' ' ' ARG . 53.9 Cg_endo -69.8 -43.72 2.46 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.652 2.235 . . . . 0.0 112.349 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 215' ' ' PRO . 15.5 mmm180 -34.46 -40.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.2 tp -40.29 127.3 1.73 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.592 0.711 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.42 33.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.73 135.99 54.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.35 57.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 38.7 t -58.93 131.51 86.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.631 0.729 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -3.57 12.25 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.252 . . . . 0.0 112.339 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -104.86 -11.54 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 53.44 53.18 12.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.573 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.3 p -76.21 -48.02 21.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 152.86 -30.09 0.82 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.48 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.573 HG12 ' SG ' ' A' ' 225' ' ' CYS . 7.3 p -42.94 -24.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 111.106 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.53 -91.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -120.14 150.13 41.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.631 HG11 HD12 ' A' ' 235' ' ' LEU . 12.5 p -158.25 133.9 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.653 ' HB3' ' OD2' ' A' ' 234' ' ' ASP . . . -44.23 142.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -54.49 -49.4 70.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.05 6.74 4.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.653 ' OD2' ' HB3' ' A' ' 231' ' ' ALA . 9.4 m-20 -112.6 -14.73 13.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.631 HD12 HG11 ' A' ' 230' ' ' VAL . 11.1 tp -61.9 -43.56 87.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.544 0.688 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.6 Cg_exo -47.99 -64.79 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.27 . . . . 0.0 112.345 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.89 -34.83 61.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.443 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . 0.559 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 18.4 t60 -65.6 -61.24 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 243' ' ' CYS . 67.2 mt -49.07 -36.86 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -50.4 -67.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' SER . 7.8 p-10 -112.4 -57.2 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.452 ' HB3' ' CG ' ' A' ' 238' ' ' HIS . 5.5 t -33.81 -67.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.559 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 1.8 t -66.47 167.07 11.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.848 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -108.96 103.68 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.3 p -120.05 112.53 19.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.55 41.05 1.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.4 tt -97.42 -62.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.11 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.4 m -128.19 106.7 9.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.795 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 13.6 t -115.56 146.27 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.65 52.79 0.89 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.548 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.5 t -51.21 127.86 20.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 0.0 110.83 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.4 m -166.87 127.52 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.865 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -143.23 102.69 0.29 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.38 156.69 29.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.53 147.89 39.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 33.0 p -110.27 141.78 42.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.52 ' O ' HD13 ' A' ' 207' ' ' ILE . 97.9 mm-40 -108.21 109.73 61.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 0.0 110.882 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.03 2.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.705 2.27 . . . . 0.0 112.301 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.56 148.36 49.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 92.6 m -90.23 -29.23 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.37 -69.65 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.52 -3.44 37.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 34.8 p 46.0 45.84 12.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -119.26 -175.36 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -119.74 123.4 43.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -138.62 160.66 39.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.681 HG22 ' H ' ' A' ' 205' ' ' ASP . 10.0 p -80.35 143.14 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.088 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -51.86 -22.81 4.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.681 ' H ' HG22 ' A' ' 203' ' ' VAL . 0.6 OUTLIER -70.76 -30.59 67.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 207' ' ' ILE . 76.7 p -99.29 -46.87 5.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.155 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 193' ' ' GLN . 4.8 tp -33.29 -38.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 206' ' ' THR . 26.2 mt-30 -54.39 -55.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.08 -44.37 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 213' ' ' GLN . 9.7 t60 -39.67 -50.65 2.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 210' ' ' HIS . 49.5 mm-40 -32.62 -39.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' HIS . 6.9 m-85 -75.84 -46.76 28.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 210' ' ' HIS . 34.8 mm-40 -59.34 -43.93 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.449 ' C ' ' O ' ' A' ' 213' ' ' GLN . 2.6 t -33.94 113.8 0.43 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.586 0.708 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -47.58 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.386 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 11.9 mmm180 -38.32 -37.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 216' ' ' ARG . 7.7 tp -37.92 130.7 0.94 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.587 0.708 . . . . 0.0 110.964 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 125.86 12.66 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.351 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 230' ' ' VAL . 18.9 m -122.29 136.02 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -67.29 139.54 57.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.34 130.61 94.23 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.726 . . . . 0.0 110.887 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -12.46 32.85 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 0.0 112.321 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -96.46 -19.94 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 61.57 48.18 5.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 7.2 p -69.04 -52.11 32.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 227' ' ' VAL . . . 162.83 -40.17 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.485 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 228' ' ' GLY . 11.5 p -36.03 -40.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 227' ' ' VAL . . . 95.56 -89.34 1.14 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.486 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 28.6 p -122.28 142.67 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.095 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 235' ' ' LEU . 12.9 p -153.87 139.32 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -41.43 138.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.083 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -52.9 -41.15 64.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.436 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.8 pt-20 -78.93 -11.77 60.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 6.1 m-20 -92.24 -25.36 18.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.599 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 11.1 tp -54.16 -43.92 97.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.587 0.708 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.2 Cg_exo -48.0 -60.36 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.222 . . . . 0.0 112.358 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -64.01 -31.92 82.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 243' ' ' CYS . 5.7 t60 -65.36 -52.02 56.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.4 mt -54.39 -33.04 58.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -48.95 -66.6 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.873 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' A' ' 242' ' ' SER . 3.3 p30 -121.39 -52.04 2.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASP . 3.3 t -32.51 -67.78 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 238' ' ' HIS . 4.5 t -54.47 155.25 4.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -128.55 87.93 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.2 m -95.74 107.32 19.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -169.31 129.79 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.088 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.1 mt 53.98 41.82 31.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.164 179.79 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 71.2 p -103.79 97.65 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 0.0 110.85 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 68.2 m -104.84 -56.59 2.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -122.47 -80.28 0.52 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.6 t -133.94 124.75 26.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.819 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.3 m -66.92 150.82 48.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 116.19 73.6 0.52 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.98 156.35 18.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 110.901 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -68.13 171.78 6.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 42.5 p -138.99 138.32 37.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.122 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.516 ' O ' HD13 ' A' ' 207' ' ' ILE . 15.3 mm-40 -110.46 106.25 57.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 99.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.699 2.266 . . . . 0.0 112.32 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 48.4 t -53.67 142.41 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 79.5 m -89.4 -20.33 24.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.185 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.444 ' CE2' HD12 ' A' ' 217' ' ' LEU . 13.7 m-85 -76.47 -65.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.93 -2.26 56.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 64.3 p 49.83 37.03 12.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -107.34 -174.45 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -130.21 112.9 13.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.404 ' CE2' ' CE1' ' A' ' 210' ' ' HIS . 75.9 m-85 -121.7 177.34 5.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 205' ' ' ASP . 60.4 t -80.27 123.11 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.131 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.3 p90 -39.63 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.73 ' H ' HG12 ' A' ' 203' ' ' VAL . 6.5 t70 -80.41 -40.06 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 203' ' ' VAL . 81.8 p -79.64 -47.35 15.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 193' ' ' GLN . 2.1 tp -34.67 -31.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 206' ' ' THR . 32.8 mm-40 -53.12 -53.8 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -76.92 -47.39 21.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' A' ' 213' ' ' GLN . 8.2 t60 -40.93 -48.01 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 210' ' ' HIS . 9.3 mt-30 -33.73 -38.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 210' ' ' HIS . 10.6 m-85 -77.65 -44.92 26.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 210' ' ' HIS . 25.6 mm-40 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.467 ' C ' ' O ' ' A' ' 213' ' ' GLN . 5.2 t -32.65 116.5 0.41 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -46.42 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.627 2.218 . . . . 0.0 112.323 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.431 ' NH1' ' OE2' ' A' ' 233' ' ' GLU . 26.8 mmt-85 -41.28 -34.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.444 HD12 ' CE2' ' A' ' 197' ' ' TYR . 7.8 tp -55.54 136.52 70.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.565 0.698 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 153.94 68.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.45 131.38 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.161 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.12 135.89 57.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 47.3 t -59.48 134.25 88.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -17.51 37.55 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -94.69 -6.54 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 49.06 51.3 16.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.547 ' SG ' HG12 ' A' ' 227' ' ' VAL . 22.8 p -74.37 -48.26 29.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 154.91 -30.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.494 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.547 HG12 ' SG ' ' A' ' 225' ' ' CYS . 4.4 p -38.58 -26.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 82.18 -84.33 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.9 p -132.37 145.62 51.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.459 ' CG1' HD12 ' A' ' 235' ' ' LEU . 12.1 p -158.05 129.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 230' ' ' VAL . . . -35.06 143.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -62.41 -44.7 95.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.431 ' OE2' ' NH1' ' A' ' 216' ' ' ARG . 16.4 pt-20 -70.04 -2.53 13.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 4.5 m-20 -115.53 -12.54 11.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 13.2 tp -58.17 -42.84 97.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.615 0.721 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 64.7 Cg_exo -47.98 -65.83 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 0.0 112.336 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -55.49 -33.65 59.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 242' ' ' SER . 45.9 t60 -66.13 -50.16 64.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.5 mt -67.56 -25.51 65.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.988 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -56.39 -67.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.85 -32.38 0.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.456 ' O ' ' ND1' ' A' ' 238' ' ' HIS . 2.5 m -77.77 45.5 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 245' ' ' THR . 17.8 t -153.24 107.41 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -37.32 93.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 243' ' ' CYS . 24.6 p -146.5 133.18 19.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -117.28 92.34 3.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.1 148.04 22.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.117 179.844 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 185' ' ' SER . 26.3 m -120.99 139.56 53.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 184' ' ' SER . 19.8 m -35.48 142.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -140.76 -152.6 5.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 77.7 p -104.36 168.13 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 110.882 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.0 t -153.72 139.63 18.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -173.01 -156.69 13.22 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -95.87 120.73 36.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 110.879 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -60.59 152.28 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 23.9 p -123.39 132.07 53.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.145 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -107.43 103.92 50.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.549 0.69 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 100.58 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.66 2.24 . . . . 0.0 112.368 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 199' ' ' THR . 51.5 t -52.26 149.62 5.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.4 m -90.59 -41.08 11.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.156 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.05 -70.12 0.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 29.5 p -75.26 -6.85 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.896 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' CYS . 22.7 p 49.71 39.71 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -113.04 174.2 6.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.866 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -109.08 121.78 45.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.82 174.25 10.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 205' ' ' ASP . 14.6 p -97.91 144.14 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.13 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -53.56 -21.94 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 203' ' ' VAL . 14.5 t70 -72.28 -27.0 62.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 208' ' ' GLN . 64.7 p -102.39 -43.08 5.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 206' ' ' THR . 3.7 tp -35.94 -30.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 206' ' ' THR . 25.9 mt-30 -62.17 -52.96 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.1 t -81.94 -38.78 24.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' A' ' 213' ' ' GLN . 18.9 t60 -49.19 -51.05 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.5 ' O ' HD22 ' A' ' 217' ' ' LEU . 24.9 mt-30 -33.74 -38.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' HIS . 54.9 m-85 -72.95 -48.22 38.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 210' ' ' HIS . 53.1 mt-30 -62.87 -50.2 71.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.448 ' C ' ' O ' ' A' ' 213' ' ' GLN . 8.2 t -34.15 113.7 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.629 0.728 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.67 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 217' ' ' LEU . 15.5 mmm180 -43.29 -41.15 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.7 HD12 ' HD2' ' A' ' 218' ' ' PRO . 11.8 tp -38.25 131.69 0.99 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.702 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 217' ' ' LEU . 53.2 Cg_endo -69.79 139.43 40.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.667 2.245 . . . . 0.0 112.3 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.3 134.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -64.44 127.87 33.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.9 t -58.21 131.45 84.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.595 0.712 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -12.42 32.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -95.19 -18.02 21.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 61.55 49.55 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.68 ' SG ' HG12 ' A' ' 227' ' ' VAL . 6.3 p -68.74 -52.07 34.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . 155.71 -35.18 0.63 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.512 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.68 HG12 ' SG ' ' A' ' 225' ' ' CYS . 5.1 p -38.47 -26.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 111.141 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 226' ' ' GLY . . . 87.71 -71.97 2.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 64.9 p -145.97 147.25 31.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.138 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 235' ' ' LEU . 10.1 p -154.13 144.16 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 234' ' ' ASP . . . -47.64 134.87 12.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -51.7 -36.57 47.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.42 ' C ' ' OE1' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.65 -17.05 58.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.825 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.464 ' C ' ' HD2' ' A' ' 236' ' ' PRO . 5.2 m-20 -91.37 -25.5 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.571 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 9.8 tp -48.27 -45.96 66.73 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 235' ' ' LEU . 65.1 Cg_exo -47.94 -60.8 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 0.0 112.371 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -65.96 -20.72 69.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -76.84 -50.46 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 26.2 mt -53.88 -22.5 10.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -56.26 -67.2 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 242' ' ' SER . 8.6 m-20 -127.15 -49.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.849 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 241' ' ' ASP . 22.0 m -31.5 -64.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 5.3 t -44.38 169.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -85.61 84.71 7.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 245' ' ' THR . 5.5 t -64.51 116.82 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.153 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 248' ' ' VAL . . . -173.36 141.9 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.12 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.9 mp 49.06 43.22 22.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 246' ' ' ALA . 91.4 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_